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ABSTRACT 
Neuropeptides are small molecules that originate as a result of cleavage of prohormones by 
convertases as well as other posttranslational modifications of the prohormones.  Neuropeptides 
are important for their roles in intercellular communication as well as regulation of many 
processes including growth, development, immune defense, and reproduction.  The use of 
sequence homology to annotate genes that code for neuropeptides in a species that have been 
sequenced recently, such as the pig, is not ideal because of the variability of posttranslational 
modification of prohormones, from which neuropeptides are derived.  So far only 40 
prohormones have been confirmed empirically in the pig, as a result of this incomplete 
knowledge, this study was undertaken to detect prohormones and convertases utilizing the recent 
release of the pig genome coupled with a proven bioinformatics pipeline.  Using 35 gene 
expression microarray experiments, prohormone and convertase genes that were identified were 
functionally annotated.  As a result, 95 unique prohormone genes, 2 alternative calcitonin-related 
sequences, 7 prohormone convertases and 1 cleavage facilitator were identified in the pig 
genome 10.2 assembly and trace archives.  The genome search performed identified 12 
prohormone genes that were previously unreported in the UniGene, UniProt, and Gene 
databases.  These genes are Intermedin (ADM2), Cortistatin (CORT), Insulin-like 5 (INSL5), 
Orexigenic neuropeptide QRFP (OX26), Prokineticin 2 (PROK2), Prolactin-releasing peptide 
(PRRP), neuropeptide S (NPS), Parathyroid hormone 2 (TIP39), Urocortin (UCN1), Urocortin 2 
(UCN2), Urocortin 3 (UCN3) and Urotensin 2 related peptide (UTS2B).  A UniProt record was 
found for Neuropeptide S, the result from our search, however, returned a more reliable result, as 
the existing entry was identical to the rabbit NPS.  Furthermore, the gene expression experiments 
analyzed were partitioned into seven separate categories with the categories of experiments 
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containing the most differentially expressed prohormone and convertase genes being immune 
response tissues, the embryo and placenta, and brain and central nervous system.  In the immune 
category, the general trend was for prohormone genes to be under-expressed when the pigs were 
immune challenged relative to the un-challenged control pigs.  There were two trends in the 
embryo and placenta category, one was for prohormone genes to be over-expressed in younger 
relative to older embryos while the other trend was for prohormone genes to be over-expressed 
in pregnant sows relative to their non-pregnant counterparts.  The tendency in the brain and 
central nervous system category was for prohormone genes to be over-expressed in neural tissue 
relative to non-neural tissue.  The cleavages of the prohormones were also predicted using a 
variety of models; the human cleavage prediction models provided the highest performance with 
a correct classification rate of 92% which suggests that prohormone processing in pigs is similar 
to that of humans.  These models also found no evidence for cleavage of CRSP2, UCN2, UCN3, 
TOR2X, TKN4, or IAPP to produce active peptides in the pig.  The genomic and functional 
characterization presented supports the use of the pig as an animal model that is effective in 
furthering the understanding of prohormones, convertases, and neuropeptides in biomedical and 
agricultural research. 
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 The Pig as a Model for Biomedical and Agricultural Research 
Research in the fields of agriculture and biomedicine has used the pig since before 1966, when 
Bustad and McClellan published a review of recent research.  This review showed that the pig 
was useful in areas such as genetic, dental, skeletal, and cardiovascular research and that projects 
had already started before that time to develop smaller pigs more tailored for biomedical 
research.  Aside from the adult pigs, piglets are also advantageous in terms of research into early 
human development (Book and Bustad, 1974).  These previous findings were confirmed in 
recent studies.  In a recent review, Butler et al. (2009) showed the development of the piglet as a 
model for the immune system and enumerated the characteristics that make it the optimal model.  
Among the positive characteristics were the large litters produced by pigs, which can be raised 
apart from the mothers to facilitate separate experimental and control groups, and ease of study 
of fetal development offered by the long gestation period.  Usefulness of the pig skeletal system 
has also been shown in a recent study that sought to determine the differences of using bypassed 
or non-bypassed cortical windows and their contribution to the risk of periprosthetic fracture 
(Wilson et al., 2011).  The authors used pig femurs in place of human femurs because the 
mechanical properties of both are comparable.  However, the morphology of the femurs is 
different, with the pig femur having a shorter length.  In another study, which was concerned 
with the polycystic kidney disease 1 (PKD1) gene, a PKD1 homolog from the pig was used to 
discover that,  through cloning and characterization of the homolog sequence, that the pig gene is 
highly similar to the human gene (He et al., 2011).  This gene was selected because mutations in 
it cause the majority of cases of autosomal dominant polycystic kidney disease (ADPKD) and 
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the pig was used because the mouse has shortcomings including a short lifespan that is not ideal 
for the study of ADPKD because the disease has a chronic nature.  The pig is useful in 
neurological studies because of the large brain it possesses, and is the species used most 
frequently in organ xenotransplantation (Sorensen et al., 2011 and Ekser et al., 2011).   
The use of pigs in agriculture also warrants extensive research, including the impact of pig 
farming on the environment (Basset-Mens and van der Werf, 2011).  Of further importance are 
transgenic pigs that could produce less phosphorus in their waste, healthier meat, and more live 
piglets (Niemann and Kues, 2007).  These techniques of increasing production of individual 
animals are important in contributing to the feasibility of overall production increase which is 
important to meet the demand for pork.  According to the National Pork Producers Council 
(NPPC), in November of 2011 the pork industry in the United States was on a course to set a 
new record for exports (http://nppc.org/uploadedfiles/CPR_OCT_NOV_11.pdf).  The demand 
for pork in the United States in 2012 is expected to increase because of beef and poultry supplies 
being smaller, this in conjunction with the projection that increase in production will be a result 
of more pigs produced per litter as opposed to herd expansion (http://www.porknetwork.com/ 
pork-news/latest/Swine-herd-expansion-modest-despite-return-to-profitability-137686823.html).  
These projections underscore the importance of furthering our understanding of the pig at the 
genomic level in order to optimize production and reduce negative environmental impact.  The 
pig is both an important model for biomedical research as well as a significant portion of the 
human diet worldwide.  These qualities make the pig an ideal candidate for further investigation. 
1.2 Pig Genome 
The Swine Genome Sequencing Consortium, which was formed in late 2003, released the 
Sscrofa9 genome sequence which was derived from BAC clones in 2009 (Archibald et al., 
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2010).  Sscrofa10, a bacterial artificial chromosome (BAC) and whole-genome shotgun (WGS) 
derived assembly, was released in 2011. BACs are a bacterial cloning system based on the E. 
coli F plasmid which has a low likelihood for recombination between DNA fragments it carries 
as a result of the low copy number of the F plasmid (Shizuya et al., 1992).  The bacterial DNA 
carrying F factors can be useful for cloning large fragments of DNA (Shizuya et al., 1992).  
Whole-genome shotgun sequencing is a method of determining nucleotide sequences in DNA 
that uses DNA polymerase as well as inhibitors to terminate synthesized chains (Sanger et al., 
1977).  DNA fragments of defined lengths are used to acquire reads which are assembled into 
contigs using overlapping sections of the sequence as a reference (Kaiser et al., 2003). The 
process was later modified by sequencing cloned inserts from both ends to get paired-end reads 
(Edwards et al., 1990).  This version contained redundancy and mapping errors which were 
corrected in Sscrofa10.2 which was released in early 2012 (http://www.ncbi.nlm.nih.gov/projects 
/genome/guide/pig/, http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid 
=9823, Archibald et al., 2010 and Schook et al., 2005).  The pig genome is diploid with 18 pairs 
of autosomes and 2 sex chromosomes for a total of 38 chromosomes, which is comparable to the 
human chromosome number.  The pig genome is about 3 billion base-pairs (or letters of genetic 
code) and is estimated to encompass approximately 24,000 protein-coding genes, a number 
similar to the human (http://www.sanger.ac.uk/about/press/2006/060116.html).  Among these 
genes, several hundred code for proteins and peptides that are involved in inter and intra cellular 
signaling. 
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1.3 Prohormones, Convertases and Neuropeptides 
Neuropeptides 
The messenger molecules that are involved in signaling between cells and control a variety of 
regulatory functions are called neuropeptides (Hummon et al., 2006).  Neuropeptides result from 
the process of cleavage via enzyme of larger prohormone precursor molecules and are generally 
between 3 and 40 amino acids long (Hook et al., 2008).  Neuropeptides include both peptide 
neurotransmitters and peptide hormones, although some neuropeptides function as both.  The 
term neuropeptides stems from the direct effects that these molecules have on neurons.  
However, neuropeptides act on non-neural organs and tissues in addition to neurons (Strand, 
1999).  As more is learned about neuropeptides, the better their functions are understood; the 
insight that  neuropeptides affect non-neural systems lead to awareness of one of the most 
important functions of neuropeptides, integration of the bodily systems with the function of the 
brain (Strand, 1999).  This integration is demonstrated by the involvement of neuropeptides in 
the regulation of reproduction; food and water intake; cardiovascular, gastrointestinal, and 
respiratory control; water and salt metabolism; temperature control; growth; and memory 
(Strand, 1999).  An example is vasoactive intestinal peptide (VIP) reported to be isolated in the 
1970s.  This neuropeptide was deemed unlike other peptides because it lacked glycine and 
proline residues (Said and Mutt, 1970).  Early classification of neuropeptides relied mostly on 
where these molecules were found, as a result the new peptide, which was isolated in the 
intestine of a pig, was named VIP.  Many neuropeptides have multiple roles; VIP is implicated in 
gastrointestinal secretion and vasodilation, as well as neuronal survival in the central nervous 
system (Strand, 1999).  More recently, VIP has been shown to have anti-inflammatory properties 
as well (Deldago et al., 2004; Szema et al., 2011).  Another neuropeptide, NPY, is very 
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important in the gastrointestinal tract and in obesity.  NPY also enhances memory processes in 
mice, is involved in regulation of the cardiovascular system, and has stimulatory effects on the 
neuroendocrine system (Strand, 1999). 
Prohormone Convertases 
Prohormone convertases are precursor processing endopeptidases that cleave the active segments 
from prohormones at single or paired basic residues (Strand, 1999).  Prohormone convertases are 
a family of proteases that are similar to subtilisin, a bacterial protease, based on strong 
evolutionary conservation demonstrated by extensive homology in the N-terminal sections 
(Strand, 1999).  All prohormone convertases have a p-domain, an approximate 150 residue long 
region located downstream of the catalytic segment that is necessary for the production of active 
convertases; a catalytic segment; a prosegment; and a signal peptide (Zhou et al., 1998; Strand, 
1999). 
Prohormones 
Neuropeptides are derived from the actions of prohormone convertases on prohormones.  A 
prohormone is inert following the removal of the signal peptide, the remaining prohormone can 
contain one or more copies of the neuropeptide which, in order to become active, would require 
processing.  Following separation from the signal peptide, the prohormone moves into the Golgi 
apparatus and further are sorted into granules from the trans-Golgi network.  It is within these 
granules that the proteolysis begins (Strand, 1999).  Prohormones have a variety of roles and are 
diverse in their size.  However, the size of the prohormone does not determine the size of the 
derived neuropeptide.  The enkephalins are an example, they are derived from proenkephalin 
which is a large prohormone and the resulting neuropeptides are only 5 amino acids in length 
(Strand, 1999).   
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1.4 The Central Dogma 
The presence of any active neuropeptide in sufficient amount to affect inter-cellular signaling 
depends on the presence of corresponding gene in the genome, the appropriate nucleotide 
sequence (polymorphisms or sequence variants can alter the transcription or translation), 
transcription into mRNA and subsequent translation into a prohormone sequence that results in 
neuropeptides after cleavage and post-translational modification.  This pipeline follows the 
ubiquitous central dogma of molecular biology.  The protein is only an end product, as the 
protein to protein, protein to RNA, and protein to DNA transfers were thought to be very 
unlikely (Crick, 1970).  This concept makes necessary the examination of both genes and 
proteins. The identification of genes and proteins in the genome and understanding of their role 
requires the consideration of multiple genomic and proteomic repositories and use of 
complementary bioinformatics tools.  
1.5 Repositories of Sequence Information 
UniProt.  The UniProt database (Universal Protein Resource, http://www.uniprot.org/) is the 
result of collaboration between the EBI (European Bioinformatics Institute), the Swiss Institute 
of Bioinformatics, and the PIR (Protein Information Resource).  UniProt is a centralized source 
of information on protein sequences, concentrating data that would otherwise be need to be 
found in a variety of large sources (The UniProt Consortium, 2010).  The database primarily 
significant to this study, UniProtKB (The UniProt Knowledgebase) is composed of two distinct 
sections UniProtKB/Swiss-Prot and UniProtKB/TrEMBL.  The Swiss-Prot section is made up of 
manually annotated records, while the TrEMBL section utilizes computer-assisted annotation.  
Two databases are required because of the volume of data that is generated.  The manual 
annotation process demands significant time and labor commitments, and cannot be expected to 
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contend with all the available data.  Therefore, a large portion of the new protein sequences need 
to be annotated automatically by computer in order to be publically available quickly (UniProt 
2012; http://www.uniprot.org/faq/7).  This process follows rules created using systems such as 
UniRule to annotate the translated sequences from EMBL, GenBank, and DDBJ (The UniProt 
Consortium 2010).  Automatically annotated records are later selected to be manually annotated 
with priority given to model organisms (Uniprot 2012, http://www.uniprot.org/program/).  The 
process of manual annotation follows the subsequent steps: sequence curation, sequence 
analysis, literature curation, family-based curation, evidence attribution, and quality assurance 
and integration of completed entries (UniProt 2012, http://www.uniprot.org/faq/45).  The manual 
annotations include information on function, associated diseases, tissue specificity, structure, 
isoforms, interactions, and posttranslational modifications (O’Donovan and Apweiler, 2011).  In 
this study, both sections of UniProtKB (release 2011_11) were considered. 
Gene.  The NCBI Gene database, also called Entrez Gene, is specific to gene information 
(Maglott et al., 2010).  This database focuses primarily on genomes that are sequenced in their 
entirety that also have ongoing research to provide additional data (NCBI 2011).  The data in the 
Gene database is the result of the Reference Sequence Projet (RefSeq) and uses unique 
identifiers (GeneID) for the loci and genes for specific organisms (Maglott et al., 2010).  As of 
November 2010, the Gene database contained information on 6.7 million genes that represents in 
excess of 6,700 organisms (Sayers et al., 2010).  The information that is consolidated includes 
chromosomal localization, associated markers and phenotypes, nomenclature, protein 
interactions and reports of pathways (Maglott et al., 2010). 
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UniGene.   The purpose of UniGene is to produce an organized view of the transcriptome.  This 
organization was necessary because the high redundancy of transcribed sequences makes using 
the data difficult (The NCBI Handbook, Ch. 21, http://www.ncbi.nlm.nih.gov/books/NBK2108 
3/).  The UniGene (http://www.ncbi.nlm.nih.gov/unigene, build #41) database contains mRNA 
sequences of genes that are well known as well as expressed sequence tag (EST) sequences.  
UniGene organizes this information into non-redundant clusters that are gene-oriented (Wheeler 
et al., 2003).  This is to say that each cluster represents a unique gene, known or putative, in the 
organism the sequences are from (NCBI 2012, http://www.ncbi.nlm.nih.gov/books/NBK21106/ 
def-item/app187/).  The procedures that UniGene is organized by are: removing foreign 
sequences, mitochondrial sequences, and rRNA from clusters; soft-masking repetitive sequences, 
allowing those sequences to be used in a sequence alignment although not to start a sequence 
alignment; and requiring clusters to be anchored at the 3’ end to help prevent multiple clusters 
being identified for one gene (The NCBI Handbook, Ch. 21).  The clusters also link to 
information on protein similarities, as well as tissues where the gene is expressed. 
GenBank.  The database GenBank (http://www.ncbi.nlm.nih.gov/genbank/) contains all public 
DNA sequences and is one third of the International Nucleotide Sequence Database 
Collaboration, which also includes DDBJ (the DNA DataBank of Japan) and ENA (the European 
Nucleotide Archive) (Benson et al., 2010).  GenBank is built from sequence data submitted by 
individual authors as well as EST (Expressed Sequence Tags) and other high-throughput data 
(Benson et al., 2010).  GenBank is organized into twenty divisions, eleven taxonomic divisions, 
seven high-throughput divisions, one PAT division with records from patent offices and one 
WGS division that constitute all sequences from whole genome shotgun projects (Benson et al., 
2010). 
9 
 
Genome.  The Genome database contains the most recent public build of the pig genome 
(Sscrofa10.2) along with the sequence and map data for over 1000 other genomes (NCBI 2011, 
http://www.ncbi.nlm.nih.gov/books/NBK3837/).  In late 2011 the Genome database was 
restructured to provide simpler navigation.  While the database previously contained separate 
records for strains and genome assemblies of organisms, the records are now consolidated by 
organism with all assemblies found in a central location.  Also included in the changes is that the 
database has expanded to include INSDC genomes as well as RefSeq genomes (NCBI 2011, 
http://www.ncbi.nlm.nih.gov/About/news/17Nov2011.html).  As of 2011, the Genome database 
contains complete genomes of 37 higher eukaryote species, and data obtained from more than 
1,100 genome sequencing projects.  The Map Viewer at NCBI can be used for a variety of 
applications within this database including displaying maps from multiple organisms or 
assemblies simultaneously in a single view (Sayers et al., 2012) 
Traces.  The Trace archive is a database that was established following the Human Genome 
Sequencing Project, as a result, traces of human origin account for only 12% of the database.  As 
of 2012, the Trace Archive has data from over 10,000 species including EST libraries, as well as 
shotgun and BAC clone projects (Sayers et al., 2012) 
EST.  Expressed sequence tags (ESTs) are small sections of cDNA that correspond to mRNA 
(Adams et al., 1991).  These cDNAs are produced by reverse transcribing mRNAs that are 
isolated on the basis of their 3’ poly-A tails (Parkinson and Blaxter, 2009).  After these cDNAs 
are cloned into a vector, single sequencing reactions are performed on some of the clones.  Low 
quality sequencing information and vector sequence contamination are removed using 
bioinformatics pipelines downstream of the sequencing reaction, and the resulting sequence is 
catalogued in the dbEST (http://www.ncbi.nlm.nih.gov/nucest) database (Parkinson and Blaxter, 
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2009).  The use of ESTs is beneficial both as an alternative process and complementary process 
to the more expensive procedure of full genome sequencing.  As of 2009, there were more than 
45 million ESTs generated from in excess of 1400 different species of Eukaryote (Parkinson and 
Blaxter, 2009).  The number of ESTs per cluster in different cDNA libraries should correlate to 
gene expression levels provided the libraries have not been normalized.  In non-normalized 
libraries, differential expression of genes between the libraries can be identified via statistical 
analysis, which is a useful alternative to approaches based on microarrays (Parkinson and 
Blaxter, 2009).  The dbEST database is then clustered using BLAST programs for the UniGene 
database. 
1.6 Tools to Identify and Characterize Sequences 
BLAST. The Basic Local Alignment Search Tool (BLAST) is a group of programs that 
calculates the statistical significance of a match of a sequence of a protein or a nucleotide to its 
respective sequence database (NCBI 2012 http://blast.ncbi.nlm.nih.gov/Blast.cgi).  Using 
maximal segment pair (MSP) score, which gauges local similarity of two sequences, and a 
heuristic approach, BLAST is able to find a relationship even if similarity occurs only in isolated 
sections of the sequence (Altschul et al., 1990). BLAST is similar to FASTA in that these two 
tools use a heuristic algorithm and search for words common to the sequences being used. 
However, BLAST filters the search by finding only those words that are most significant 
(Mount, 2007).  The comparison of two sequences for homology allows extrapolation of function 
from the known sequence to the unknown sequence.  Homology is assumed only when the 
statistical significance, expressed as an E-value, exceeds a predetermined threshold.  
ClustalW.  Clustal W is a multiple sequence alignment tool that can be used for multiple 
sequence or profile alignments (Thompson et al., 1994).  The basic method for alignment used in 
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Clustal W consists of three steps: initially, a distance matrix that shows the divergence of 
sequence pairs is calculated and, all sequence pairs are separately aligned; then the distance 
matrix is used to calculate a guide tree; finally the branching order in the guide tree is used to 
progressively align all sequences (Thompson et al., 1994).  Clustal W can be accessed online at 
the European Bioinformatics Institute (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
Wise2.  Wise2 is a tool used to parse gene sequence information using that GeneWise algorithm 
first detailed by Birney et al. in 2004.  The GeneWise model was made to integrate a gene 
prediction model and a protein homology model.  GeneWise allows comparison of one protein 
sequence to genomic DNA and accounts for sequencing errors and the known statistical 
properties of gene structures such as the poly(A) signal AAUAAA, the G+U rich site to 
recognize the poly(A) site at the beginning of the gene or the 3’ splice acceptor site that is always 
AG (Zhang, 2002; Birney et al., 2004). The GeneWise algorithm can be represented in two pair-
HMMs, the function of pair-HMMs is to convert one sequence of letters into another sequence. 
An example is the pair-HMMs S and T, where S maps letters from an alphabet A to letters in 
alphabet B, and T maps letters from alphabet B to letters in alphabet C.  This example is present 
in GeneWise with A being the genomic sequence, B being the predicted protein sequence, and C 
being the homologous protein sequence used to guide gene prediction (Birney et al., 2004).  The 
method the GeneWise uses to handle insertion and deletion errors is deliberately naïve, because 
correctly handling the errors is difficult and expensive from a calculation standpoint (Birney et 
al., 2004).  The GeneWise algorithm was developed by combining two highly accurate hidden 
Markov models (HMMs).Wise2 can be used to predict the gene, gene structure and associated 
protein on a region in the genome that could be identified using BLAST. 
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1.7 Prediction of Cleavage Sites in Prohormones 
Known-motif Model.  The known-motif model, which is detailed in Southey et al., (2006a), 
outlines five basic cleavage motifs.  These cleavage motifs are x-x-K-K, x-x-K-R, x-x-R-R, R-x-
x-K, and R-x-x-R where K, R, and x represent Lysine, Arginine, and any amino acid, 
respectively.  These motifs are found prior to cleavage sites, such that the cleavage would occur 
immediately after the last R or K.  The probability of cleavage is approximately 0.88 and 0.997 
when there were one and multiple motifs present, respectively (Southey et al., 2006).  Multiple 
motifs would be present simultaneously and not in sequence, such an instance could occur where 
x-x-K-K and R-x-x-K would combine to become R-x-K-K and give a 0.997 probability of 
cleavage. 
Logistic and Neural Network Models.  The use of a logistic regression model to predict 
cleavage sites was first proposed by Hummon et al. (2003) and applied to an Aplysia dataset.  
Amare et al. (2006) showed a logistic regression model that was more sensitive and for 
mammalian precursors.  As explained in Tegge et al. (2008) the probability of cleavage is 
denoted πi which applies to the ith window, while the regression coefficient βj corresponds to the 
jth model term (j=1 to p, amino acid or amino acid property at peri-cleavage locations) and xij 
represents the presence or absence of that jth model term in the ith window.  This is represented 
in the following binary logistic regression model: 
𝑙𝑜𝑔 �
𝜋𝑖1 − 𝜋𝑖� =�𝛽𝑗𝑥𝑖𝑗𝑝
𝑗=1
 
The human cleavage model is based on the human genome and the cleavage information is based 
on a large number of precursors and neuropeptides that have been confirmed (Tegge et al., 
2008). This level of information is also true of the mouse and the rat which are included in the 
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mammalian model along with the human, cow, and pig information. The use of models that 
include experimentally derived cleavage information helps avoid pitfalls of using sequence 
homology and motif finding in determining cleavage sites (Tegge et al., 2008). 
Neuropred.  Neuropred is a neuropeptide cleavage site prediction tool available on the internet 
at http://neuroproteomics.scs.uiuc.edu/neuropred.html (Southey et al., 2006b).  Neuropred uses 
known motif, and logistic regression models in order to predict cleavages and can also estimate 
the mass of the predicted peptides as well as calculate the accuracy of the model (Southey et al., 
2006b). 
1.8 Microarray Gene Expression Experiments 
A gene expression microarray is a platform in which a series of gene-specific probes are affixed 
to a substrate such as glass or plastic. This platform is used to analyze the expression of 
thousands of genes simultaneously.  The probes are segments of single stranded DNA which will 
hybridize to their complimentary DNA or RNA if that complimentary sequence is present in the 
sample added to the microarray (Trachtenberg et al., 2012).  The probes can be PCR products, 
oligos from 25 to 85 base pairs, or gene fragments (Trachtenberg et al., 2012).  Microarrays can 
use one or two dyes, these fluorescent labels are used to indicate the locations where the 
DNA/RNA from the sample has hybridized to the probe on the array.  Methods that use one dye 
consider transcripts from a single sample whereas two dye methods are used to examine 
differential expression of genes on one microarray by assigning one dye to the experimental 
group and the other dye to the control group.  Results derived from the one dye methods tend to 
be more consistent among replicates than the two dye methods (Trachtenberg et al., 2012; Kuo et 
al., 2006). 
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Affymetrix.  The Affymetrix in situ synthesized oligonucleotide arrays are widely used 
microarray platforms available for a wide range of species.  Affymetrix arrays are one dye 
platforms which have superior performance compared to two dye platforms as well as more 
consistent results compared to arrays produced in-house at academic institutions (Liu et al., 
2012).  There are several approaches to normalize data from microarray experiments including: 
RMA, GCRMA, quantile, and log2.  The log2 transformation normalizes microarray data that 
has a tendency to be skewed.  As the name implies, the log2 transformation involves taking the 
log2 of all values which results in a relatively normal distribution of data.  The log2 method has 
several drawbacks including the fact that it is a one-size-fits-all solution that ignores potential 
noise differences associated with separate runs (Lin et al., 2008).  Quantile normalization is used 
to make the distribution of data on the individual arrays identical.  The process involves 
standardizing data, arranging measurements on each array from lowest to highest, calculating a 
new distribution using the average of all arrays for each feature, and replacing all original 
measurements with newly calculated averages (Bolstad et al., 2003).  RMA (robust multichip 
analysis) is an additive model based on quantile normalized and background corrected PM s 
(perfect matches).  PMs are oligos that are exactly complementary to genes, while MMs 
(mismatches) are identical to PMs but have transversions in the middle.  This model can be 
represented as: 
𝑇�𝑃𝑀𝑖𝑗� = 𝑒𝑖 + 𝛼𝑗 + 𝜀𝑖𝑗 
In this model T represents the transformation to normalize, log, and background correct PM 
intensities; 𝑒𝑖represents the log2 value on the arrays; 𝛼𝑗 represents log affinity effects; and 𝜀𝑖𝑗 
represents the errors (Irizarry et al., 2003).  To estimate 𝑒𝑖, median polish, a robust linear 
regression, is used.  The GCRMA (GeneChip Robust Multichip average) is a model very similar 
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to and an improvement on RMA.  The difference between the models is that GCRMA considers 
the sequence specificity of the oligos in the background correction step (Binder et al., 2010).   
These normalizations are available the software suite Beehive (http://stagbeetle.animal.uiuc.edu/ 
Beehive/). 
1.9 Normalization and Analysis of Microarray Experiments 
Preprocessing, Normalization and Analysis 
Beehive.  Beehive (http://stagbeetle.animal.uiuc.edu/Beehive/) is a set of tools for management, 
statistical analysis, and query and interpretation of microarray experiment data.  Beehive can be 
used to preprocess and normalize the data gathered from microarray gene expression 
experiments as well as analyze them to determine which probes displayed differential 
expression.   The normalized gene expression data can be analyzed using ANOVA (analysis of 
variance) models.  ANOVA can be used to identify differential gene expression between levels 
of one (one-way ANOVA) or multiple factors such as tissue and age (multifactor 
ANOVA).ANOVA is useful in considering the possible multiple sources of variation in 
microarray experiments (Churchill, 2004).  The multifactor ANOVA model can be written as: 
𝑦𝑖𝑗𝑘 = 𝜇 + 𝑎𝑖 + 𝛽𝑗 + (𝛼𝛽)𝑖𝑗 + 𝜀𝑖𝑗𝑘 
in which 𝑦𝑖𝑗𝑘 is the response of the k
th subject to the ith level of factor α and the jth level of factor 
β; µ is the overall effect, 𝑎𝑖 is the effect of the i
th level of factor α; 𝛽𝑗 is the effect of the j
th level 
of factor ß, (𝛼𝛽)𝑖𝑗 is the interaction of factors α and ß; and 𝜀𝑖𝑗𝑘 is the error. 
Gene Expression Omnibus.  The Gene Expression Omnibus (GEO, 
http://www.ncbi.nlm.nih.gov/geo/) is a repository for gene expression data that was established 
in 2000.  GEO is the largest all public resource of gene expression data holding more than 
50,000 samples from over 100 organisms contributed by nearly 1,500 laboratories (Barrett and 
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Edgar, 2006).  The Affymetrix in situ oligonucleotide platforms was the most commonly used 
platform across multiple species including pig (GEO GPL3533) 
 
Current State of Pig Neuropeptide Research and Objectives 
 The pig is a biomedical model and neuropeptides have a major role in health, behavior 
and traits of agricultural importance.  Lines of research on neuropeptide that have been studied in 
pigs include defining the distribution of NPS and the corresponding receptor (NPSR), in which 
NPS was found to be highly expressed in the central nervous system and brain (Yao et al., 2009). 
A study to determine how ACTH responds differently to hemorrhage when several different 
anesthetics are used found that ACTH concentration increased when propofol or pentobarbitone 
were used but not when alphaxalone-alphadolone was used (Ruane-O’Hora et al., 2011). 
Examining the impact that both severe sepsis and hemofitration has on VIP concentrations in 
plasma and tissues, Kuncova et al. (2011) found that sepsis caused concentrations of VIP in the 
mesenteric artery and plasma to increase while simultaneously decreasing in the coronary artery.  
Kuncova et al. also determined that hemofiltration decreased VIP concentration in the mesenteric 
artery. A study in 2010 explored the effect that LEPR (leptin receptor) genotype has on 
expression of NPY, CART, and LEPR in the hypothalamus.  Ovilo et al. (2010) determined that 
NPY was over-expressed in the LEPR TT genotype in the Iberian-Duroc backcross, and that 
CART was under-expressed in the Iberian-Landrace backcross, the T allele having a negative 
additive effect.  Robich et al. (2010) examined the role NPY has in angiogenesis during chronic 
myocardial ischemia.  The result was that exogenous NPY improved myocardial function and 
up-regulated pro-angiogenic receptors, increasing angiogenesis and arteriogenesis.  Hausman et 
al. (2008) investigated the gene expression of NPY as well as other secreted factors in adipose 
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tissue.  In this experiment, in middle subcutaneous adipose tissue expression of NPY was 
decreased significantly with age.  Some understanding of the role of neuropeptides in the pig has 
been uncovered.  However, few prohormones that produce neuropeptides following the cleavage 
by prohormone convertases have been confirmed experimentally in the pig.  This situation can 
be resolved by integrating information from the recently released pig genome sequence with 
gene expression experiments and bioinformatics tools. The objectives of this study were: a) to 
identify prohormone and prohormone convertase genes in the pig genome, b) to functionally 
annotate the identified genes using gene expression microarray data, c) to predict the cleavage 
sites of prohormones and determining the resulting neuropeptides. 
  
18 
 
REFERENCES 
1. Bustad LK, McClellan RO: Swine in biomedical research. Science 1966, 152:1526-
1530.  
2. Book SA, Bustad LK: The fetal and neonatal pig in biomedical research. J Anim Sci 
1974, 38:997-1002.  
3. Butler JE, Lager KM, Splichal I, Francis D, Kacskovics I, Sinkora M, Wertz N, Sun J, 
Zhao Y, Brown WR, DeWald R, Dierks S, Muyldermans S, Lunney JK, McCray PB, 
Rogers CS, Welsh MJ, Navarro P, Klobasa F, Habe F, Ramsoondar J: The piglet as a 
model for B cell and immune system development. Vet Immunol Immunopathol 2009, 
128:147-170. 
4. Wilson LJ, Richards CJ, Irvine D, Tillie A, Crawford RW: Risk of periprosthetic femur 
fracture after anterior cortical bone windowing: a mechanical analysis of short 
versus long cemented stems in pigs. Acta Orthop 2011, 82:674-678. 
5. He J, Wang Q, Ye J, Hu X, Li N: Identification of porcine polycystic kidney disease 1 
(PKD1) gene: molecular cloning, expression profile, and implication in disease 
model. Gene 2011, 490:37-46. 
6. Sorensen JC, Nielsen MS, Rosendal F, Deding D, Ettrup KS, Jensen KN, Jorgensen RL, 
Glud AN, Meier K, Fitting LM, Moller A, Alstrup AK, Ostergaard L, Bjarkam CR: 
Development of neuromodulation treatments in a large animal model--do 
neurosurgeons dream of electric pigs? Prog Brain Res 2011, 194:97-103. 
7. Ekser B, Gridelli B, Veroux M, Cooper DK: Clinical pig liver xenotransplantation: 
how far do we have to go? Xenotransplantation 2011, 18:158-167. 
19 
 
8. Basset-Mens C, van der Werf H: Scenario-based environmental assessment of 
farming systems: the case of pig production in France.  Agriculture, Ecosystems & 
Environment 2011, 105:127-144. 
9. Niemann H, Kues WA: Transgenic farm animals: an update. Reprod Fertil Dev 2007, 
19:762-770. 
10. The National Pork Producers Council 
[http://nppc.org/uploadedfiles/CPR_OCT_NOV_11.pdf] 
11. Pork Network [http://www.porknetwork.com/pork-news/latest/Swine-herd-expansion-
modest-despite-return-to-profitability-137686823.html] 
12. Archibald AL, Bolund L, Churcher C, Fredholm M, Groenen MA, Harlizius B, Lee KT, 
Milan D, Rogers J, Rothschild MF, Uenishi H, Wang J, Schook LB, Swine Genome 
Sequencing Consortium: Pig genome sequence--analysis and publication strategy. 
BMC Genomics 2010, 11:438. 
13. Shizuya H, Birren B, Kim UJ, Mancino V, Slepak T, Tachiiri Y, Simon M: Cloning and 
stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia 
coli using an F-factor-based vector. Proc Natl Acad Sci U S A 1992, 89:8794-8797. 
14. Sanger F, Nicklen S, Coulson AR: DNA sequencing with chain-terminating inhibitors. 
Proc Natl Acad Sci U S A 1977, 74:5463-5467. 
15. Kaiser O, Bartels D, Bekel T, Goesmann A, Kespohl S, Puhler A, Meyer F: Whole 
genome shotgun sequencing guided by bioinformatics pipelines--an optimized 
approach for an established technique. J Biotechnol 2003, 106:121-133. 
20 
 
16. Edwards A, Voss H, Rice P, Civitello A, Stegemann J, Schwager C, Zimmermann J, 
Erfle H, Caskey CT, Ansorge W: Automated DNA sequencing of the human HPRT 
locus. Genomics 1990, 6:593-608. 
17. Pig Genome Resources [http://www.ncbi.nlm.nih.gov/projects/genome/guide/pig/] 
18. NCBI Map Viewer 
[http://www.ncbi.nlm.nih.gov/projects/mapview/map_search.cgi?taxid=9823] 
19. Schook LB, Beever JE, Rogers J, Humphray S, Archibald A, Chardon P, Milan D, 
Rohrer G, Eversole K: Swine Genome Sequencing Consortium (SGSC): a strategic 
roadmap for sequencing the pig genome. Comp Funct Genomics 2005, 6:251-255. 
20. Wellcome Trust Sanger Institute 
[http://www.sanger.ac.uk/about/press/2006/060116.html] 
21. Hummon AB, Amare A, Sweedler JV: Discovering new invertebrate neuropeptides 
using mass spectrometry. Mass Spectrom Rev 2006, 25:77-98.  
22. Hook V, Funkelstein L, Lu D, Bark S, Wegrzyn J, Hwang SR: Proteases for processing 
proneuropeptides into peptide neurotransmitters and hormones. Annu Rev 
Pharmacol Toxicol 2008, 48:393-423. 
23. Strand FL: Neuropeptides.  Massachusetts Institute of Technology, Cambridge, 
Massachusetts; 1999. 
24. Said SI, Mutt V: Polypeptide with broad biological activity: isolation from small 
intestine. Science 1970, 169:1217-1218.  
25. Delgado M, Pozo D, Ganea D: The significance of vasoactive intestinal peptide in 
immunomodulation. Pharmacol Rev 2004, 56:249-290. 
21 
 
26. Szema AM, Hamidi SA, Koller A, Martin DW: Vasoactive Intestinal Peptide 
Knockout (VIP KO) Mouse Model of Sulfite-Sensitive Asthma: Up-regulation of 
Novel Lung Carbonyl Reductase. BMC Immunol 2011, 12:66.  
27. Zhou A, Martin S, Lipkind G, LaMendola J, Steiner DF: Regulatory roles of the P 
domain of the subtilisin-like prohormone convertases. J Biol Chem 1998, 273:11107-
11114.  
28. Crick F: Central dogma of molecular biology. Nature 1970, 227:561-563.  
29. UniProt [http://www.uniprot.org/] 
30. UniProt Consortium: The Universal Protein Resource (UniProt) in 2010. Nucleic 
Acids Res 2010, 38:D142-8. 
31. UniProt [http://www.uniprot.org/faq/7] 
32. Uniprot [http://www.uniprot.org/program/]. 
33. UniProt [http://www.uniprot.org/faq/45] 
34. O'Donovan C, Apweiler R: A guide to UniProt for protein scientists. Methods Mol 
Biol 2011, 694:25-35. 
35. Maglott D, Ostell J, Pruitt KD, Tatusova T: Entrez Gene: gene-centered information at 
NCBI. Nucleic Acids Res 2011, 39:D52-7. 
36. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, Chetvernin V, 
Church DM, DiCuccio M, Federhen S, Feolo M, Fingerman IM, Geer LY, Helmberg W, 
Kapustin Y, Landsman D, Lipman DJ, Lu Z, Madden TL, Madej T, Maglott DR, 
Marchler-Bauer A, Miller V, Mizrachi I, Ostell J, Panchenko A, Phan L, Pruitt KD, 
Schuler GD, Sequeira E, Sherry ST, Shumway M, Sirotkin K, Slotta D, Souvorov A, 
Starchenko G, Tatusova TA, Wagner L, Wang Y, Wilbur WJ, Yaschenko E, Ye J: 
22 
 
Database resources of the National Center for Biotechnology Information. Nucleic 
Acids Res 2011, 39:D38-51. 
37. Pontius J, Wagner L, Schuler G: The NCBI Handbook, Ch. 21, 
[http://www.ncbi.nlm.nih.gov/books/NBK21083/] 
38. UniGene [http://www.ncbi.nlm.nih.gov/unigene]  
39. Wheeler DL, Church DM, Federhen S, Lash AE, Madden TL, Pontius JU, Schuler GD, 
Schriml LM, Sequeira E, Tatusova TA, Wagner L: Database resources of the National 
Center for Biotechnology. Nucleic Acids Res 2003, 31:28-33 
40. UniGene Cluster [http://www.ncbi.nlm.nih.gov/books/NBK21106/def-item/app187/] 
41. GenBank [http://www.ncbi.nlm.nih.gov/genbank/] 
42. Benson DA, Karsch-Mizrachi I, Lipman DJ, Ostell J, Sayers EW: GenBank. Nucleic 
Acids Res 2011, 39:D32-7. 
43. Entrez Help [http://www.ncbi.nlm.nih.gov/books/NBK3837/] 
44. NCBI [http://www.ncbi.nlm.nih.gov/About/news/17Nov2011.html] 
45. Sayers EW, Barrett T, Benson DA, Bolton E, Bryant SH, Canese K, Chetvernin V, 
Church DM, Dicuccio M, Federhen S, Feolo M, Fingerman IM, Geer LY, Helmberg W, 
Kapustin Y, Krasnov S, Landsman D, Lipman DJ, Lu Z, Madden TL, Madej T, Maglott 
DR, Marchler-Bauer A, Miller V, Karsch-Mizrachi I, Ostell J, Panchenko A, Phan L, 
Pruitt KD, Schuler GD, Sequeira E, Sherry ST, Shumway M, Sirotkin K, Slotta D, 
Souvorov A, Starchenko G, Tatusova TA, Wagner L, Wang Y, Wilbur WJ, Yaschenko E, 
Ye J: Database resources of the National Center for Biotechnology Information. 
Nucleic Acids Res 2012, 40:D13-25. 
23 
 
46. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril 
CR, Wu A, Olde B, Moreno RF: Complementary DNA sequencing: expressed 
sequence tags and human genome project. Science 1991, 252:1651-1656. 
47. Parkinson J, Blaxter M: Expressed sequence tags: an overview. Methods Mol Biol 
2009, 533:1-12. 
48. EST [http://www.ncbi.nlm.nih.gov/nucest] 
49. NCBI BLAST [http://blast.ncbi.nlm.nih.gov/Blast.cgi] 
50. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ: Basic local alignment search 
tool. J Mol Biol 1990, 215:403-410. 
51. Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: improving the sensitivity of 
progressive multiple sequence alignment through sequence weighting, position-
specific gap penalties and weight matrix choice. Nucleic Acids Res 1994, 22:4673-
4680. 
52. Clustal W- Multiple Sequence Alignment [http://www.ebi.ac.uk/Tools/msa/clustalw2/] 
53. Birney E, Clamp M, Durbin R: GeneWise and Genomewise. Genome Res 2004, 14:988-
995. 
54. Zhang MQ: Computational prediction of eukaryotic protein-coding genes. Nat Rev 
Genet 2002, 3:698-709. 
55. Southey BR, Amare A, Zimmerman TA, Rodriguez-Zas SL, Sweedler JV: NeuroPred: a 
tool to predict cleavage sites in neuropeptide precursors and provide the masses of 
the resulting peptides. Nucleic Acids Res 2006, 34:W267-72. 
56. Southey BR, Rodriguez-Zas SL, Sweedler JV: Prediction of neuropeptide prohormone 
cleavages with application to RFamides. Peptides 2006, 27:1087-1098. 
24 
 
57. Hummon AB, Hummon NP, Corbin RW, Li L, Vilim FS, Weiss KR, Sweedler JV: From 
precursor to final peptides: a statistical sequence-based approach to predicting 
prohormone processing. J Proteome Res 2003, 2:650-656. 
58. Amare A, Hummon AB, Southey BR, Zimmerman TA, Rodriguez-Zas SL, Sweedler JV: 
Bridging neuropeptidomics and genomics with bioinformatics: Prediction of 
mammalian neuropeptide prohormone processing. J Proteome Res 2006, 5:1162-
1167. 
59. Tegge AN, Southey BR, Sweedler JV, Rodriguez-Zas SL: Comparative analysis of 
neuropeptide cleavage sites in human, mouse, rat, and cattle. Mamm Genome 2008, 
19:106-120. 
60. Neuropred [http://neuroproteomics.scs.uiuc.edu/neuropred.html] 
61. Trachtenberg A, Robert J, Abdalla A, Fraser A, He S, Lacy J, Rivas-Morello C, Truong 
A, Hardiman G, Ohno-Machado L, Liu F, Hovig E, Kuo W: A Primer on the Current 
State of Microarray Technologies. In Next Generation Microarray Bioinformatics. 
Volume 802. Edited by Wang J. New York: Springer; 2012: 3-17. 
62. Kuo WP, Liu F, Trimarchi J, Punzo C, Lombardi M, Sarang J, Whipple ME, Maysuria 
M, Serikawa K, Lee SY, McCrann D, Kang J, Shearstone JR, Burke J, Park DJ, Wang X, 
Rector TL, Ricciardi-Castagnoli P, Perrin S, Choi S, Bumgarner R, Kim JH, Short 
GF,3rd, Freeman MW, Seed B, Jensen R, Church GM, Hovig E, Cepko CL, Park P, 
Ohno-Machado L, Jenssen TK: A sequence-oriented comparison of gene expression 
measurements across different hybridization-based technologies. Nat Biotechnol 
2006, 24:832-840. 
25 
 
63. Liu F, Kuo WP, Jenssen T, Hovig E: Performance Comparison of Multiple 
Microarray Platforms for Gene Expression Profiling. In Next Generation Microarray 
Bioinformatics. Volume 802. Edited by Wang J. New York: Springer; 2012:141-155. 
64. Lin SM, Du P, Huber W, Kibbe WA: Model-based variance-stabilizing 
transformation for Illumina microarray data. Nucleic Acids Res 2008, 36:e11. 
65. Bolstad BM, Irizarry RA, Astrand M, Speed TP: A comparison of normalization 
methods for high density oligonucleotide array data based on variance and bias. 
Bioinformatics 2003, 19:185-193. 
66. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of 
Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15. 
67. Binder H, Preibisch S, Berger H: Calibration of microarray gene-expression data. 
Methods Mol Biol 2010, 576:375-407. 
68. Beehive [http://stagbeetle.animal.uiuc.edu/Beehive/] 
69. Churchill GA: Using ANOVA to analyze microarray data. BioTechniques 2004, 
37:173-5, 177. 
70. GEO [http://www.ncbi.nlm.nih.gov/geo/] 
71. Barrett T, Edgar R: Gene expression omnibus: microarray data storage, submission, 
retrieval, and analysis. Methods Enzymol 2006, 411:352-369.  
72. Yao Y, Lin X, Su J, Yang G, Hou Y, Lei Z: Cloning and distribution of neuropeptide 
S and its receptor in the pig. Neuropeptides 2009, 43:465-481. 
73. Ruane-O'Hora T, Hall WJ, Markos F: The effect of alphaxalone-alphadolone, 
propofol, and pentobarbitone anaesthesia on the beta-endorphin and ACTH 
response to haemorrhage in the pig. Can J Physiol Pharmacol 2011, 89:521-526. 
26 
 
74. Kuncova J, Chvojka J, Sykora R, Sviglerova J, Stengl M, Nalos L, Krouzecky A, 
Matejovic M: Tissue concentrations of vasoactive intestinal peptide are affected by 
peritonitis-induced sepsis and hemofiltration in pigs. Physiol Res 2011, 60:531-540. 
75. Ovilo C, Fernandez A, Fernandez AI, Folch JM, Varona L, Benitez R, Nunez Y, 
Rodriguez C, Silio L: Hypothalamic expression of porcine leptin receptor (LEPR), 
neuropeptide Y (NPY), and cocaine- and amphetamine-regulated transcript 
(CART) genes is influenced by LEPR genotype. Mamm Genome 2010, 21:583-591. 
76. Robich MP, Matyal R, Chu LM, Feng J, Xu SH, Laham RJ, Hess PE, Bianchi C, Sellke 
FW: Effects of neuropeptide Y on collateral development in a swine model of 
chronic myocardial ischemia. J Mol Cell Cardiol 2010, 49:1022-1030. 
  
27 
 
CHAPTER 2: FIRST SURVEY AND FUNCTIONAL ANNOTATION OF 
PROHORMONE AND CONVERTASE GENES IN THE PIG 
2.1 Introduction 
In addition to its importance in livestock production, the pig is a well-established biomedical 
model to study human health due to the genomic, anatomic and physiologic similarities with 
humans.  A wide variety of human health traits including cancer, reproductive health, drug 
metabolism, wound healing, and cardiovascular disease have been successfully studied using the 
pig (Book and Bustad, 1974; Anzenbacherova et al., 2003; Sullivan et al., 2001; Kurahashi et al., 
2004). Underlying these and other important traits such as growth and development, stress, 
memory and substance abuse are neuropeptides, a class of cell-cell signaling peptides that have 
paracrine, endocrine, and autocrine effects (Fricker, 2005; Hook, 2008). Research in selected pig 
neuropeptides has offered insights into cell transplantation, nervous system diseases, and injury 
(Schwartz et al., 2005). For example, Yang et al. (2010) reported on the inhibitory effect of 
neuromedin S (NMS) on luteinizing hormone secretion which is mediated via melanocyte-
stimulating hormone (MSH) neurons in the hypothalamus-pituitary axis of ovariectomized pigs.  
Kaminski et al. (2010) concluded that orexin A and B, hypothalamic peptides involved in the 
control of food intake, sleep patterns, autonomic and neuroendocrine systems, may also affect 
reproductive functions through the influence on the hypothalamic-pituitary-ovarian axis in pigs.  
The identification of neuropeptides is a difficult process because neuropeptides are derived from 
larger prohormone proteins as a result of complex processing. The conversion of the large 
prohormone to one or multiple smaller neuropeptides involves cleavage by one or many 
prohormone convertases and additional post-translational modifications such as amidation and 
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glycosilation (Fricker et al., 2005).  This complex processing of prohormones into neuropeptides 
challenges the identification of neuropeptide genes across genomes solely based on sequence 
homology to better understood species (Fricker, 2005; Hook , 2008).   
Only 40 prohormone and two prohormone convertase genes have been empirically confirmed in 
the pig compared to approximately 100 genes identified in human, rat, mouse, cow and rhesus 
monkey (Southey et al., 2008; Southey et al., 2009; Tegge et al., 2008). This partial knowledge 
of the prohormone, prohormone convertase and associated neuropeptides in the pig is a critical 
shortcoming, especially considering the important role of pig in biomedical and agricultural 
research (Book and Bustad, 1974).  In addition, few gene expression studies have discussed the 
expression profile of prohormone or prohormone convertase genes.  Ross et al. (2007) found that 
estradiol treatment at day 9 of gestation was associated with changes in the expression of the 
prohormone neuromedin (NMB) in the endometrium of glits. Hausman et al., (2008) concluded 
that the expression of neuropeptide Y (NPY) was down-regulated with age in gilts ranging from 
90 to 210 days old.  
Understanding the role of neuropeptides in human and livestock traits using the pig as 
biomedical model requires a more comprehensive knowledge of the neuropeptide complement in 
the recently released pig genome (SScrofa 10.2v18, 
http://pre.ensembl.org/Sus_scrofa/Location/Genome). This understanding includes the 
identification of prohormone and prohormone convertase genes, prediction of cleavage sites in 
prohormones that may result in potentially bioactive neuropeptides, and characterization of gene 
expression and protein abundance across conditions to gain insights into the role of 
neuropeptides.  A complete survey of the prohormone and prohormone convertase genes in the 
pig is critical not only to support the interpretation of gene expression experiments and the 
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effectiveness of tandem mass spectrometry studies to identify neuropeptides (Li and Sweedler, 
2008). Functional annotation of these genes can be obtained by the analysis of the large number 
of gene expression experiments already available (e.g. Ross et al., 2009; Chen et al., 2009). To 
address the lack of a comprehensive understanding of the prohormone and prohormone 
convertase genes in the pig, we present the first comprehensive survey and functional annotation 
of these genes.  An all-inclusive catalogue of prohormone and prohormone convertase genes 
known in other species was used to search complementary pig genome databases.  These genes 
were then characterized by analyzing a large number of gene expression experiments across a 
wide range of conditions.  The potential cleavage sites of prohormones that can result in 
bioactive neuropeptides were predicted and compared to the cleavages based on known 
neuropeptide sequences. 
2.2 Methods 
Search for Pig Prohormone and Convertase Genes 
A registry of approximately 100 candidate mammalian prohormone and convertase genes was 
built from public proteomic and genomic databases (including NCBI Gene –release date 
September 2011, UniGene – release date April 13 2011, and UniProt –release 2011_11 
November 16, 2011) and a literature review (Amare et al, 2006; Southey et al., 2008; Southey et 
al., 2009; Delfino et al., 2010).  
Candidate genes were searched for in the pig genome 10.2 assembly using the bioinformatics 
pipeline developed by Southey et al. (2009). The protein sequence of each candidate gene in the 
registry was searched on the pig genome assembly using the NCBI BLAST (version 2.18) with 
default parameters settings (E-value < 10 and BLOSUM62 scoring matrix) and filtering disabled. 
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In addition, sequences not used in the pig genome assembly (including unassigned genomic 
regions, whole genome shotgun sequencing and trace archives) were searched when there was no 
suitable BLAST match to a candidate gene or when the alignment to the genome assembly 
suggested a missing genomic region. This strategy allowed the annotation of genomic regions 
that were partly or not included in the assembly.  
The BLAST matches were examined based on the alignment score and E-value to identify the 
most likely matches and genomic location of the corresponding prohormone. The identified pig 
genomic region that encompassed the BLAST match was further extended approximately 500 
base pairs to the 5' and 3' ends of the match. Matches were also screened for alignments to 
multiple homologous prohormone genes that could indicate gene duplication events in the pig 
genome. The gene parsing tool Wise2 was used to predict the protein sequence within the 
genome regions detected with BLAST (http://www.ebi.ac.uk/Wise2, Birney et al., 2004). In this 
study, Wise2 compared the target protein (preference was given to pig protein sequences, 
followed by human, cattle and other mammals) to the pig genomic DNA sequence identified by 
BLAST to infer the gene structure based on a model that includes introns and frameshift errors. 
Each predicted gene was compared to the UniProt (http://www.uniprot.org/) and NCBI Gene 
(http://www.ncbi.nlm.nih.gov/gene/)databases to assess the accuracy of the prediction based on 
previously reported pig genes. To further confirm the Wise2 predictions, the protein sequence 
predicted from the gene model was also compared to the corresponding published mammalian 
sequences using the multiple sequence alignment tool Clustalw 
(www.ebi.ac.uk/Tools/msa/clustalw2/). The predicted sequences were also searched against the 
pig EST database to confirm the presence of the predicted protein sequence. The EST database 
was also used to complete the protein sequence when the genome coverage was incomplete. 
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Functional Annotation of the Pig Prohormone and Convertase Genes 
A review of the pig microarray gene expression experiments available in the NCBI GEO 
database (http://www.ncbi.nlm.nih.gov/geo/) indicated that the Affymetrix Porcine Genome 
Array GPL3533 was the most commonly used platform 
(http://www.affymetrix.com/support/technical/byproduct.affx?product=porcine). The UniGene 
database was searched for sequences that represent prohormone and prohormone convertase 
genes. This information was used to identify the probes representing prohormone and 
prohormone convertase genes in the Affymetrix Porcine Genome platform.  
Thirty-five experiments were identified in GEO that used The Affymetrix Porcine Genome 
platform. Selected experiments had a minimum of 6 microarrays and a maximum of 80 
microarrays.  Table 1 summarizes the main features of these experiments.  The wide range of 
selected microarray experiments (Table 1) available supported a comprehensive characterization 
of the association of prohormone and associated neuropeptide and convertase genes with various 
biological processes.  
The experiments were grouped into 7 classes: primary immune-response tissues, embryo and 
placenta, brain and central nervous system, reproduction, muscle, fat, and gut. Within each class, 
the number of experiments including GEO series identification and tissue identification 
whenever multiple tissues were studied was immune was: 6 (GSE7313, GSE7314, GSE11787, 
GSE17492, GSE14758-mediastinal lymph nodes, and GSE14790), embryo and placenta: 5 
(GSE18467, GSE18641, GSE18343, GSE11853, and GSE12705), brain and nervous system: 5 
(GSE16855, GSE12604, GSE14739-hypothalamus, GSE14739-thyroid, and GSE14739-
adenohypophsis), reproduction: 2 (GSE11590, and GSE14739-gonads), muscle: 7 (GSE18653, 
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GSE19275, GSE8974, GSE14643, GSE15211, GSE21096, and GSE16348-skeletal muscle), fat: 
8 (GSE17309, GSE14373, GSE14739-fat, GSE9333, GSE18359-fat, GSE18359-liver, 
GSE13528-fat and GSE13528-liver) and gut: 2 (GSE14357 and GSE15256).  When experiments 
encompassed multiple tissues (GSE14739, GSE18359, GSE13528), the samples corresponding 
to each tissue were analyzed separately to facilitate the interpretation of results. 
 
The gene expression data was pre-processed and normalized using the Affy R package 
(http://www.biostat.jhsph.edu/~ririzarr/affy/). Steps included the log-2 transformation and GC-
robust multichip average normalization of the gene expression measurements.  All probes in the 
platform were analyzed using ANOVA to identify those that exhibited differential expression 
across the conditions studied. The false discovery rate (Benjamini and Hochberg, 1995) approach 
was used to adjust the statistical significance of the differential expression and account for 
multiple testing across all probes.  The normalization, one or two-way ANOVA and multiple test 
adjustment of the results were done using Beehive (http://stagbeetle.animal.uiuc.edu/Beehive). 
Due to the multiple probes analyzed, a minimum false discovery rate, multiple-test adjusted P-
value < 0.05 threshold (corresponds to an approximate unadjusted P-value < 0.005) and a 
minimum fold-change equal to 1.2 were used to identify differentially expressed prohormone 
and prohormone convertase genes. 
 
Prediction of Cleavage Sites 
The location of the cleavage in pig prohormone proteins that would result in potentially active 
neuropeptides was predicted using NeuroPred 
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(http://neuroproteomics.scs.uiuc.edu/neuropred.html; Southey et al., 2006a). Complete 
prohormone sequences from UniProt were used to predict cleavage in preference to the predicted 
sequences. In limited cases, EST sequences were combined with the genomic data and published 
partial sequences to predict the complete prohormone sequence. For example, for 
Chromogranin-A (CMGA), three Glutamic acids were missing in the genome-based predictions 
that were present in the corresponding Uniprot fragment sequence (P04404) and EST sequence 
EW261315 permitted the prediction of the complete pig CMGA protein sequence. The location 
of the potential cleavage sites in the pig prohormones were inferred by homology to human data. 
Complementary cleavage prediction models trained on confirmed cleavages from mammalian 
sequences (Amare et al. 2006; Southey et al., 2006b; Tegge et al., 2008) were used to predict 
cleavages in the pig prohormone sequences. These models included the known motif model that 
searches for sites with specific combinations of basic amino acid associated to reported 
cleavages in other species (Southey et al., 2006a), mammalian logistic regression (Amare et al., 
2006), and human logistic regression and artificial neural network models based on amino acids 
only or amino acids combined with the physicochemical properties of amino acids (Tegge et al., 
2008).  
Known or predicted cleavage sites on all 97 prohormone sequences were used to assess the 
performance of the models to predict cleavage. The “observed” cleavage sites known or inferred 
from homology to other species were compared to the cleavage sites predicted by the models. 
The counts of the true positives (number of correctly predicted cleaved sites), true negatives 
(number of correctly predicted non-cleaved sites), false positives (the number of incorrectly 
predicted cleaved sites) and false negatives (number of incorrectly predicted non-cleaved sites) 
or functions of the counts were used to assess the model performance. These measurements were 
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used to compute the correct classification rate (number of correctly predicted sites divided by the 
total number of all sites), sensitivity (number of true positives divided by the total number of 
cleaved sites), specificity (number of true negatives divided by the total number of non-cleaved 
sites), positive predictive power (number of true positives divided by the total number of sites 
predicted to be cleaved), negative predictive power (number of true negatives divided by the 
total number of sites predicted to not be cleaved), Mathew's correlation coefficient between 
observed and predicted cleavage. The area under the receiver operator characteristic or ROC 
curve relating sensitivity and 1 - specificity (Southey et al., 2006a) was also calculated where 
area values lower than 0.7 indicate poor model performance.  
 
2.3 Results and Discussion 
Pig Prohormone Genes 
A comprehensive catalogue of 95 potential pig prohormone genes, 7 prohormone convertase 
genes and one prohormone convertase facilitator gene (7B2) were identified in the pig genome.  
Table 2 lists the genes and the corresponding BLAST matches on the pig Genome, UniProt, and 
UniGene databases. Our search enabled the detection of 11 previously unreported (i.e. without 
empirical confirmation) prohormone genes in pig and complete sequences when only partially or 
incomplete sequences have been previously reported.  Newly identified genes included 
intermedin (ADM2), cortistatin (CORT), insulin-like 5 (INSL5), orexigenic neuropeptide QRFP 
(OX26), prokineticin 2 (PROK2), prolactin-releasing peptide (PRRP), parathyroid hormone 2 
(TIP39), urocortin (UCN1), urocortin 2 (UCN2), urocortin 3 (UCN3), and urotensin II-related 
peptide (UTS2B).  Our search also identified two different calcitonin protein entries in public 
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databases that are isoforms of other calcitonin genes.  Additional information on the 
comprehensive catalogue of genes is available in supplementary material Table S1. The 
predicted prohormone sequences and corresponding prohormone cleavage predictions are 
available at http://neuroproteomics.scs.uiuc.edu/neuropred.html. 
The genome predicted prohormone genes had 63 UniProt entries (Table 3) and 74 NCBI Gene 
entries on the database releases studied. All UniProt entries were present in Gene database with 
three exceptions: gastrin-releasing peptide (GRP), neuromedin-U (NMU), and prothyroliberin 
(TRH). For these three cases, “-like” versions of these prohormone genes were present in the 
Gene database.  Of the prohormones available in UniProt, 48 sequences had evidence at the 
protein level, 14 sequences had evidence at the transcript level, and 4 were inferred by 
homology. With 14 exceptions, all the prohormone genes present in the Gene database had a 
corresponding record in UniGene.  The exceptions are ADM2, apelin (APEL), CORT, 
endothelin-2 (EDN2), progonadoliberin-2 (GON2), INSL5, OX26, PRRP, TIP39, prothyroliberin 
(TRH), UCN1, UCN2, UCN3, and UTS2B. The absence of UniGene entries stems from the lack 
of ESTs information for these genes.  However, Saida et al. (2004) has reported the nucleic and 
protein sequence of EDN2 have been reported.  
Table 3 compares the evidence of the 95 unique prohormone genes and two alternative 
sequences (Preprocalcitonin gene-related peptide and Calcitonin-2) to previously published 
UniProt evidence. Of our 79 complete genome identifications, 41 and 14 sequences have been 
previously reported in UniProt as complete and fragment sequences, respectively. Additionally 
17 complete genome identifications had other experimental support including, ESTs, UniGene 
clusters or reported sequences that have not been assigned to a UniGene cluster and 10 
predictions had no external validation (Tables 2 and 3). In addition, 4 incomplete predictions had 
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complete UniProt sequences, 3 incomplete predictions had partial UniProt sequence, 4 
incomplete predictions has experimental support but no UniProt entry, and 1 incomplete 
prediction (EDN2) has been reported but is not in present in public databases.  A partial match to 
UCN1 was found in the trace archives but was not found in the current assembly and lacks any 
external validation.  Progonadoliberin-2 (GON2) was not matched in the current pig genome 
assembly but was matched in earlier revisions and trace archives and has no current experimental 
evidence outside homology to other mammalian species. The apparent lack of UCN1 and GON2 
in the assembly and fragment evidence of other prohormones is most likely due to poor coverage 
of the genomic regions where these prohormone genes are located. 
 
At least four calcitonin (CALCs) genes, also known as or calcitonin receptor-stimulating peptide 
genes (CRSPs), were identified with two genes exhibiting alternative splicing. The genome 
permitted the assignment of the UniProt pre-procalcitonin (A6P7L6) and preprocalcitonin gene-
related peptide (A6P7L7) entries to the same gene that also produces the UniProt calcitonin 
(CALC, P01259) and calcitonin gene-related peptide (CALCA, P30880) peptides, respectively. 
This gene corresponds to CALCA gene found in other mammalian species.  
Our gene prediction pipeline also found that the separate Q766Y6 and A0A761 UniProt entries 
are alternatively spliced variants of the same calcitonin receptor-stimulating peptide 3 (CRSP3) 
gene as initially reported by Rezaeian et al. (2008). A single genome match was identified for 
calcitonin receptor-stimulating peptide 2 (CRSP2, Q766Y7). While the calcitonin receptor-
stimulating peptide 1 (CRSP1) gene has been reported, the actual gene maybe inaccurately 
assembled in the 10.2 genome release because the region appears to contain a small duplication 
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leading to two starting locations.  Further supporting this argument, a conserved 19 amino acid 
region in all CRSP-related protein sequences matched to an additional 5th genome site which 
was part of a discontinued NCBI Gene entry (Gene ID 100624618).  There is insufficient 
information to conclude whether there is a separate coding gene involved or an assembly-related 
problem. 
Neuropeptide S (NPS) is a potential 12th prohormone gene discovered by our bioinformatics 
strategy. Although UniProt has a pig NPS entry, the pig NPS protein and nucleic sequences are 
100% and 99% identical, respectively, to the rabbit sequence (EU978456). The similarity 
between the UniProt pig and rabbit sequences was also evident in the phylogenetic relationships 
among NPS sequences reported by Yao et al. (2009). These findings call into question the 
present pig NPS entry in UniProt. Our approach identified two matches on different 
chromosomes for the NPS gene. However, the complete identity of the matched sequence across 
chromosome implied that this was an assembly error rather than a duplication event. The 
predicted protein sequence from these matches differed from the UniProt partial pig sequence 
(B5M997).  Our pig genome sequence was more similar to the bovine than the partial UniProt 
pig sequence as expected from the observed homology of other mammalian prohormones.   
 
Prohormone Genes Previously Unreported in Pig 
Our genome search identified 11 prohormone genes that do not have empirical confirmation in 
the UniProt, UniGene or Gene databases (Table 2). These genes are ADM2, CORT, INSL5, 
OX26, PROK2, PRRP, NPS, TIP39, UCN1, UCN2, UCN3, and UTS2B. Of these genes, NPS has 
a questionable UniProt entry. Only inferred sequences are available for ADM2 and CORT in 
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UniProt and the current pig NPS entry is identical to the rabbit NPS.  There is evidence for 
mammalian homologs of all these genes in the UniProt database. The protocol followed to 
identify these genes included a high percentage of identities and similarities with a minimum 
percentage of mismatches and gaps and conservation of the region encompassing the potential 
neuropeptide. Intermedin or adrenomedullin 2 (ADM2) is part of the CGRP/calcitonin family of 
peptides and has effects similar to those of adrenomedullin (ADML). In humans, intermedin 
causes hypotension when given peripherally and augments blood pressure and causes 
sympathetic activation when given to the central nervous system (Hong et al., 2011). This 
neuropeptide induces prolactin release, has anti-diuretic and natriuretic properties and reduces 
food intake. The amino acid sequences of CORT and somatostatin are highly similar and both 
reduce neuronal activity. In addition, CORT has unique roles such as induction of slow-wave 
sleep, reduction of locomotor activity, and activation of cation selective currents not responsive 
to somatostatin (Spier and deLecea, 2000). Although the function of INSL5 is still being 
determined, high expression in the colon, as well as in the brain and hypothalamus, indicates 
roles in gut contractility and neuroendocrine signaling (Huagaard-Jonsson et al., 2009). 
Likewise, the function of OX26 is still being elucidated, although studies in chicken confirm the 
orexigenic, appetite stimulating activity of this neuropeptide (Ukena et al., 2010). Takayanagi 
and Onaka (2010) demonstrated that PRRP plays a role in control of energy metabolism and 
stress response. Prokineticins are involved in tumorigenesis process (prostate, testicles, 
neuroblastoma, colon, and pancreas) acting as a growth factor for cancer cells, an angiogenic and 
a chemotactic factor for pro-inflammatory neutrophils (Monnier and Samson, 2010).  NPS has 
anxiolytic-like effects (stress reduction) and can induce arousal and wakefulness (Reinscheid, 
2008). TIP39 and its receptor form a neuromodulator system and the anatomical distribution 
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indicates a role in limbic, endocrine, viscerosensory, and auditory functions. This system has 
been postulated as potential drug target in anxiety, depression and chronic pain management 
(Dobolyi et al., 2010). Urocortins and their receptors has been found in the central nervous, 
digestive, reproductive, cardiovascular, immune and endocrine systems, suggesting a variety of 
roles including cardiovascular activity and cell survival (Venkatasubramanian et al., 2010). 
UTSB2 is a paralog of urotensin 2 that exerts similar biological effects including relaxation of 
muscles and reduction of blood pressure (Vaudry, 2008). 
 
Pig Prohormone Convertase Genes 
The sequence of 7 prohormone convertase genes and the 7B2 facilitator gene were identified in 
the pig genome (Table 2). Our approach identified the complete sequence of 6 prohormone 
convertase genes that were previously unreported or not based on empirical evidence (furin or 
PCSK3, PCSK4, PCSK5, PCSK6, PCSK7, and PCSK9). The UniProt and Gene databases only 
had supporting evidence for PCSK1, PCSK2, and 7B2. Only transcript evidence supports the 
PCSK1 and PCSK2 entries in UniProt, meanwhile protein evidence is available for 7B2 also 
known as secretogranin V (SCG5). Dai et al. (1995) isolated PCSK1 from the ovary cDNA 
library of a pregnant sow and Renegar et al. (2000) detected PCSK1 in the corpus luteum and 
brain of pregnant sows. Also, mRNA from PCSK1 and PCSK2 has been identified in the 
pituitary neurointermediate lobes of pigs (Seidah et al., 1992). Among the prohormone 
convertases, furin, PCSK4, PCSK5, PCKS6 and PCSK7 do not have UniGene entries. The 
present catalogue enhances the currently limited work on pig prohormone convertases.  
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Functional Characterization of the Pig Prohormone and Prohormone Convertase Genes  
Analysis of the large number of microarray gene expression experiments enabled the first 
comprehensive characterization of the role of prohormone and prohormone convertase genes in 
biological processes in the pig. The results from these analyses augmented the understanding of 
the role of these genes on reproduction, health, growth, and other traits of importance to 
biomedical research and agricultural production. 
The query of Affymetrix Porcine Genome Array (GPL3533) identified 77 probes representing 56 
prohormone and 3 prohormone convertase genes. Table 4 lists the total number of differentially 
expressed probes (P-value < 0.005) within the seven experimental classes considered.  
Supplementary materials Table S2 presents the detailed distribution of the differential expression 
level of each probe and experiment. A discussion of the findings for the three groups with 
highest number of differentially expressed probes (immune-related, embryo and placenta, and 
brain and central nervous system) is presented below. Although neuropeptides expressed in the 
brain and the immune system interact with circulating cytokines to support two-way 
communications between the brain and immune system (Jessop, 2008), we describe the profiles 
of prohormones in immune-related tissues separately from the brain and central nervous system 
tissues to facilitate the interpretation of results. 
Immune-related Profiling.  Several studies have demonstrated that prohormone genes play an 
important role in pig immune response (Pampusch et al., 2000).  This was evidenced by the high 
number of differentially expressed prohormone and prohormone convertase genes (24 genes) 
among experiments that evaluated immune-response in blood, spleen, and lymph nodes (Table 
4). Differentially expressed genes were: Adrenomedullin (ADML), Augurin (AUGN), 
41 
 
Cholecystokinin (CCKN), CRSP3, Endothelin-1 (EDN1), Galanin (GALA), Galanin-like peptide 
(GALP), Progonadoliberin-1 (GON1), Insulin-like growth factor I (IGF1), Insulin-like growth 
factor II (IGF2), Neuromedin-B (NMB), Neuromedin-U-25 (MNU), Neuropeptide Y (NPY), 
Platelet-derived growth factor subunit A (PDGFA), Proenkephalin-A (PENK), Prorelaxin 1 
(REL1), Secretogranin-1 (SCG1), Secretogranin-2 (SCG2), Secretogranin-3 (SCG3), 
Somatostatin (SMS), Vascular endothelial growth factor C (VEGFC), Vascular endothelial 
growth factor D (VEGFD), PCSK1 and PCSK7.   
In general, prohormone genes were under-expressed in pigs under immune challenge relative to 
the un-challenged controls.  AUGN was differentially expressed in two experiments; GSE7313 
(Wang et al. 2007) that profiled lymph nodes and GSE14790 (Tomás et al. 2010) that profiled 
blood.  In GSE14790, 7 day-old pigs were inoculated with porcine circovirus type 2 (PCV2), a 
virus that is widely spread across pig farms, and gene expression was profiled at 0, 7, 14, 21 and 
29 dpi.  AUGN was over expressed in un-inoculated pigs at 29 dpi relative to 7 dpi, regardless of 
inoculation and relative 21 dpi inoculated pigs (P-value < 2.5 x 10-4). Both contrasts indicate that 
the expression of AUGN increases with age and this trend is slower in pigs infected with PCV2.  
In GSE7313, the gene expression of seven week old piglets inoculated with Salmonella 
Typhimurium was profiled at 8 hours post inoculation (hpi), 24 hpi, 48 hpi, and 21 days post 
inoculation (dpi).  AUGN was over expressed at 21 dpi relative to 24 hpi and 48 hpi (P-values < 
6.8 x 10-5 and 2.7 x 10-6, respectively).  Consistent with the differential expression in relation to 
immune-response observed in this study, AUGN is a putative tumor suppressor gene and is 
down-regulated in many cancers (Gonzalez et al., 2011).  
IGF2, a member of the insulin family and is involved in development and growth, was 
differentially expressed across immune-related experiments. IGF2 was represented by 12 probes 
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in the microarray platform and six probes were differentially expressed across experiments.  Five 
probes (Ssc.9365.1.S1_at, Ssc.9365.2.S1_a_at, Ssc.9365.5.A1_at, Ssc.9365.5.S1_at, 
Ssc.9365.6.S1_x_at) and one probe (Ssc.9365.3.S1_a_at) were differentially expressed in 
experiments GSE14790 (Tomás et al., 2010) and GSE7314 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE7314), respectively.  In GSE14790, 
IGF2 was under-expressed in non-inoculated piglets at 7 dpi relative to inoculated pigs at various 
days (P-value < 1.7 x 10-5, fold change = 0.71).  In experiment GSE7314, IGF2 was over-
expressed in pigs inoculated with Salmonella choleraesuis at 21 dpi relative to non-inoculated 
pigs (P-value < 8.1 x 10-4).  These results are consistent with reports that IGF2 is down-regulated 
in pigs immune-challenged with lypopolysaccharide (Solinhac et al. 2011). 
SCG1, SCG2, SCG3, members of the secretogranin family, exhibited differential expression 
among immune-challenge experiments consistent with the known association of these genes with 
cell activation, cytotoxicity and microbial defense (Radek et al., 2008).  Probes on all three SCGs 
exhibited differential expression on two immune-related experiments.  SCG1 and SCG2 both had 
one probe differentially expressed in GSE14790 (probes Ssc.15718.1.A1_at, and 
Ssc.13645.1.A1_at, respectively) while SCG3 had one probe (Ssc.6770.1.A1_at) differentially 
expressed in GSE11787 (Chen et al., 2009). In GSE11787 SCG3 was under-expressed in 
inoculated pigs relative to controls (P-value < 1.2 x 10-3, fold change = 0.33).  Our results are 
consistent with the lack of synthesis of endogenous granins in rat PC12 cells infected with 
recombinant vaccinia viruses (Krömer et al., 1998). In GSE14790, SCG1 and SCG2 were under-
expressed in pigs inoculated with PCV2 relative to un-inoculated control pigs (P-value < 1.8 x 
10-4, fold change = 0.88 and P-value < 1.5 x 10-5, fold change = 0.93, respectively).  
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Two members of the vascular endothelial growth factor family, vascular endothelial growth 
factor C (VEGFC, probe Ssc.12790.1.A1_at) and vascular endothelial growth factor D (VEGFD, 
probe Ssc.29289.1.A1_at) were under-expressed in PCV2 inoculated pigs relative to control pigs 
(P-value < 1.8 x 10-5, fold change = 0.62) and also under-expressed at early stages (7 dpi) 
relative to later stages (19 and 29 dpi) in GSE14790.  In agreement with our findings, a loss of 
endothelial growth factor transcription and increase in pro-inflammatory indicators were reported 
in the endometrial lymphocytes of pigs at sites of fetal arrest (Tayade et al., 2007). 
NPY (probe Ssc.15981.1.A1_at) was under-expressed in PCV2-inoculated pigs relative to control 
pigs (P-value < 6.6 x 10-4) and within infection level, NPY was under-expressed at earlier stages 
relative to 29 dpi in GSE14790.  Consistent with our findings, the levels of NPY mRNA 
decreased in the blood of rats treated with vinblastine, an anti-cancer drug known to decrease the 
number of white blood cells of the immune system involved in defense (Ericsson et al., 1991). 
Similarly, NPY was found to decrease in cattle infected with Bovine Spongiform Encephalopathy 
(Almeida et al., 2011).   
ADML was differentially expressed in GSE14758-D and GSE7314. In GSE14758-D (Tomas et 
al., 2010), ADML was under-expressed in the mediastinal lymph nodes of PCV2-infected pigs 
relative to control pigs at 29 dpi (P-value < 1.7 x 10-3, fold change = 0.6).  Whereas, in GSE7314 
ADML was over-expressed at 48 dpi in the blood of pigs inoculated with Salmonella 
choleraesuis relative to controls (P-value 4.8 x 10-3).  The latter result is consistent with the up-
regulation of ADML gene expression and increases in systemic circulatory concentrations of 
ADML in response to the onset and progression of trauma, infection, and sepsis (Elasser and 
Kahl, 2002).  The apparent inconsistency between both experiments may be associated with the 
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differential effects that ADML has on cellular metabolism, immune function, endocrine function, 
and cardiovascular function. 
Of the three prohormone convertases available in the microarray platform, PCSK1 (probe 
Ssc.141.1.S1_at) and PCSK7 (probe Ssc.5628.1.S1_at) were significantly differentially 
expressed (P-value < 1.3 x 10-3) and PCSK2 (probe Ssc.109.1.S1_at) was marginally 
significantly differentially expressed (P-value < 6.5 x 10-3) in GSE14790. PCSK1 was under-
expressed in PCV2-inoculated pigs already at 7 dpi relative to 29 dpi, regardless of inoculation at 
the later stage (P-value < 5.7 x 10-5). Likewise, PCSK7 is under-expressed in PCV2-inoculated 
pigs relative to controls already at 7 dpi (P-value < 4.2 x 10-4) and, within controls, PCSK7 was 
under-expressed at early stages (7 dpi, 21 dpi) relative to 29 dpi (P-value < 4.1 x 10-4). These 
results are in agreement with similar findings that furin, another prohormone convertase, was 
dysregulated in the immune cells of advanced human atherosclerotic plaques (Turpeinen et al., 
2011) and imply that prohormone convertase, like prohormone genes, are down regulated under 
immune challenges. 
Embryo and Placenta Profiling. In GSE18641 (Østrup et al., 2010), IGF2 (Ssc.9365.2.S1_a_at) 
was over-expressed in pregnant sows relative to non-pregnant sows (P-value < 2.7 x 10-3, fold 
change 1.23).  In GSE12705 (Ross et al., 2009), IGF2 (Ssc.9365.4.S1_a_at, and 
Ssc.9365.5.S1_at) was over-expressed in earlier stage (day 11 spherical and day 11 and 12 
tubular) relative to later stage (day 12 and 14 filamentous) conceptuses (P-value < 2.1 x 10-4).  
This IGF2 profile is supported by Pantaleon et al. (2003) that showed that IGF2 is needed in 
order for mouse embryos to progress from early stages to blastocyst stages. Gupta et al. (2007, 
2008) reported that the expression of the embryo survival related gene IGF2 increased with the 
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addition of nonessential amino acids or phytohemaglutinin in pig embryos and blastocysts, 
respectively.  
PENK (probes Ssc.11281.1.A1_at, Ssc.11281.2.S1_at) was over-expressed in tubular and 
spherical conceptuses relative to filamentous conceptuses (P-Value < 2.6 x 10-6) in experiment 
GSE12705 (Ross et al., 2009).  This is consistent with results that found PENK mRNA to 
increase linearly during gestation in the hippocampus of pigs (Pittius et al., 1987) PTHR was 
under-expressed in tubular and spherical relative to filamentous conceptuses (P-Value < 6.4 x 10-
7, fold change = 0.02) in experiment GSE12705. This finding is supported by reports that PTHR 
is present in higher concentrations in fetal pigs than in sows (Abbas et al., 1994).  VEGFC is a 
representative of the vascular endothelial growth factor family of prohormones that have an 
important role in the survival and mitogenesis of endothelial cells and lymphaniogenesis and 
angiogenesis of embryos (Anisimov et al., 2009). VEGFC (was over-expressed in pregnant sows 
relative to non-pregnant sows (P-Value < 7.8 x 10-4) in experiment GSE18641 (Østrup et al., 
2010). This finding is supported by a study in the chicken, demonstrating that the chorioallantoic 
membrane (analogous to the placenta in mammals) contained growth of embryonic microvessels 
stimulated by VEGFC (Cao et al., 1998).  Our profile is also supported by the finding that in 
mice embryos, VEGFC is required for successful lymphatic vasculature development and 
lymphatic endothelial cell migration (Kakkainen et al., 2003). 
Brain and Central Nervous System. Eleven differentially expressed prohormone genes were 
identified in experiments concerning the hypothalamus, thyroid, and olfactory bulb (neuroblasts).  
These genes are Adrenomedullin-5 (ADM5), ADML, C-type natriuretic peptide (ANFC), Cocaine 
and amphetamine regulated transcript protein CART, IGF1, IGF2, NPY, Platelet-derived growth 
factor subunit A (PDGFA), Prodynorphin (PDYN), PTHR, and VEGFC. 
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ADML was over-expressed in the immortalized porcine olfactory bulb neuroblasts relative to the 
non-neural epithelial cells (P-value < 2.2 x 10-6, fold change > 10) in experiment GSE16855 
(Uebing-Czipura et al., 2009). This result is supported by a previous study that found that ADML 
is important for regulation of proliferation and differentiation of neural stem/progenitor cells 
using the mouse olfactory bulb (Vergaro-Vera et al., 2010).  
IGF1 was over-expressed in the neuroblasts relative to non-neural epithelial cells (average P-
value < 5 x 10-7, fold change > 10) in experiment GSE16855 (Uebing-Czipura et al., 2009).  Our 
result is supported by a study in chickens showing that IGF1 was expressed in the olfactory bulb 
(Mathonnet et al., 2001).  Also, IGF2, (probe Ssc.9365.6.S1_x_at) was consistently over-
expressed in the hypothalamus of male Iberian pigs relative to all other seven breed-gender 
combinations (on average, P-value < 2.3 x 10-4, fold change = 2.42) in experiment GSE14739-H 
(Perez-Enciso et al., 2009 and Yang et al., 2011).  NPY was over-expressed (P-value < 8.1 x 10-
4, fold change = 7.94) in neuroblasts relative to non-neuronal cells in GSE16855 (Uebing-
Czipura et al., 2009). This result is consistent with reports that the olfactory bulb exhibit high 
levels of immunoreactive NPY in the brain of pigs (Busch-Sørensen et al., 1989) and that NPY 
may inhibit excitatory neurotransmission in the rat olfactory bulb (Blakemore et al., 2006).  
VEGFC was over-expressed in neuroblasts relative to non-neuronal cells (P-value < 1.5 x 10-9, 
fold change > 10) in experiment GSE16855.  This result agrees with a 30% increase in dividing 
neuroblasts in olfactory bulb in culture stimulated with VEGFC compared to controls reported by 
Le Bras et al. (2006).  PTHLH was under-expressed in neuroblasts relative to non-neuronal cells 
(P-value < 2.6 x 10-4, fold change = 0.20) in GSE16855.  This finding is consistent with reports 
that PTHLH may be a negative regulator in the differentiation of chondrocytes (Zenmyo et al., 
2000). PDGFA was over-expressed in neuroblasts relative to non-neuronal cells (P-value < 1.2 x 
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10-4) in experiment GSE16855. Related to this result, Fressinaud et al. (1991) reported that 
platelet-derived growth factors increase the glutamine synthetase activity in astrocytes in the 
brain. 
 
Prediction of Cleavage Sites in Pig Prohormones 
All 97 prohormone sequences were used to predict cleavage and confirm the prediction against 
known or predicted cleavage sites. These sequences were inferred to have 228 cleavage sites that 
resulting in a 14.6% prevalence rate. Most sites were cleaved at an Arginine (R) such that the 
most frequently cleaved motifs were xxKR (71%), RxxR (34%) and xxRR (41%), where x 
denotes any amino acid and K denotes Lysine. There were 5% (38) C-terminal single R sites that 
were cleaved without a basic amino acid in the second and fourth positions preceding the 
cleavage site (P2 or P4 locations, respectively).  
The performance of the cleavage prediction models is presented in Table 5.  The correct 
classification rate ranged from 82% to 92% indicating that a large proportion of the sites were 
accurately predicted across all models. The Human cleavage prediction models had the best 
performance for most of the statistics followed by the Mammalian model. The Known Motif 
model provided the highest number of true positive predictions but also the highest number of 
false positive predictions. The Known Motif model provided the highest sensitivity, 77%, 
indicating more than three quarters of the cleaved sites were correctly predicted as cleaved. 
However this model also provided the highest number of false positive predictions. 
Consequently the Known Motif positive predictive power was 35% indicating that, on average, 
only 35% of sites predicted to be cleaved are expected to be true cleavage sites.  
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The Human models provided the highest number of true negatives resulting in the best model 
performance compared to the Known Motif and Mammalian models. The Human artificial 
neural network models had approximately 60% positive predictive power indicating that most 
sites predicted as cleaved are expected to be true positives.  Although the Human logistic models 
had lower sensitivity than their artificial neural network counterparts, the differences with the 
Human artificial neural network model were only 4 cleaved and 11 non-cleaved sites. The high 
performance of the Human models suggests that the cleavage of prohormones that result in 
potential biologically active neuropeptides in the pig is similar to humans.  Noteworthy is that 
the Mammalian model was trained on 51 mammalian prohormones that included 8 pig 
prohormones. This model provided slightly more true positive predictions and a higher 
sensitivity than the Human logistic model. However, the Mammalian model had noticeably more 
false positive predictions than the Human logistic model resulting in lower performance in the 
other accuracy measures. 
The comparison of results across models also provides information on the accuracy of the 
cleavage assignment, prediction accuracy and potential for a gene to produce bioactive peptides. 
For ten prohormones, at least five of the models did not predict any cleavage site.  However, it 
must be noted that four of the prohormones (ANF, GHRL, IGF1 and PDGFD) are likely to have 
sites cleaved by proteases other than prohormone convertases. For example, ANF is cleaved by 
type II transmembrane serine protease Corin (Wu, 2007).  
Genes with no predicted cleavage or assigned cleavage that differ from other species can be used 
to identify proteins are not cleaved to form smaller peptides.  There is no evidence for cleavage 
of UCN2 and UCN3 to produce mature peptides in mammals (Fekete and Zorrilla, 2007). All 
models failed to predict two cleavage sites in TOR2X. The first site, an N-terminal dibasic 'RK', 
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is known to be rarely cleaved across species (Southey et al. 2006a). The second site is a cleavage 
found in humans that forms alpha- and beta-salusin but this site may not be cleaved in the pig 
since the pig sequence, like the bovine sequence, only has a single basic site instead of the 
human dibasic 'RR' site.  Similarly for TKN4, the genomic prediction and supporting EST data 
indicates a change from an R in other species to a Glycine amino acid in the pig sequence that 
may prevent the formation of the 'Hemokinin' peptide.  
The pig CRSP2 protein sequence lacks the 'KR' and a C-terminal cleavage site that are cleaved in 
human CALC and CALCB genes to produce 'Calcitonin gene-related peptide 1' and 'Calcitonin 
gene-related peptide 2'. Therefore it is unlikely that this protein would provide these calcitonin 
peptides. The assigned cleavages in the RES18 protein are necessary to provide a potential 
'Triskadecapeptide' peptide reported by Bloomquist et al. (1994). This potential peptide has 
flanking dibasic cleavage sites in the mouse and rat but this peptide has not been experimentally 
confirmed. However, the corresponding region in human, bovine and pig sequences are 
monobasic and lack common PC cleavage motifs suggesting that these species probably cannot 
form this peptide. 
Examination of the potential cleavage sites in IAPP indicated that a mutation from R to Q in the 
N-terminal cleavage sites necessary to produce the Islet amyloid polypeptide. Examination of the 
corresponding ESTs indicated that two swine ESTs (AJ649149andAJ649469) were 100% 
identical to the rat genome and consequently invalid sequences. Two other ESTs (EW569366, 
BF712755) matched the region that supported the genomic prediction. The predicted protein 
sequence including the potential cleavages sites of the expected IAPP was less than 80% 
identical to other mammals sequences compared to typically over 85% identity between the 
human and most other mammalian sequences. Potter et al. (2010) questioned the capability of 
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IAPP to form amyloids after examining the functionality of a synthesized pig sequence based on 
the BF712755 EST sequence. Our prohormone sequence and cleavage prediction results also 
strongly suggest that the pig is unlikely to be able to form IAPP. This reflects the importance of 
proteomic studies involving cleavage to first determine that a species can produce a peptide. 
 
2.4 Conclusion 
The pig is a fundamental biomedical and agricultural research species. Results from the first 
genome-wide study of pig prohormone and prohormone convertase genes, functional annotation 
and prediction of prohormone cleavage are presented. This study was enabled by the availability 
of the pig genome sequence and of 35 gene expression experiments that evaluated a wide range 
of conditions in pigs. These results offer more insights into the role of neuropeptides on 
biological processes such as reproduction, development, growth, and health and support targeted 
empirical confirmation.  The bioinformatics strategy used in this study can be used to identify 
prohormones or other sets of genes in species with similar sequence resources. Confirmatory 
insight into the pig prohormones can be expected from proteomic mass spectrometry studies.   
Combining complementary bioinformatic resources, 95 prohormone genes, 7 prohormone 
convertases and one cleavage facilitator were discovered in the pig genome and raw sequence 
repositories. We uncovered 11 prohormone genes that have not been previously reported and one 
potentially incorrectly reported.  The high performance of the models used to predict cleavage in 
the pig prohormones suggests that the prohormone cleavage in pigs is similar to humans. The 
analysis of 35 gene expression experiments identified various neuropeptide genes differentially 
expressed in immune-related tissues, embryo and placenta and the central nervous system 
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including AUGN, IGF2, the family of SCGs, NPY, ADM and ADML, PENK, PTHR, and VEGFC.  
Experiments are required to confirm that the pig does not produce the bioactive neuropeptides 
UCN2, UCN3, TOR2X, TKN4, IAPP, and CRSP2 as suggested by the cleavage prediction 
models. 
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TABLES 
 
Table 1. Main features of the 35 microarray experiments analyzed to functionally annotate 
prohormone and prohormone convertase genes 
Experimenta Tissue Class Gender Age  Comparison(s) Reference 
GSE7313 Mesenteric 
Lymph 
Nodes 
Immune NAb 7 weeks Non-Infected, 8 hpi, 24 
hpi, 48 hpi, 21 dpi 
Wang et al. 
(2007) 
GSE7314 Mesenteric 
Lymph 
Nodes 
Immune NA 7 weeks Non-Infected, 8 hpi, 24 
hpi, 48 hpi, 21 dpi 
GEO 
GSE8974 Endothelial 
Cells 
Muscle Female 1 week Cultured, Regenerated GEO 
GSE9333 Adipose 
Tissue 
Fat NA 6-7 
months 
Korean Native Pig, 
Yorkshire 
GEO 
GSE11590 Oocytes Reprod
uction 
Female 42-44 
hours 
Sow, Gilt Paczkowski et 
al. (2011) 
GSE11787 Spleen Immune M/Fc 30 days Haemophilusparasuis 
infected, non-infected  
Chen et al. 
(2009) 
GSE11853 Placenta Embryo 
and 
Placenta 
Female 75 or 90 
days 
after 
gestation 
Erhualian, Large White, 
day 75, day 90 
Zhou et al. 
(2009) 
GSE12604 Corneal/Con
juctival 
clone 
Brain 
and 
Nervous 
System 
NA NA Corneal, Conjuctival 
clone 
 Majo et al. 
(2008) 
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Table 1. (cont.) 
 
 
Experimenta Tissue Class Gender Age  Comparison(s) Reference 
GSE12705 Embryo Embryo 
and 
Placenta 
Female 11, 12 or 
14 days 
Spherical, tubular, 
filamentous 
Ross et al. 
(2009) 
GSE13457 Jejunum Gut NA 21-35 
days 
day 21, 24, 28,35, 
animal, vegetable 
protein diet 
GEO 
GSE13528-F Fat Fat Female 6 months fed ad lubitum, fasted 3 
days, homozygous 
D298, homozygous 
N298 
Lkhagvadorj et 
al. (2009) 
GSE13528-L Liver Fat Female 6 months fed ad lubitum, fasted 3 
days, homozygous 
D298, homozygous 
N298 
Lkhagvadorj et 
al. (2009) 
GSE14373 Kidney Fat NA NA naïve, transplanted, 
non-transplanted, 4 or 
24 hours, CO treated or 
untreated 
GEO 
GSE14643 Heart Muscle Female 3 months stem cell injection, 
saline injection 
Jameel et al. 
(2010) 
GSE14739-B Fat Fat M/F 80, 83, 
87, 89 
days 
Male, Female, Large 
White, Iberian, Duroc, 
Youli 
Perez-Enciso 
et al. (2009), 
Yang et al. 
(2011) 
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Table 1. (cont.) 
 
 
Experimenta Tissue Class Gender Age  Comparison(s) Reference 
GSE14739-G Gonads Reprod
uction 
M/F 80, 83, 
87, 89 
days 
Male, Female, Large 
White, Iberian, Duroc, 
Youli 
Perez-Enciso 
et al. (2009), 
Yang et al. 
(2011) 
GSE14739-H Hypothalam
us 
Brain 
and 
Nervous 
System 
M/F 80, 83, 
87, 89 
days 
Male, Female, Large 
White, Iberian, Duroc, 
Youli 
Perez-Enciso 
et al. (2009), 
Yang et al. 
(2011) 
GSE14739-T Thyroid 
Gland 
Brain 
and 
Nervous 
System 
M/F 80, 83, 
87, 89 
days 
Male, Female, Large 
White, Iberian, Duroc, 
Youli 
Perez-Enciso 
et al. (2009), 
Yang et al. 
(2011) 
GSE14739-A Adenohypop
hsis 
Brain 
and 
Nervous 
System 
M/F 80, 83, 
87, 89 
days 
Male, Female, Large 
White, Iberian, Duroc, 
Youli 
Perez-Enciso 
et al. (2009), 
Yang et al. 
(2011) 
GSE14758 Mediastinal 
Lymph 
nodes 
Immune NA 7 days Inoculated with PCV2, 
uninoculated, 1, 2, 5, 8, 
or 29 dpi 
Tomas et al. 
(2010) 
GSE14790 Blood Immune NA 7-36 
days 
Inoculated with PCV2, 
uninoculated, 0, 7, 14, 
21 or 29 dpi 
GEO 
GSE15211 Aortic Valve Muscle Female Adult normotensive, 
hypertensive 
GEO 
70 
 
Table 1. (cont.) 
Experimenta Tissue Class Gender Age  Comparison(s) Reference 
GSE15256 Ileum Gut NA 5, 28 and 
56 days 
isolation/antibiotics/ind
oors,  with sow indoors, 
outdoors, 5, 28 or 56 
days 
Mulder et al. 
(2009) 
GSE16348 Skeletal 
Muscle 
Muscle Female NA sepsis, corticosteroids, 
NBMA/CS/sepsis, 
control 
Banduseela et 
al. (2009) 
GSE16855 Neuroblasts/
epithelial 
cells 
Brain 
and 
Nervous 
System 
Female  
neurobla
sts from 
female 
newborn 
neuroblasts, epithelial 
cells 
Uebing-
Czipura et al. 
(2009) 
GSE17309 Liver  Fat M/F 211 days Male, Female, high, 
low feeding level 
GEO 
GSE17492 Spleen cells Immune Male Adult Brucella suis infected, 
uninfected 
Galindo et al. 
(2010) 
GSE18343 Endometriu
m 
Embryo 
and 
Placenta 
Female day 13 
and 15 of 
psuedopr
egnancy 
estrogen treated, non 
estrogen treated, day 
13, day 15 
GEO 
GSE18359-A Adipose 
Tissue 
Fat Female 6 Months Low, High RFI, ad lib, 
calorie restricted 
Lkhagvadorj et 
al. (2010) 
GSE18359-L Liver Fat Female 6 Months Low, High RFI, ad lib, 
calorie restricted, 
Lkhagvadorj et 
al. (2010) 
GSE18467 Cortical Embryo 
and 
Placenta 
NA 60 or 80 
days 
day 60, day 80 GEO 
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Table 1. (cont.) 
 
a Experiment ID, Gene Expression Omnibus GEO Series identifier. 
b NA, not available. 
c M/F, male and female. 
  
Experimenta Tissue Class Gender Age  Comparison(s) Reference 
GSE18641 Endometriu
m 
Embryo 
and 
Placenta 
Female day 14 
after 
insemina
tion 
Non-pregnant, 
pregnant, Yorkshire, 
Landrace 
Ostrup et al. 
(2010) 
GSE18653 Longissimus 
Dorsi 
Muscle Male 6 or 7 
months 
Korean Native Pig, 
Yorkshire, 6 or 7 
months 
Kim et al. 
(2009) 
GSE19275 Gluteus 
Medius 
Muscle 
Muscle Male 190 days High, low 
carcass/plasma/muscle 
fat content 
Canovas et al. 
(2010) 
GSE21096 Heart Muscle Female NA control, RCO, SWOP, 
RCS 
Depre et al. 
(2010) 
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Table 2. Prohormone and convertase genes identified across three pig genome resources. 
Symbol Gene Name Genome Sequence1 UniProt ID 
UniGene 
Cluster ID 
Prohormone Genes 
ADM2 Intermedin Complete     
ADM5 Adrenomedullin-5 Complete A5LHG2 Ssc.26627 
ADML Adrenomedullin Complete P53366 Ssc.314 
ANF Atrial natriuretic factor Complete P24259 Ssc.16245 
ANFB Natriuretic peptide B Complete P07634 Ssc.629 
ANFC C-type natriuretic peptide Complete P18104 Ssc.23867 
APEL Apelin Complete     
AUGN Augurin Complete   Ssc.22487 
CALC2 Calcitonin/calcitonin gene-related peptide 1 Complete A6P7L6 Ssc.14052 
  Preprocalcitonin gene-related peptide Complete A6P7L7 Ssc.56129 
CART Cocaine- and amphetamine-regulated transcript protein Complete Q307W6 Ssc.15900 
CCKN Cholecystokinin Complete P01356 Ssc.717 
CMGA Chromogranin-A Complete P04404 Ssc.4653 
COLI Pro-opiomelanocortin Complete P01192 Ssc.14556 
CORT Cortistatin Complete     
CRF Corticoliberin Complete P06296 Ssc.69887 
CRSP1 Calcitonin receptor-stimulating peptide 1 Complete Q862B1 Ssc.3741 
CRSP2 Calcitonin receptor-stimulating peptide 2 Complete Q766Y7 Ssc.18558 
CRSP32 Calcitonin receptor-stimulating peptide 3 Complete Q766Y6 Ssc.17879 
  Calcitonin-2 Complete A0A761   
EDN1 Endothelin-1 Complete P09558 Ssc.9364 
EDN2 Endothelin-2 Fragment     
EDN3 Endothelin-3 Complete A5A752 Ssc.31972 
GALA Galanin Complete P07480 Ssc.713 
GALP Galanin-like peptide Complete Q9TT95 Ssc.4875 
GAST Gastrin Complete P01351 Ssc.644 
GHRL Obestatin Complete Q9GKY5 Ssc.440 
GIP Gastric inhibitory polypeptide Complete P01281 Ssc.38713 
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Table 2. (cont.) 
Symbol Gene Name Genome Sequence1 UniProt ID 
UniGene 
Cluster ID 
Prohormone Genes 
GLUC Glucagon Complete P01274 Ssc.17225 
GON1 Progonadoliberin-1 Complete P49921 Ssc.16310 
GON2 Progonadoliberin-2 Not Present     
GRP Gastrin-releasing peptide Fragment P63153 Ssc.13923 
HEPC Hepcidin Complete Q8MJ80 Ssc.376 
IAPP Islet amyloid polypeptide Complete Q29119 Ssc.8324 
IGF1 Insulin-like growth factor 1 Complete P16545 Ssc.16231 
IGF2 Insulin-like growth factor 2 Fragment P23695 Ssc.9365 
INS Insulin Fragment P01315 Ssc.583 
INSL3 Insulin-like 3 Complete P51461 Ssc.11990 
INSL5 Insulin-like 5 Complete     
INSL6 Insulin-like 6 Complete   Ssc.46919 
KISS1 Metastasis-suppressor KiSS-1 Complete B5M447 Ssc.73565 
MCH Pro-melanin-concentrating hormone Complete   Ssc.3287 
MOTI Motilin Complete P01307 Ssc.714 
NEU1 Oxytocin Complete P01177 Ssc.15668 
NEU2 Neurophysin-II Complete P01183 Ssc.4210 
NEUT Neurotensin Complete   Ssc.38680 
NMB Neuromedin-B Fragment B0LUW4 Ssc.2083 
NMS Neuromedin-S Complete C3UZJ1 Ssc.12508 
NMU Neuromedin-U Complete P34964 Ssc.12508 
NPB Neuropeptide B Complete   Ssc.82498 
NPFF Neuropeptide FF Complete   Ssc.44958 
NPS Neuropeptide S Complete   Ssc.73596 
NPW Neuropeptide W Complete Q8MI35 Ssc.15796 
NPY Neuropeptide Y Complete P01304 Ssc.15981 
OREX Orexin Complete O77668 Ssc.15983 
OSTN Osteocrin (Musclin) Complete   Ssc.5148 
OX26 Orexigenic neuropeptide QRFP Complete     
PACA Pituitary adenylatecyclase-activating polypeptide Complete P41535 Ssc.27598 
PAHO Pancreatic polypeptide Fragment P01300 Ssc.456 
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Table 2. (cont.) 
Symbol Gene Name Genome Sequence1 UniProt ID 
UniGene 
Cluster ID 
Prohormone Genes 
PCSK1N Proproteinconvertasesubtilisin/kexin type 1 inhibitor Fragment   Ssc.17429
3 
PDGFA Platelet-derived growth factor alpha polypeptide Complete   Ssc.6173 
PDGFB Platelet-derived growth factor beta polypeptide Fragment P20034 Ssc.54182 
PDGFD Platelet-derived growth factor D Complete   Ssc.49835 
PDYN Proenkephalin-B Complete P01214 Ssc.121 
PENK Proenkephalin Fragment   Ssc.11281 
PNOC Prepronociceptin Complete P55791 Ssc.15910 
PROK2 Prokineticin 2 Fragment     
PRRP Prolactin-releasing peptide Fragment     
PTHR Parathyroid hormone-related peptide Complete Q866H2 Ssc.9991 
PTHY Parathyroid hormone Complete P01269 Ssc.668 
PYY Peptide YY Complete P68005 Ssc.63650 
REL1 Pro-relaxin 1 Complete P01348 Ssc.162 
REL3 Relaxin 3 Complete Q8HY17 Ssc.42647 
RES18 Regulated endocrine-specific protein 18 Complete   Ssc.49266 
RFRP Neuropeptide VF precursor Complete C4P9W1 Ssc.75350 
SCG1 Secretogranin-1 Fragment Q9GLG4 Ssc.15718 
SCG2 Secretogranin-2 Complete Q5FZP5 Ssc.13645 
SCG3 Secretogranin-3 Complete   Ssc.6770 
SECR Secretin Complete P63298 Ssc.710 
SLIB Somatoliberin Complete P01287 Ssc.71374 
SMS Somatostatin Complete P01168 Ssc.19520 
SPXN Spexin Complete   Ssc.57764 
TIP39 Parathyroid hormone 2 Complete     
TKN1 Tachykinin, precursor 1 Complete   Ssc.18075 
TKN4 Tachykinin-4 Complete   Ssc.23153 
TKNK Tachykinin 3 Complete P67934 Ssc.19565 
TOR2X Torsin family 2, member A Fragment   Ssc.67158 
TRH Prothyroliberin Complete P62968   
UCN1 Urocortin Traces     
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Table 2. (cont.) 
Symbol Gene Name Genome Sequence1 UniProt ID 
UniGene 
Cluster ID 
Prohormone Genes 
UCN2 Urocortin 2 Complete     
UCN3 Urocortin 3 Complete     
UTS2 Urotensin 2 Complete Q95J46 Ssc.437 
UTS2B Urotensin II-related peptide Complete     
VEGFC Vascular endothelial growth factor C Fragment   Ssc.12790 
VEGFD Vascular endothelial growth factor D Complete   Ssc.29289 
VGF Neurosecretory protein VGF Fragment   Ssc.90772 
VIP Vasoactive intestinal peptide Complete E0Y441 Ssc.47759 
Prohormone Convertase-related genes 
PCSK1 Proprotein convertase subtilisin/kexin type 1 PC1/3 Complete Q28959 Ssc.92884 
PCSK2 Proprotein convertase subtilisin/kexin type 2 Complete Q03333 Ssc.109 
PCSK3 Furin Complete   Ssc.94009 
PCSK4 Proprotein convertase subtilisin/kexin type 4 Complete     
PCSK5 Proprotein convertase subtilisin/kexin type 5  Complete     
PCSK6 Proprotein convertase subtilisin/kexin type 6  Complete     
PCSK7 Proprotein convertase subtilisin/kexin type 7 Complete     
PCSK9 Proprotein convertase subtilisin/kexin type 9 Complete   Ssc.84357
3 
7B2 Neuroendocrine protein 7B2 (secretogranin V) Complete P01165 Ssc.155 
1 Gene sequences detected in this study. Complete = the complete gene sequence was identified 
in the pig genome assembly 10.2; Traces = a fragment of the gene sequence was identified in the 
pig trace archives; Fragment = fragment gene sequence was identified in the pig genome 
assembly 10.2; Not Present = gene sequence is not detected in the 10.2 assembly but a match 
was detected in earlier gene assemblies. 
2 Alternative splicing resulted in multiple reported/published protein sequences. 
3 Not exact assignments (e.g. moderately similar or –like gene) 
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Table 3. Distribution of the prohormone gene predictions across resources. 
Genome Prediction UniProt 
Status 
Experimental Support (EST, 
UniGene or sequence) 
No Experimental 
Support 
Complete UniProt 50 1 
 No UniProt 17 10 
Fragment UniProt 7 0 
 No UniProt 7 1 
Not found  No UniProt 0 2 
 
  
77 
 
Table 4. Differentially expressed prohormone and prohormone convertase genes (P-value < 
0.005) across 35 microarray experiments by tissue class. 
Name Probea Imm.b Emb. CNS Repro. Musc. Fat Gut Total 
Prohormone Genes 
ADM5 Ssc.26627.1.A1_at 0 0 1 0 0 0 0 1 
ADML Ssc.314.1.S1_at 2 0 1 0 1 0 1 5 
ANF Ssc.16245.1.S1_at 0 0 0 0 1 0 0 1 
ANFB Ssc.629.1.S1_at 0 0 0 0 1 0 0 1 
ANFC Ssc.23867.1.A1_at 0 1 1 0 0 0 0 2 
AUGN Ssc.22487.1.S1_at 2 0 0 0 1 1 0 4 
CART Ssc.15900.1.S1_at 0 1 1 0 0 0 0 2 
CCKN Ssc.717.1.S1_at 1 0 0 1 1 0 0 3 
CMGA Ssc.4653.1.S1_at 0 0 0 0 0 1 1 2 
COLI Ssc.14556.1.S1_at 0 1 0 0 0 0 0 1 
CRSP1 Ssc.3741.1.S1_at 0 0 0 0 0 0 0 0 
CRSP2 Ssc.18558.1.S1_at 0 1 0 0 0 0 0 1 
CRSP3 Ssc.17879.1.S1_at 1 0 0 0 0 0 0 1 
EDN1 Ssc.9364.1.S1_at 2 0 0 0 0 1 0 3 
GALA Ssc.713.1.S1_at 1 1 0 0 0 0 1 3 
GALP Ssc.4875.1.S1_at 1 1 0 0 1 0 0 3 
GAST Ssc.644.1.S1_at 0 1 0 0 0 0 0 1 
GHRL Ssc.440.1.S1_at 0 0 0 0 0 0 0 0 
GLUC Ssc.17225.1.S1_at 0 1 0 1 0 0 1 3 
GON1 Ssc.16310.1.S1_at 1 1 0 0 0 0 0 2 
HEPC Ssc.376.1.S1_at 0 0 0 0 0 0 0 0 
IAPP Ssc.8324.1.A1_at 0 1 0 0 0 0 0 1 
IGF1 Ssc.16231.1.S1_a_at 1 0 1 0 0 0 0 2 
  Ssc.16231.2.A1_a_at 0 0 0 0 0 0 0 0 
  Ssc.16231.3.S1_a_at 0 0 1 0 0 0 0 1 
IGF2 Ssc.9365.1.S1_at 1 0 0 0 0 0 0 1 
  Ssc.9365.2.S1_a_at 1 1 0 0 0 1 0 3 
  Ssc.9365.3.S1_a_at 1 0 0 0 0 0 0 1 
  Ssc.9365.3.S1_x_at 0 0 0 0 0 0 0 0 
  Ssc.9365.4.S1_a_at 0 1 0 0 0 0 0 1 
  Ssc.9365.5.A1_at 1 0 0 0 0 0 0 1 
  Ssc.9365.5.S1_at 1 1 0 0 0 0 0 2 
  Ssc.9365.5.S1_a_at 0 0 0 0 0 1 0 1 
  Ssc.9365.6.A1_a_at 0 0 0 0 0 0 0 0 
  Ssc.9365.6.A1_x_at 0 0 0 0 0 0 0 0 
  Ssc.9365.6.S1_x_at 1 0 1 0 0 0 0 2 
  Ssc.9365.7.A1_x_at 0 0 0 0 0 0 0 0 
INS Ssc.583.1.S1_at 0 0 0 0 0 0 0 0 
INSL3 Ssc.11990.1.S1_at 0 1 0 0 0 0 0 1 
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Table 4. (cont.) 
Name Probea Imm.b Emb. CNS Repro. Musc. Fat Gut Total 
Prohormone Genes 
MCH Ssc.3287.1.S1_at 0 0 0 0 0 0 0 0 
MOTI Ssc.714.1.S1_at 0 0 0 0 0 0 0 0 
NEU1 Ssc.15668.1.A1_at 0 0 0 0 0 0 0 0 
NEU2 Ssc.4210.1.S1_at 0 0 0 0 1 0 0 1 
NMB Ssc.2083.1.A1_at 1 0 0 0 0 0 0 1 
NMU Ssc.12508.1.A1_at 1 0 0 0 0 0 0 1 
NPW Ssc.15796.1.S1_at 0 1 0 0 0 0 0 1 
NPY Ssc.15981.1.A1_at 1 1 0 0 1 0 0 3 
  Ssc.15981.1.S1_at 0 2 1 0 0 0 0 3 
OREX Ssc.15983.1.S1_at 0 0 0 0 0 0 0 0 
PACA Ssc.27598.1.S1_at 0 1 0 0 0 0 0 1 
PAHO Ssc.456.1.S1_at 0 1 0 0 0 0 0 1 
PCSK1N Ssc.17429.1.S1_at 0 1 0 1 0 0 0 2 
PDGFA Ssc.6173.3.S1_a_at 1 0 1 0 0 0 1 3 
PDYN Ssc.121.1.S1_at 0 1 1 0 0 0 0 2 
PENK Ssc.11281.1.A1_at 0 1 0 1 0 1 1 4 
  Ssc.11281.2.S1_at 1 1 0 0 0 0 0 2 
PNOC Ssc.15910.1.A1_at 0 0 0 0 0 0 0 0 
  Ssc.15910.1.S1_at 0 0 0 0 0 0 0 0 
PTHR Ssc.9991.1.S1_at 0 1 1 2 0 0 0 4 
PTHY Ssc.668.1.S1_at 0 1 0 0 0 0 0 1 
REL1 Ssc.162.1.S1_at 1 1 0 0 0 0 0 2 
SCG1 Ssc.15718.1.A1_at 1 1 0 0 0 0 1 3 
SCG2 Ssc.13645.1.A1_at 1 0 0 0 0 1 1 3 
SCG3 Ssc.6770.1.A1_at 1 1 0 1 0 0 0 3 
SECR Ssc.710.1.S1_at 0 1 0 0 0 0 0 1 
SMS Ssc.19520.1.A1_at 1 1 0 0 1 0 0 3 
TKN1 Ssc.18075.1.A1_at 0 0 0 0 0 0 0 0 
  Ssc.18075.2.S1_at 0 1 0 0 0 0 0 1 
TKN4 Ssc.23153.1.S1_at 0 0 0 0 0 0 0 0 
TKNK Ssc.19565.1.S1_at 0 0 0 0 0 0 0 0 
  Ssc.19565.2.A1_at 0 0 0 0 0 0 0 0 
UTS2 Ssc.437.1.S1_a_at 0 1 0 0 0 0 0 1 
VEGFC Ssc.12790.1.A1_at 1 1 1 0 1 0 1 5 
VEGFD Ssc.29289.1.A1_at 1 1 0 0 0 0 0 2 
Prohormone Total  30 35 12 7 10 7 9 110 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at  1 1 0 0 0 0 1 3 
PCSK2 Ssc.109.1.S1_at 0 0 0 0 0 0 0 0 
PCSK7 Ssc.5628.1.S1_at 1 1 0 0 0 0 1 3 
Prohormone Convertase Total 2 2 0 0 0 0 2 6 
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a Affymetrix microarray gene probe identifier 
b Experiment classes: Imm: primary immune-response tissues, Emb: embryo and placenta, CNS: 
brain and central nervous system, Repro: reproduction, Musc: muscle, fat, and gut. 
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Table 5. Performance of various models to predict cleavage in pig prohormones. 
  Mammalian Human 
 Known Logistic  Logistic Regression Artificial Neural 
Network 
Model Motif Regression AA2 AA Prop.3 AA AA 
Prop. 
True Positives1 181 165 160 158 164 167 
True Negatives  1520 1640 1724 1670 1735 1747 
False Positives  329 209 125 179 114 102 
False Negatives  54 70 75 77 71 68 
Correct Classification  0.8162 0.8661 0.904 0.8772 0.9112 0.9184 
Sensitivity  0.7702 0.7021 0.6809 0.6723 0.6979 0.7106 
Specificity  0.8221 0.887 0.9324 0.9032 0.9383 0.9448 
Positive  predictive 
power 
0.3549 0.4412 0.5614 0.4688 0.5899 0.6208 
Negative predictive pow  0.9657 0.9591 0.9583 0.9559 0.9607 0.9625 
Correlation  0.4358 0.4856 0.5645 0.4944 0.5919 0.6184 
AUC 0.8006 0.8470 0.8600 0.8186 0.8589 0.8802 
 
1 True positives: number of correctly predicted cleaved sites; True negatives: number of correctly 
predicted non-cleaved sites; False positives: number of incorrectly predicted cleaved sites; False 
negatives: number of incorrectly predicted non-cleaved sites; Correct classification rate: number 
of correctly predicted sites divided by the total number of sites; Sensitivity (one minus false 
positive rate): number of true positives divided by the total number of sites cleaved; Specificity 
(one minus false negative rate): number of true negatives divided by the total number of sites not 
cleaved; Positive predictive power: number of true positives divided by the total number of sites 
predicted to be cleaved; Negative predictive power: number of true negatives divided by the total 
number of sites predicted to not be cleaved; Correlation coefficient: Mathew's correlation 
coefficient between observed and predicted cleavage; and Area under the receiver operator 
characteristic or ROC curve relating sensitivity and 1-specificity.  
2 Models trained only on amino acids. 
3 Models trained with amino acids combined with the physicochemical properties of amino acids. 
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Supplementary Table S1. Comprehensive catalogue of prohormone and prohormone convertase genes 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
ADM2 Intermedin complete 
 
None 
  
ENSSSCT00
000001052 
ENSSSCP0000
0001030 
ENSSSCG00
000000962 
ADM5 Adrenomedullin-5 complete A5LHG2 Ssc.26627 Protein 100101476 ENSSSCT00000003545 
ENSSSCP0000
0003462 
ENSSSCG00
000003190 
ADML Adrenomedullin complete P53366 Ssc.314 Protein 397195 ENSSSCT00000014648 
ENSSSCP0000
0014253 
ENSSSCG00
000013408 
ANF Atrial natriuretic factor complete P24259 Ssc.16245 Protein 397496 
ENSSSCT00
000003808 
ENSSSCP0000
0003721 
ENSSSCG00
000003430 
ANFB Natriuretic peptide B complete P07634 Ssc.629 Protein 396844 
ENSSSCT00
000003809 
ENSSSCP0000
0003722 
ENSSSCG00
000003431 
ANFC C-type natriuretic peptide complete P18104 Ssc.23867 Protein 493772 nomatch nomatch nomatch 
APEL Apelin complete 
 
None 
 
 ENSSSCT00000001847 
ENSSSCP0000
0001800 
ENSSSCG00
000001657 
AUGN Augurin (ECRG4) complete 
 
Ssc.22487 
 
 ENSSSCT00000008919 
ENSSSCP0000
0008693 
ENSSSCG00
000008142 
CALC 
Calcitonin/calcito
nin gene-related 
peptide 1 
complete A6P7L6 Ssc.14052 Protein 100125547    
CALCalt 
Preprocalcitonin 
gene-related 
peptide 
complete A6P7L7 Ssc.56129 Protein 100124407    
CART 
Cocaine- and 
amphetamine-
regulated 
transcript protein 
complete Q307W6 Ssc.15900 
Inferred 
from 
Homology 
397252 ENSSSCT00000018481 
ENSSSCP0000
0017981 
ENSSSCG00
000016972 
CCKN Cholecystokinin complete P01356 Ssc.717 Protein 397468 ENSSSCT00000012346 
ENSSSCP0000
0012023 
ENSSSCG00
000011277 
CMGA Chromogranin-A complete P04404 Ssc.4653 Protein 397540 ENSSSCT00000002727 
ENSSSCP0000
0002658 
ENSSSCG00
000002456 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
COLI Pro-opiomelanocortin complete P01192 Ssc.14556 Protein 396863 
ENSSSCT00
000011914 
ENSSSCP0000
0011608 
ENSSSCG00
000010890 
CORT Cortistatin complete  None   ENSSSCT00000003775 
ENSSSCP0000
0003688 
ENSSSCG00
000003403 
CRF Corticoliberin complete P06296 Ssc.69887 Protein 100127468 ENSSSCT00000006811 
ENSSSCP0000
0006626 
ENSSSCG00
000006215 
CRSP1 CRSP1_PIG complete Q862B1 Ssc.3741 Protein 396563 ENSSSCT00000014627 
ENSSSCP0000
0014232 
ENSSSCG00
000013390 
CRSP2 CRSP2_PIG complete Q766Y7 Ssc.18558 Transcript 396574 ENSSSCT00000014623 
ENSSSCP0000
0014228 
ENSSSCG00
000013387 
CRSP3 CRSP3_PIG complete Q766Y6 Ssc.17879 Transcript 396573 ENSSSCT00000014621 
ENSSSCP0000
0014226 
ENSSSCG00
000013386 
CRSP3al
t Calcitonin-2 complete A0A761       
EDN1 Endothelin-1 complete P09558 Ssc.9364 Protein 396915 ENSSSCT00000001144 
ENSSSCP0000
0001121 
ENSSSCG00
000001050 
EDN2 Endothelin-2 complete  None   nomatch nomatch nomatch 
EDN3 Endothelin-3 complete A5A752 Ssc.31972 Transcript 100049663 ENSSSCT00000008255 
ENSSSCP0000
0008036 
ENSSSCG00
000007527 
GALA Galanin complete P07480 Ssc.713 Protein 397465 ENSSSCT00000014084 
ENSSSCP0000
0013698 
ENSSSCG00
000012883 
GALP Galanin-like peptide complete Q9TT95 Ssc.4875 Protein 396772 
ENSSSCT00
000003683 
ENSSSCP0000
0003598 
ENSSSCG00
000003318 
GAST Gastrin complete P01351 Ssc.644 Protein 445524 ENSSSCT00000018972 
ENSSSCP0000
0018467 
ENSSSCG00
000017426 
GHRL Obestatin complete Q9GKY5 Ssc.440 
Inferred 
from 
Homology 
396728 ENSSSCT00000012660 
ENSSSCP0000
0012327 
ENSSSCG00
000011568 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
GIP Gastric inhibitory polypeptide complete P01281 Ssc.38713 Protein  nomatch nomatch Nomatch 
GLUC Glucagon complete P01274 Ssc.17225 Protein 397595 ENSSSCT00000017307 
ENSSSCP0000
0016844 
ENSSSCG00
000015895 
GON1 Progonadoliberin-1 complete P49921 Ssc.16310 Protein 397516 
ENSSSCT00
000010581 
ENSSSCP0000
0010305 
ENSSSCG00
000009651 
GON2 Progonadoliberin-2 
Not in 
10.2v18 
(F1S8B1
) None   
ENSSSCT00
000007832 
ENSSSCP0000
0007621 
ENSSSCG00
000007159 
GRP Gastrin-releasing peptide 
fragmentv1
8 P63153 Ssc.13923 Protein  
ENSSSCT00
000005421 
ENSSSCP0000
0005286 
ENSSSCG00
000004913 
HEPC Hepcidin complete Q8MJ80 Ssc.376  397207 ENSSSCT00000003189 
ENSSSCP0000
0003108 
ENSSSCG00
000002886 
IAPP Islet amyloid polypeptide complete Q29119 Ssc.8324   
ENSSSCT00
000000626 
ENSSSCP0000
0000612 
ENSSSCG00
000000582 
IGF1 Insulin-like growth factor 1 complete P16545 Ssc.16231 Transcript 397491 
ENSSSCT00
000000936 
ENSSSCP0000
0000916 
ENSSSCG00
000000857 
IGF2 Insulin-like growth factor 2 
fragmentv1
8 P23695 Ssc.9365 Protein 396916 nomatch nomatch Nomatch 
INS Insulin fragmentv18 P01315 Ssc.583 Protein 397415 nomatch nomatch Nomatch 
INSL3 Insulin-like 3 complete P51461 Ssc.11990 Transcript 397024 ENSSSCT00000015173 
ENSSSCP0000
0014767 
ENSSSCG00
000013887 
INSL5 Insulin-like 5 complete  None   ENSSSCT00000005747 
ENSSSCP0000
0005605 
ENSSSCG00
000005214 
INSL6 Insulin-like 6 complete  Ssc.46919  100158105 ENSSSCT00000005747 
ENSSSCP0000
0005605 
ENSSSCG00
000005214 
KISS1 
Metastasis-
suppressor KiSS-
1 
complete B5M447 Ssc.73565  100145896 ENSSSCT00000016651 
ENSSSCP0000
0016205 
ENSSSCG00
000015280 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
MCH 
Pro-melanin-
concentrating 
hormone 
complete  Ssc.3287  396962 ENSSSCT00000000937 
ENSSSCP0000
0000917 
ENSSSCG00
000000858 
MOTI Motilin complete_10.2.f P01307 Ssc.714 Protein 397466 
ENSSSCT00
000001694 
ENSSSCP0000
0001650 
ENSSSCG00
000001521 
NEU1 Oxytocin complete P01177 Ssc.15668 Protein 100152272 ENSSSCT00000007837 
ENSSSCP0000
0007626 
ENSSSCG00
000007164 
NEU2 Neurophysin-II complete P01183 Ssc.4210 Protein 396995 ENSSSCT00000007836 
ENSSSCP0000
0007625 
ENSSSCG00
000007163 
NEUT Neurotensin complete  Ssc.38680   ENSSSCT00000001018 
ENSSSCP0000
0000996 
ENSSSCG00
000000932 
NMB Neuromedin-B fragmentv18 
B0LUW
4 Ssc.2083 Protein 100141313 
ENSSSCT00
000019060 
ENSSSCP0000
0018554 
ENSSSCG00
000017507 
NMS Neuromedin-S complete_10.2.f C3UZJ1 Ssc.12508  100294685 
ENSSSCT00
000008951 
ENSSSCP0000
0008725 
ENSSSCG00
000008173 
NMU Neuromedin-U complete_10.2.f P34964 Ssc.12508 Protein  
ENSSSCT00
000009752 
ENSSSCP0000
0009500 
ENSSSCG00
000008907 
NPB Neuropeptide B complete  CA778466.1/EW120651.2   
ENSSSCT00
000003809 
ENSSSCP0000
0003722 
ENSSSCG00
000003431 
NPFF Neuropeptide FF complete  Ssc.44958   ENSSSCT00000000298 
ENSSSCP0000
0000293 
ENSSSCG00
000000277 
NPS Neuropeptide S complete  Ssc.73596  100188981 ENSSSCT00000006864 
ENSSSCP0000
0006678 
ENSSSCG00
000006265 
NPW Neuropeptide W complete Q8MI35 Ssc.15796 Protein 396680 ENSSSCT00000008806 
ENSSSCP0000
0008582 
ENSSSCG00
000008037 
NPY Neuropeptide Y complete P01304 Ssc.15981 Protein 397304 ENSSSCT00000018199 
ENSSSCP0000
0017708 
ENSSSCG00
000016718 
OREX Orexin complete O77668 Ssc.15983 Transcript 397305 ENSSSCT00000018952 
ENSSSCP0000
0018447 
ENSSSCG00
000017410 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
OSTN Osteocrin (Musclin) complete  Ssc.5148  100049691 
ENSSSCT00
000012927 
ENSSSCP0000
0012586 
ENSSSCG00
000011815 
OX26 
Orexigenic 
neuropeptide 
QRFP 
complete  None   ENSSSCT00000006274 
ENSSSCP0000
0006112 
ENSSSCG00
000005705 
PACA 
Pituitary 
adenylate cyclase-
activating 
polypeptide 
complete P41535 Ssc.27598 Protein 414283 ENSSSCT00000004097 
ENSSSCP0000
0004005 
ENSSSCG00
000003698 
PAHO Pancreatic polypeptide 
fragmentv1
8 P01300 Ssc.456 Protein 397272 
ENSSSCT00
000018907 
ENSSSCP0000
0018403 
ENSSSCG00
000017368 
PCSK1N 
Proprotein 
convertase 
subtilisin/kexin 
type 1 inhibitor 
fragmentv1
8  Ssc.17429   
ENSSSCT00
000018690 
ENSSSCP0000
0018189 
ENSSSCG00
000017166 
PDGFA 
Platelet-derived 
growth factor 
alpha polypeptide 
complete  Ssc.6173   ENSSSCT00000008273 
ENSSSCP0000
0008054 
ENSSSCG00
000007541 
PDGFB 
Platelet-derived 
growth factor beta 
polypeptide 
fragmentv1
8 P20034 Ssc.54182 Protein 100126843 nomatch nomatch nomatch 
PDGFD Platelet-derived growth factor D complete  Ssc.49835   
ENSSSCT00
000016357 
ENSSSCP0000
0015918 
ENSSSCG00
000014994 
PDYN Proenkephalin-B complete P01214 Ssc.121 Protein 445529 ENSSSCT00000007854 
ENSSSCP0000
0007643 
ENSSSCG00
000007180 
PENK Proenkephalin fragmentv18  Ssc.11281   
ENSSSCT00
000006841 
ENSSSCP0000
0006655 
ENSSSCG00
000006243 
PNOC Prepronociceptin complete P55791 Ssc.15910 Protein 397257 ENSSSCT00000010609 
ENSSSCP0000
0010333 
ENSSSCG00
000009675 
PROK2 Prokineticin 2 fragmentv18  None   
ENSSSCT00
000007453 
ENSSSCP0000
0007257 
ENSSSCG00
000006805 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
PRRP Prolactin-releasing peptide 
fragmentv1
8  None   
ENSSSCT00
000000079 
ENSSSCP0000
0000078 
ENSSSCG00
000000073 
PTHR 
Parathyroid 
hormone-related 
peptide 
complete Q866H2 Ssc.9991  396951 ENSSSCT00000000587 
ENSSSCP0000
0000574 
ENSSSCG00
000000544 
PTHY Parathyroid hormone complete P01269 Ssc.668 Protein 399502 
ENSSSCT00
000014631 
ENSSSCP0000
0014236 
ENSSSCG00
000013394 
PYY Peptide YY complete P68005 Ssc.63650 Protein 445018 ENSSSCT00000018902 
ENSSSCP0000
0018398 
ENSSSCG00
000017363 
REL1 Pro-relaxin 1 complete P01348 Ssc.162  396891 ENSSSCT00000005749 
ENSSSCP0000
0005607 
ENSSSCG00
000005216 
REL3 Relaxin 3 complete Q8HY17 Ssc.42647 Protein 503836 ENSSSCT00000015039 
ENSSSCP0000
0014634 
ENSSSCG00
000013765 
RES18 
Regulated 
endocrine-specific 
protein 18 
complete  Ssc.49266  100154377 ENSSSCT00000017660 
ENSSSCP0000
0017182 
ENSSSCG00
000016219 
RFRP Neuropeptide VF precursor 
complete_1
0.2.f C4P9W1 Ssc.75350  100302024 
ENSSSCT00
000018193 
ENSSSCP0000
0017702 
ENSSSCG00
000016712 
SCG1 Secretogranin-1 fragmentv18 Q9GLG4 Ssc.15718 Protein 397154 
ENSSSCT00
000007714 
ENSSSCP0000
0007507 
ENSSSCG00
000007045 
SCG2 Secretogranin-2 complete Q5FZP5 Ssc.13645 Transcript 497237 ENSSSCT00000017563 
ENSSSCP0000
0017090 
ENSSSCG00
000016130 
SCG3 Secretogranin-3 complete  Ssc.6770  100154760 ENSSSCT00000005113 
ENSSSCP0000
0004989 
ENSSSCG00
000004630 
SECR Secretin complete P63298 Ssc.710 Protein 397464 ENSSSCT00000014047 
ENSSSCP0000
0013662 
ENSSSCG00
000012852 
SLIB Somatoliberin complete P01287 Ssc.71374 Protein  ENSSSCT00000008023 
ENSSSCP0000
0007809 
ENSSSCG00
000007332 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
SMS Somatostatin complete P01168 Ssc.19520 Protein 494469 ENSSSCT00000012920 
ENSSSCP0000
0012579 
ENSSSCG00
000011808 
SPXN Spexin complete  Ssc.57764  100155886 ENSSSCT00000000622 
ENSSSCP0000
0000608 
ENSSSCG00
000000578 
TIP39 Parathyroid hormone 2 complete  None   
ENSSSCT00
000003521 
ENSSSCP0000
0003438 
ENSSSCG00
000003171 
TKN1 Tachykinin, precursor 1 complete  Ssc.18075   
ENSSSCT00
000016711 
ENSSSCP0000
0016265 
ENSSSCG00
000015338 
TKN4 Tachykinin-4 complete  Ssc.23153   ENSSSCT00000019109 
ENSSSCP0000
0018603 
ENSSSCG00
000017554 
TKNK Tachykinin 3 complete P67934 Ssc.19565  492314 ENSSSCT00000000452  
ENSSSCP0000
0000446 
 ENSSSCG00
000000418  
TOR2X Torsin family 2, member A fragment  
FS688259/B
W972021   
ENSSSCT00
000006179 
ENSSSCP0000
0006020 
ENSSSCG00
000005619 
TRH Prothyroliberin complete P62968 None   ENSSSCT00000012693 
ENSSSCP0000
0012360 
ENSSSCG00
000011596  
UCN1 Urocortin fragment_traces  None   
ENSSSCT00
000016739 
ENSSSCP0000
0016293 
ENSSSCG00
000015364 
UCN2 Urocortin 2 complete  None   ENSSSCT00000012431 
ENSSSCP0000
0012107 
ENSSSCG00
000011354 
UCN3 Urocortin 3 complete  None   ENSSSCT00000012195 
ENSSSCP0000
0011882 
ENSSSCG00
000011143 
UTS2 Urotensin 2 complete Q95J46 Ssc.437 Transcript 397268 ENSSSCT00000005848 
ENSSSCP0000
0005703 
ENSSSCG00
000005310 
UTS2B Urotensin Ii-related peptide complete  None   
ENSSSCT00
000012928 
ENSSSCP0000
0012587 
ENSSSCG00
000011816 
VEGFC 
Vascular 
endothelial 
growth factor C 
fragmentv1
8  Ssc.12790   
ENSSSCT00
000017171 
ENSSSCP0000
0016710 
ENSSSCG00
000015770 
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Supplementary Table S1. (cont.) 
Symbol Prohormone Name 
Genome 
Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
VEGFD 
Vascular 
endothelial 
growth factor D 
complete  Ssc.29289  100155670 ENSSSCT00000013274 
ENSSSCP0000
0012918 
ENSSSCG00
000012135 
VGF Neurosecretory protein VGF 
fragmentv1
8  FS665444      
VIP Vasoactive intestinal peptide complete E0Y441 Ssc.47759 Protein  
ENSSSCT00
000004508 
ENSSSCP0000
0004406 
ENSSSCG00
000004079 
 Convertase         
PCSK1 
Proprotein 
convertase 
subtilisin/kexin 
type 1 PC1/3 
complete Q28959 Ssc.92884 Transcript 397103 ENSSSCT00000018690 
ENSSSCP0000
0018189 
ENSSSCG00
000017166 
PCSK2 Neuroendocrine convertase 2 complete Q03333 Ssc.109 Transcript 445533 
ENSSSCT00
000007755 
ENSSSCP0000
0007546 
ENSSSCG00
000007083 
PCSK3 Furin complete  Ssc.94009  100156882 ENSSSCT00000002036 
ENSSSCP0000
0001987 
ENSSSCG00
000001817 
PCSK4 
Proprotein 
convertase 
subtilisin/kexin 
type 4 
complete     ENSSSCT00000015478 
ENSSSCP0000
0015068 
ENSSSCG00
000014169 
PCSK5 
Proprotein 
convertase 
subtilisin/kexin 
type 5  
complete    100519237 ENSSSCT00000005810 
ENSSSCP0000
0005666 
ENSSSCG00
000005275 
PCSK6 
Proprotein 
convertase 
subtilisin/kexin 
type 6  
complete     ENSSSCT00000006359 
ENSSSCP0000
0006197 
ENSSSCG00
000005783 
PCSK6 
Proprotein 
convertase 
subtilisin/kexin 
type 6 Isoform  
complete        
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Supplementary Table S1. (cont.) 
Symbol Convertase Genome Sequence1 
UniProt 
ID UniGene ID 
SwissProt 
Evidence 
Gene 
Database  
ID 
Ensembl 
DNA ID 
Ensembl 
Protein ID 
Ensembl 
Gene ID 
PCSK7 
Proprotein 
convertase 
subtilisin/kexin 
type 7 
complete    100523009 ENSSSCT00000016438 
ENSSSCP0000
0015996 
ENSSSCG00
000015072 
7b2 Neuroendocrine proetin 7B2 complete P01165 Ssc.155 Protein     
1 Gene sequences detected in this study. Complete = the complete gene sequence was identified in the pig genome assembly 10.2; 
Traces = a fragment of the gene sequence was identified in the pig trace archives; Fragment = fragment gene sequence was identified 
in the pig genome assembly 10.2; Not Present = gene sequence is not detected in the 10.2 assembly but a match was detected in earlier 
gene assemblies. 
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Supplementary Table S2. Detailed distribution of differential expression by tissue group    
Symbol Affy Probe ID 
Experiments 
Immune1 
GSE73132 GSE7314 GSE11787 GSE17492 GSE14758-D GSE14790 
ADM5 Ssc.26627.1.A1_at 5.40E-01 2.60E-02 8.00E-02 7.20E-02 8.10E-01 3.10E-01 
ADML Ssc.314.1.S1_at 1.90E-02 3.40E-04 2.40E-02 5.20E-01 1.70E-03 7.50E-02 
ANF Ssc.16245.1.S1_at 9.70E-01 5.00E-01 1.70E-01 5.90E-01 5.00E-01 2.30E-02 
ANFB Ssc.629.1.S1_at 5.20E-01 3.70E-01 6.70E-01 9.60E-02 9.40E-01 2.10E-01 
ANFC Ssc.23867.1.A1_at 9.20E-01 1.30E-01 3.40E-01 7.40E-02 5.10E-01 3.20E-01 
AUGN Ssc.22487.1.S1_at 4.10E-05 9.00E-03 3.90E-01 6.10E-01 1.90E-01 7.30E-04 
CART Ssc.15900.1.S1_at 2.00E-01 8.40E-02 7.70E-01 4.60E-02 7.10E-01 1.40E-02 
CCKN Ssc.717.1.S1_at 5.40E-01 6.00E-01 5.30E-01 5.00E-02 9.50E-01 1.20E-03 
CMGA Ssc.4653.1.S1_at 1.20E-01 7.30E-01 5.00E-01 2.60E-01 9.70E-01 9.50E-02 
COLI Ssc.14556.1.S1_at 5.90E-01 3.70E-01 6.00E-01 2.10E-01 6.50E-01 8.10E-02 
CRSP1 Ssc.3741.1.S1_at 9.00E-01 1.60E-01 8.10E-01 1.50E-02 2.50E-01 1.80E-01 
CRSP2 Ssc.18558.1.S1_at 8.10E-01 5.30E-01 6.70E-01 1.00E-01 5.10E-01 8.10E-03 
CRSP3 Ssc.17879.1.S1_at 9.30E-01 1.50E-01 9.20E-01 6.30E-02 6.50E-01 2.30E-03 
EDN1 Ssc.9364.1.S1_at 2.00E-03 5.20E-04 1.50E-01 1.20E-01 8.70E-02 6.60E-02 
GALA Ssc.713.1.S1_at 3.80E-01 1.10E-01 8.30E-01 2.00E-02 4.00E-01 2.50E-04 
GALP Ssc.4875.1.S1_at 1.10E-01 3.90E-01 1.90E-01 2.20E-01 5.20E-01 1.30E-03 
GAST Ssc.644.1.S1_at 5.80E-01 3.20E-01 6.30E-01 1.40E-01 2.40E-01 4.60E-01 
GHRL Ssc.440.1.S1_at 2.40E-01 1.70E-01 7.50E-01 1.40E-01 5.40E-01 5.80E-01 
GLUC Ssc.17225.1.S1_at 4.40E-01 3.30E-01 9.30E-01 1.90E-01 4.60E-01 2.30E-02 
GON1 Ssc.16310.1.S1_at 9.70E-01 1.80E-01 9.10E-01 4.40E-02 6.10E-01 4.00E-05 
HEPC Ssc.376.1.S1_at 9.10E-01 4.80E-01 9.40E-01 2.60E-02 7.90E-01 1.20E-02 
IAPP Ssc.8324.1.A1_at 4.40E-01 4.20E-01 7.20E-01 2.10E-02 7.50E-01 1.80E-01 
IGF1 Ssc.16231.1.S1_a_at 5.70E-01 4.30E-03 4.30E-01 1.10E-01 4.20E-01 1.50E-01 
 Ssc.16231.2.A1_a_at 6.40E-01 1.20E-01 5.70E-01 2.20E-01 7.50E-01 1.20E-01 
 Ssc.16231.3.S1_a_at 6.50E-01 8.10E-02 3.00E-01 1.40E-01 1.20E-01 1.00E-02 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Immune1 
GSE73132 GSE7314 GSE11787 GSE17492 GSE14758-D GSE14790 
IGF2 Ssc.9365.1.S1_at 3.90E-01 2.40E-01 2.70E-01 2.60E-01 9.40E-01 2.70E-03 
 Ssc.9365.2.S1_a_at 3.40E-02 5.50E-02 1.00E-01 5.50E-03 2.70E-01 9.60E-04 
 Ssc.9365.3.S1_a_at 1.90E-01 3.10E-03 1.50E-01 6.40E-02 1.80E-01 6.90E-03 
 Ssc.9365.3.S1_x_at 3.90E-02 9.60E-02 2.00E-01 3.70E-02 2.60E-01 3.50E-02 
 Ssc.9365.4.S1_a_at 7.50E-01 1.50E-01 7.20E-01 5.00E-01 6.00E-01 5.10E-03 
 Ssc.9365.5.A1_at 6.90E-01 1.50E-01 2.70E-01 1.10E-01 3.30E-01 1.70E-03 
 Ssc.9365.5.S1_at 9.30E-01 9.60E-01 8.20E-01 2.80E-02 2.30E-01 7.10E-04 
 Ssc.9365.5.S1_a_at 6.30E-01 4.10E-01 1.00E-01 9.30E-02 1.20E-01 9.00E-03 
 Ssc.9365.6.A1_a_at 1.90E-01 3.30E-01 5.30E-01 8.10E-01 4.20E-01 4.50E-02 
 Ssc.9365.6.A1_x_at 4.20E-01 6.40E-01 9.90E-01 6.40E-01 6.10E-01 6.60E-03 
 Ssc.9365.6.S1_x_at 3.20E-02 4.20E-02 1.10E-01 2.70E-02 1.10E-01 2.90E-03 
 Ssc.9365.7.A1_x_at 7.00E-01 4.50E-01 3.30E-01 5.10E-01 6.70E-01 2.00E-01 
INS Ssc.583.1.S1_at 8.50E-01 1.10E-01 7.70E-01 1.60E-02 6.20E-01 1.90E-02 
INSL3 Ssc.11990.1.S1_at 3.10E-01 8.90E-01 4.40E-01 6.30E-02 5.10E-01 7.20E-02 
MCH Ssc.3287.1.S1_at 5.70E-02 1.90E-01 6.60E-01 2.60E-02 5.80E-01 4.80E-02 
MOTI Ssc.714.1.S1_at 8.20E-01 1.80E-01 5.40E-01 1.90E-01 7.80E-01 2.20E-01 
NEU1 Ssc.15668.1.A1_at 5.60E-01 4.60E-02 5.40E-01 9.40E-02 2.80E-01 8.00E-03 
NEU2 Ssc.4210.1.S1_at 6.50E-01 3.30E-02 4.80E-01 2.00E-01 3.30E-01 6.90E-02 
NMB Ssc.2083.1.A1_at 9.70E-01 3.80E-02 9.00E-01 2.20E-01 2.50E-01 3.20E-03 
NMU Ssc.12508.1.A1_at 9.10E-01 4.80E-01 5.80E-01 1.50E-02 8.50E-01 1.40E-03 
NPW Ssc.15796.1.S1_at 4.10E-01 2.80E-01 3.90E-01 3.20E-02 1.50E-01 6.20E-02 
NPY Ssc.15981.1.A1_at 3.30E-01 2.40E-01 4.10E-01 1.80E-02 6.20E-01 6.40E-04 
 Ssc.15981.1.S1_at 5.40E-01 8.30E-01 1.50E-01 2.20E-02 3.40E-01 1.30E-01 
OREX Ssc.15983.1.S1_at 4.40E-01 6.70E-03 3.70E-01 1.10E-01 1.30E-01 4.10E-02 
PACA Ssc.27598.1.S1_at 5.10E-01 4.00E-01 9.20E-01 2.70E-02 6.50E-01 2.60E-01 
PAHO Ssc.456.1.S1_at 7.30E-01 1.50E-01 7.00E-01 3.00E-02 4.70E-01 9.40E-03 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Immune1 
GSE73132 GSE7314 GSE11787 GSE17492 GSE14758-D GSE14790 
PCSK1 Ssc.17429.1.S1_at 2.00E-01 2.80E-01 3.10E-01 8.90E-01 1.40E-01 1.70E-02 
PDGFA Ssc.6173.3.S1_a_at 3.00E-01 5.20E-03 3.90E-01 2.20E-01 1.60E-01 1.30E-04 
PDYN Ssc.121.1.S1_at 5.30E-01 4.30E-01 5.30E-01 1.10E-01 4.90E-01 2.10E-01 
PENK Ssc.11281.1.A1_at 2.90E-02 1.20E-01 6.00E-01 1.60E-02 4.60E-01 5.80E-01 
 Ssc.11281.2.S1_at 1.90E-01 4.30E-01 6.50E-01 9.50E-02 7.20E-01 2.60E-05 
PNOC Ssc.15910.1.A1_at 9.00E-01 9.00E-01 9.00E-01 2.50E-01 5.00E-01 1.00E-01 
 Ssc.15910.1.S1_at 2.90E-01 5.10E-01 4.60E-01 8.10E-02 6.00E-01 1.50E-01 
PTHR Ssc.9991.1.S1_at 6.10E-02 4.20E-01 3.80E-01 8.70E-02 5.50E-01 3.40E-02 
PTHY Ssc.668.1.S1_at 3.90E-02 3.20E-01 9.00E-01 1.30E-02 7.40E-01 8.10E-03 
REL1 Ssc.162.1.S1_at 6.50E-01 2.00E-02 8.90E-01 4.60E-02 9.80E-01 1.30E-03 
SCG1 Ssc.15718.1.A1_at 9.50E-01 3.10E-02 9.60E-01 8.20E-02 8.00E-01 1.90E-03 
SCG2 Ssc.13645.1.A1_at 8.40E-02 8.20E-03 6.90E-01 7.60E-02 3.90E-01 4.80E-05 
SCG3 Ssc.6770.1.A1_at 6.70E-01 2.60E-01 1.20E-03 7.50E-01 3.50E-02 7.70E-02 
SECR Ssc.710.1.S1_at 3.90E-01 2.40E-02 1.00E+00 5.10E-02 4.40E-01 5.20E-02 
SMS Ssc.19520.1.A1_at 7.60E-01 1.60E-01 9.40E-01 2.00E-01 1.00E+00 7.40E-05 
TKN1 Ssc.18075.1.A1_at 7.00E-01 7.10E-02 5.30E-01 1.50E-02 4.00E-01 8.00E-03 
 Ssc.18075.2.S1_at 6.80E-01 8.40E-01 5.10E-01 1.00E-01 6.70E-01 6.30E-03 
TKN4 Ssc.23153.1.S1_at 7.20E-01 4.80E-01 5.00E-01 7.40E-02 7.10E-01 6.90E-02 
TKNK Ssc.19565.1.S1_at 7.80E-01 5.10E-02 3.20E-01 2.10E-02 5.60E-02 1.90E-01 
 Ssc.19565.2.A1_at 1.50E-01 1.90E-01 3.80E-01 5.40E-02 3.20E-02 5.30E-01 
UTS2 Ssc.437.1.S1_a_at 9.30E-01 3.90E-01 4.10E-01 2.00E-02 8.60E-01 3.40E-02 
VEGFC Ssc.12790.1.A1_at 4.10E-01 2.30E-02 1.40E-02 7.10E-01 1.30E-01 1.20E-03 
VEGFD Ssc.29289.1.A1_at 2.70E-01 2.30E-01 7.10E-01 1.20E-01 4.00E-01 1.00E-04 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   9.50E-01 1.70E-01 8.60E-01 1.50E-02 5.80E-01 3.40E-04 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID Immune
1 
GSE73132 GSE7314 GSE11787 GSE17492 GSE14758-D GSE14790 
PCSK2 Ssc.109.1.S1_at 4.40E-01 2.70E-01 3.50E-01 2.50E-02 5.80E-01 6.50E-03 
PCSK7 Ssc.5628.1.S1_at 3.80E-01 2.70E-01 7.30E-01 2.90E-02 7.40E-02 1.30E-03 
Total P-
value in 
Column 
<0.005 
 
2 4 1 0 1 24 
Totals 
by 
Group 
 
     32 
 
Symbol Affy Probe ID 
Experiments 
Embryo and Placenta 
GSE18467 GSE18641 GSE18343 GSE11853 GSE12705 
ADM5 Ssc.26627.1.A1_at 1.10E-02 1.50E-01 3.70E-01 7.00E-01 1.80E-01 
ADML Ssc.314.1.S1_at 8.50E-01 8.60E-02 7.20E-01 4.70E-02 1.20E-02 
ANF Ssc.16245.1.S1_at 1.80E-01 7.80E-01 2.70E-01 7.90E-01 7.40E-02 
ANFB Ssc.629.1.S1_at 4.00E-01 3.00E-01 5.40E-01 1.10E-01 3.00E-01 
ANFC Ssc.23867.1.A1_at 6.10E-01 4.70E-01 3.10E-01 5.90E-01 2.90E-05 
AUGN Ssc.22487.1.S1_at 9.00E-01 7.10E-01 6.50E-01 4.00E-01 1.50E-01 
CART Ssc.15900.1.S1_at 3.40E-01 3.90E-01 2.90E-01 3.40E-01 2.30E-03 
CCKN Ssc.717.1.S1_at 1.60E-01 9.80E-02 5.30E-01 5.30E-01 1.10E-01 
CMGA Ssc.4653.1.S1_at 1.40E-01 8.20E-01 4.10E-01 9.40E-01 2.00E-01 
COLI Ssc.14556.1.S1_at 2.40E-03 6.30E-01 9.20E-01 7.00E-01 1.20E-01 
CRSP1 Ssc.3741.1.S1_at 4.40E-01 3.70E-01 7.70E-01 7.40E-01 7.10E-02 
CRSP2 Ssc.18558.1.S1_at 2.20E-01 4.10E-01 8.80E-01 5.50E-01 3.30E-05 
CRSP3 Ssc.17879.1.S1_at 1.10E-01 4.20E-01 8.50E-01 8.00E-01 1.20E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Embryo and Placenta 
GSE18467 GSE18467 GSE18467 GSE18467 GSE18467 
EDN1 Ssc.9364.1.S1_at 9.60E-01 1.20E-01 2.70E-01 1.50E-01 4.70E-01 
GALA Ssc.713.1.S1_at 1.30E-02 7.30E-01 7.50E-01 6.80E-01 1.10E-03 
GALP Ssc.4875.1.S1_at 2.90E-01 6.40E-01 4.60E-01 7.20E-01 2.10E-04 
GAST Ssc.644.1.S1_at 1.50E-01 2.60E-01 8.60E-01 5.90E-01 5.30E-04 
GHRL Ssc.440.1.S1_at 2.00E-01 6.70E-01 8.20E-01 7.30E-01 7.50E-01 
GLUC Ssc.17225.1.S1_at 2.60E-01 3.00E-01 6.10E-01 2.20E-01 5.30E-05 
GON1 Ssc.16310.1.S1_at 2.20E-01 4.50E-01 7.80E-01 7.80E-01 2.10E-04 
HEPC Ssc.376.1.S1_at 1.50E-01 9.50E-01 6.00E-01 6.70E-01 2.30E-01 
IAPP Ssc.8324.1.A1_at 1.30E-01 9.00E-01 5.70E-01 7.90E-01 1.20E-03 
IGF1 Ssc.16231.1.S1_a_at 2.40E-01 3.70E-01 1.60E-01 9.50E-02 1.10E-02 
 Ssc.16231.2.A1_a_at 1.20E-01 3.70E-01 9.50E-01 7.80E-01 1.30E-02 
 Ssc.16231.3.S1_a_at 5.80E-01 3.80E-01 9.50E-02 5.30E-01 3.60E-02 
IGF2 Ssc.9365.1.S1_at 2.00E-01 8.50E-01 6.20E-01 5.00E-01 8.90E-03 
 Ssc.9365.2.S1_a_at 8.60E-01 2.70E-03 7.10E-01 6.80E-01 2.60E-02 
 Ssc.9365.3.S1_a_at 9.40E-01 1.50E-02 5.90E-01 3.90E-01 3.50E-01 
 Ssc.9365.3.S1_x_at 7.20E-01 2.00E-02 7.50E-01 3.90E-01 1.90E-02 
 Ssc.9365.4.S1_a_at 2.40E-01 1.00E+00 9.30E-01 5.80E-01 5.20E-04 
 Ssc.9365.5.A1_at 8.50E-01 5.40E-01 8.00E-01 6.20E-01 1.90E-02 
 Ssc.9365.5.S1_at 1.80E-01 5.20E-01 2.80E-01 7.10E-01 5.30E-04 
 Ssc.9365.5.S1_a_at 8.70E-01 1.60E-02 2.10E-01 6.80E-01 3.00E-01 
 Ssc.9365.6.A1_a_at 2.30E-01 7.00E-01 9.10E-01 3.40E-01 7.70E-02 
 Ssc.9365.6.A1_x_at 3.40E-01 2.90E-01 3.00E-01 1.80E-01 6.20E-02 
 Ssc.9365.6.S1_x_at 1.30E-01 3.40E-02 7.00E-01 4.80E-01 1.20E-01 
 Ssc.9365.7.A1_x_at 1.90E-01 6.90E-01 5.30E-01 3.90E-01 2.60E-02 
INS Ssc.583.1.S1_at 2.20E-01 4.90E-01 8.90E-01 9.10E-01 4.40E-01 
INSL3 Ssc.11990.1.S1_at 3.50E-01 6.10E-01 8.60E-01 8.80E-01 1.30E-03 
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Supplementary Table. S2. (cont.) 
Symbol Affy Probe ID Embryo and Placenta 
GSE18467 GSE18467 GSE18467 GSE18467 GSE18467 
MCH Ssc.3287.1.S1_at 3.60E-01 9.20E-01 8.40E-01 8.50E-01 2.50E-01 
MOTI Ssc.714.1.S1_at 3.90E-01 9.60E-01 6.20E-01 6.10E-01 9.10E-01 
NEU1 Ssc.15668.1.A1_at 5.50E-01 3.50E-01 6.30E-01 7.80E-01 6.30E-02 
NEU2 Ssc.4210.1.S1_at 5.30E-01 5.30E-01 6.70E-01 4.70E-01 6.20E-01 
NMB Ssc.2083.1.A1_at 2.10E-01 1.40E-02 7.70E-01 8.40E-01 1.40E-02 
NMU Ssc.12508.1.A1_at 3.00E-01 1.30E-02 3.90E-01 8.50E-01 1.30E-01 
NPW Ssc.15796.1.S1_at 3.00E-01 5.00E-01 7.60E-01 4.90E-01 3.30E-05 
NPY Ssc.15981.1.A1_at 7.50E-01 9.30E-01 7.60E-01 8.80E-01 7.30E-04 
 Ssc.15981.1.S1_at 7.20E-02 1.40E-03 5.70E-01 9.70E-01 3.50E-04 
OREX Ssc.15983.1.S1_at 5.60E-01 2.20E-01 9.60E-01 7.50E-01 1.00E-01 
PACA Ssc.27598.1.S1_at 6.40E-01 5.80E-01 1.90E-01 5.30E-01 3.90E-04 
PAHO Ssc.456.1.S1_at 3.00E-01 4.20E-01 5.50E-01 8.20E-01 6.00E-05 
PCSK1 Ssc.17429.1.S1_at 1.60E-01 4.90E-01 5.30E-01 4.20E-01 4.80E-03 
PDGFA Ssc.6173.3.S1_a_at 6.70E-02 4.50E-01 3.50E-01 3.50E-01 6.50E-03 
PDYN Ssc.121.1.S1_at 9.30E-01 9.90E-01 7.80E-01 6.20E-01 3.00E-03 
PENK Ssc.11281.1.A1_at 1.90E-01 5.40E-02 8.50E-02 7.90E-01 1.90E-04 
 Ssc.11281.2.S1_at 2.40E-01 9.40E-02 7.90E-01 6.30E-01 7.70E-06 
PNOC Ssc.15910.1.A1_at 1.60E-01 4.00E-01 5.10E-01 5.40E-01 6.80E-01 
 Ssc.15910.1.S1_at 5.70E-02 3.50E-01 8.90E-01 2.00E-01 1.20E-01 
PTHR Ssc.9991.1.S1_at 2.70E-01 7.60E-03 2.00E-01 1.50E-01 3.50E-07 
PTHY Ssc.668.1.S1_at 1.90E-01 5.10E-01 8.30E-01 6.80E-01 3.30E-04 
REL1 Ssc.162.1.S1_at 3.40E-01 7.70E-01 4.50E-01 2.90E-01 4.50E-04 
SCG1 Ssc.15718.1.A1_at 1.10E-01 8.10E-01 6.10E-01 6.60E-01 3.60E-05 
SCG2 Ssc.13645.1.A1_at 3.20E-02 8.70E-01 8.30E-01 4.10E-01 1.70E-02 
SCG3 Ssc.6770.1.A1_at 4.40E-01 5.10E-01 6.10E-01 7.30E-01 9.60E-05 
SECR Ssc.710.1.S1_at 5.90E-01 8.60E-01 8.20E-01 6.40E-01 3.50E-05 
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Supplementary Table. S2. (cont.) 
Symbol Affy Probe ID Embryo and Placenta 
GSE18467 GSE18467 GSE18467 GSE18467 GSE18467 
SMS Ssc.19520.1.A1_at 4.80E-01 3.90E-02 1.30E-01 8.60E-01 6.80E-04 
TKN1 Ssc.18075.1.A1_at 6.00E-01 3.00E-01 3.50E-01 5.40E-01 1.50E-01 
 Ssc.18075.2.S1_at 6.30E-01 4.30E-01 7.00E-01 7.20E-01 1.30E-04 
TKN4 Ssc.23153.1.S1_at 2.00E-01 9.30E-01 1.00E+00 2.30E-01 5.60E-03 
TKNK Ssc.19565.1.S1_at 2.60E-01 6.10E-01 5.20E-01 5.30E-01 6.60E-01 
 Ssc.19565.2.A1_at 2.20E-01 3.20E-01 5.30E-01 7.10E-01 3.20E-01 
UTS2 Ssc.437.1.S1_a_at 1.50E-01 6.60E-01 4.90E-01 7.60E-01 7.80E-05 
VEGFC Ssc.12790.1.A1_at 1.90E-02 7.80E-04 9.00E-01 8.70E-01 6.40E-01 
VEGF
D Ssc.29289.1.A1_at 7.40E-02 1.40E-01 3.10E-01 2.70E-01 3.60E-05 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   2.70E-02 6.60E-01 5.10E-01 8.40E-01 1.40E-04 
PCSK2 Ssc.109.1.S1_at 9.90E-02 4.20E-01 5.70E-01 8.30E-01 5.10E-01 
PCSK7 Ssc.5628.1.S1_at 6.20E-01 2.40E-01 4.10E-01 7.30E-01 9.70E-04 
Total P-
value in 
Column 
<0.005 
 
1 3 0 0 33 
Totals 
by 
Group 
 
    37 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Experiments 
Brain and Central Nervous System Reproduction 
GSE1685
5 GSE12604 
GSE14739-
H 
GSE14739-
T 
GSE14739-
A GSE11590 
GSE14739
-G 
ADM5 Ssc.26627.1.A1_at 3.40E-01 5.30E-01 9.70E-01 1.90E-03 5.00E-01 3.90E-01 6.20E-02 
ADML Ssc.314.1.S1_at 2.20E-06 2.60E-01 5.20E-01 7.20E-01 8.70E-02 1.60E-01 5.20E-02 
ANF Ssc.16245.1.S1_at 3.50E-01 9.70E-01 9.30E-01 3.30E-01 5.40E-01 2.00E-01 8.60E-01 
ANFB Ssc.629.1.S1_at 1.90E-01 6.20E-01 7.30E-01 5.10E-01 1.00E-01 6.00E-02 6.60E-01 
ANFC Ssc.23867.1.A1_at 9.40E-02 4.20E-01 9.40E-04 3.20E-01 4.80E-01 1.60E-01 6.10E-01 
AUGN Ssc.22487.1.S1_at 3.50E-01 1.30E-01 4.70E-02 2.80E-01 9.00E-02 1.20E-01 7.90E-02 
CART Ssc.15900.1.S1_at 3.60E-01 7.60E-01 3.60E-01 2.40E-03 2.50E-01 1.50E-01 3.20E-01 
CCKN Ssc.717.1.S1_at 6.30E-01 1.60E-01 2.60E-01 4.10E-01 5.00E-01 1.80E-01 1.20E-07 
CMGA Ssc.4653.1.S1_at 4.10E-01 2.70E-01 5.00E-01 8.70E-01 5.30E-01 1.50E-01 4.70E-01 
COLI Ssc.14556.1.S1_at 8.70E-01 6.40E-01 9.10E-01 3.50E-01 2.90E-01 1.50E-01 7.40E-01 
CRSP1 Ssc.3741.1.S1_at 7.00E-02 4.80E-01 7.70E-01 6.50E-01 6.10E-03 1.40E-01 6.60E-01 
CRSP2 Ssc.18558.1.S1_at 3.20E-01 5.40E-01 6.00E-01 1.70E-01 5.10E-01 1.40E-01 7.10E-01 
CRSP3 Ssc.17879.1.S1_at 8.50E-01 8.80E-01 4.00E-01 7.30E-01 3.30E-02 1.60E-01 2.20E-01 
EDN1 Ssc.9364.1.S1_at 9.70E-01 7.90E-01 7.10E-01 6.60E-01 5.40E-02 1.60E-01 1.60E-02 
GALA Ssc.713.1.S1_at 8.80E-01 5.10E-01 8.90E-01 3.30E-01 4.10E-01 1.50E-01 6.10E-01 
GALP Ssc.4875.1.S1_at 8.10E-01 4.70E-01 6.20E-01 1.50E-01 6.70E-02 1.40E-01 1.70E-02 
GAST Ssc.644.1.S1_at 1.90E-01 3.40E-01 9.00E-01 3.10E-01 5.30E-01 1.50E-01 5.20E-01 
GHRL Ssc.440.1.S1_at 2.90E-01 6.40E-01 9.80E-01 3.60E-01 2.50E-01 1.60E-01 5.50E-01 
GLUC Ssc.17225.1.S1_at 6.80E-01 8.00E-01 7.00E-01 5.00E-01 3.60E-01 5.60E-04 6.70E-01 
GON1 Ssc.16310.1.S1_at 8.40E-01 6.90E-01 4.10E-01 3.20E-01 2.20E-01 1.40E-01 7.50E-01 
HEPC Ssc.376.1.S1_at 5.50E-01 6.50E-01 8.20E-01 6.20E-01 1.50E-01 1.60E-01 8.40E-01 
IAPP Ssc.8324.1.A1_at 9.20E-01 9.70E-01 2.30E-01 3.50E-01 8.20E-02 1.20E-01 6.10E-01 
IGF1 Ssc.16231.1.S1_a_at 4.70E-06 4.60E-01 7.60E-01 3.80E-01 1.60E-01 1.70E-01 8.60E-03 
 Ssc.16231.2.A1_a_at 7.70E-01 7.30E-01 8.40E-01 1.30E-01 4.70E-01 1.40E-01 7.90E-01 
 Ssc.16231.3.S1_a_at 2.40E-07 4.90E-01 9.70E-01 4.90E-01 5.40E-01 1.70E-01 7.20E-02 
IGF2 Ssc.9365.1.S1_at 4.70E-01 4.30E-01 8.20E-01 1.50E-01 2.40E-01 7.80E-01 3.60E-01 
 Ssc.9365.2.S1_a_at 2.90E-01 3.20E-01 8.70E-02 4.40E-01 8.50E-01 1.40E-01 1.40E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Brain and Central Nervous System Reproduction 
GSE1685
5 GSE12604 
GSE14739-
H 
GSE14739-
T 
GSE14739-
A GSE11590 
GSE14739
-G 
 Ssc.9365.3.S1_a_at 6.10E-02 5.70E-01 1.10E-02 6.30E-01 9.40E-01 1.70E-01 2.50E-01 
 Ssc.9365.3.S1_x_at 7.70E-01 6.00E-01 5.10E-01 5.50E-01 6.60E-01 1.50E-01 3.50E-01 
 Ssc.9365.4.S1_a_at 3.50E-01 4.70E-01 9.10E-01 2.00E-01 1.00E-01 1.60E-01 3.90E-01 
 Ssc.9365.5.A1_at 1.30E-01 3.40E-01 9.10E-01 7.90E-01 4.70E-01 1.60E-01 4.70E-01 
 Ssc.9365.5.S1_at 9.30E-01 4.80E-01 7.50E-01 5.20E-01 3.40E-01 1.50E-01 9.20E-01 
 Ssc.9365.5.S1_a_at 6.40E-02 6.00E-01 9.60E-03 6.30E-01 6.20E-01 1.70E-01 3.70E-01 
 Ssc.9365.6.A1_a_at 7.60E-01 6.50E-01 6.90E-01 6.10E-02 6.80E-02 1.60E-01 3.00E-01 
 Ssc.9365.6.A1_x_at 2.70E-01 7.50E-01 4.60E-01 6.00E-02 3.00E-01 5.30E-01 3.20E-01 
 Ssc.9365.6.S1_x_at 1.80E-02 3.40E-01 2.30E-03 5.70E-01 3.40E-01 1.40E-01 3.50E-01 
 Ssc.9365.7.A1_x_at 3.80E-01 4.50E-01 8.50E-01 1.80E-01 1.60E-01 2.20E-01 3.20E-01 
INS Ssc.583.1.S1_at 6.00E-01 4.00E-01 9.10E-01 2.20E-01 4.20E-01 1.50E-01 6.80E-01 
INSL3 Ssc.11990.1.S1_at 2.00E-01 5.40E-01 8.10E-01 3.80E-01 4.70E-01 1.50E-01 7.20E-02 
MCH Ssc.3287.1.S1_at 9.40E-01 2.10E-01 3.50E-01 3.30E-01 1.60E-01 1.60E-01 6.10E-01 
MOTI Ssc.714.1.S1_at 7.90E-01 6.00E-01 8.20E-01 6.70E-01 1.10E-01 1.60E-01 7.30E-01 
NEU1 Ssc.15668.1.A1_at 3.90E-01 6.30E-01 1.30E-01 3.90E-01 9.80E-01 1.40E-01 1.80E-01 
NEU2 Ssc.4210.1.S1_at 1.20E-01 6.60E-01 1.60E-01 3.00E-01 7.20E-01 1.60E-01 4.30E-01 
NMB Ssc.2083.1.A1_at 5.00E-01 5.20E-01 2.10E-01 2.10E-01 1.50E-02 1.50E-01 6.80E-01 
NMU Ssc.12508.1.A1_at 6.90E-01 3.90E-02 5.50E-01 3.40E-01 1.70E-01 1.30E-01 5.60E-01 
NPW Ssc.15796.1.S1_at 6.60E-01 4.30E-01 9.40E-01 4.10E-01 5.20E-01 1.60E-01 6.30E-01 
NPY Ssc.15981.1.A1_at 7.60E-01 9.50E-01 8.50E-01 5.10E-01 1.00E-01 1.60E-01 5.50E-01 
 Ssc.15981.1.S1_at 8.10E-04 3.20E-01 9.80E-01 7.20E-01 2.30E-01 1.40E-01 7.30E-01 
OREX Ssc.15983.1.S1_at 5.10E-01 1.60E-01 2.00E-01 7.50E-01 6.30E-01 2.60E-01 8.40E-01 
PACA Ssc.27598.1.S1_at 1.10E-01 3.30E-01 2.30E-02 2.20E-01 7.40E-01 7.40E-01 8.00E-01 
PAHO Ssc.456.1.S1_at 6.10E-01 6.60E-01 9.80E-01 3.50E-01 3.00E-01 1.40E-01 5.80E-01 
PCSK1 Ssc.17429.1.S1_at 7.50E-02 8.80E-01 9.90E-01 5.40E-01 9.80E-01 3.00E-01 3.70E-05 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Brain and Central Nervous System Reproduction 
GSE1685
5 GSE12604 
GSE14739-
H 
GSE14739-
T 
GSE14739-
A GSE11590 
GSE14739
-G 
PDGFA Ssc.6173.3.S1_a_at 1.20E-03 3.00E-01 9.90E-02 5.40E-01 1.90E-01 9.60E-02 1.10E-01 
PDYN Ssc.121.1.S1_at 4.90E-05 8.80E-01 3.50E-01 5.00E-01 5.10E-01 1.20E-01 7.20E-01 
PENK Ssc.11281.1.A1_at 9.30E-01 6.50E-01 4.50E-01 7.50E-01 5.00E-01 4.30E-01 2.00E-05 
 Ssc.11281.2.S1_at 2.40E-01 3.00E-01 6.80E-01 3.60E-01 4.60E-01 3.10E-01 7.20E-02 
PNOC Ssc.15910.1.A1_at 3.80E-01 5.20E-01 8.60E-01 7.00E-01 3.80E-01 1.60E-01 4.90E-01 
PTHR Ssc.15910.1.S1_at 7.20E-01 7.90E-01 4.60E-01 5.00E-01 1.40E-01 1.60E-01 6.80E-01 
PTHY Ssc.9991.1.S1_at 2.60E-04 9.20E-02 1.80E-01 4.70E-01 1.80E-01 1.50E-03 7.10E-10 
REL1 Ssc.668.1.S1_at 5.60E-01 8.20E-01 5.30E-01 2.20E-01 6.10E-02 1.50E-01 5.70E-01 
SCG1 Ssc.162.1.S1_at 3.00E-01 8.90E-01 4.60E-01 2.80E-01 1.60E-01 2.40E-01 4.90E-01 
SCG2 Ssc.15718.1.A1_at 8.30E-01 6.70E-01 5.20E-01 1.70E-01 9.80E-01 1.40E-01 7.80E-01 
SCG3 Ssc.13645.1.A1_at 6.30E-01 6.70E-01 4.80E-01 1.80E-01 1.30E-01 1.60E-01 6.80E-01 
SECR Ssc.6770.1.A1_at 8.70E-01 4.90E-01 5.80E-03 4.00E-01 3.80E-02 1.00E-03 4.60E-01 
SMS Ssc.710.1.S1_at 6.30E-01 1.90E-01 9.00E-02 2.90E-01 4.10E-01 9.30E-01 5.50E-01 
TKN1 Ssc.19520.1.A1_at 5.00E-01 7.20E-01 6.70E-01 3.00E-01 1.60E-01 2.40E-01 6.90E-01 
 Ssc.18075.1.A1_at 7.30E-01 1.60E-01 9.30E-01 5.60E-01 1.80E-01 1.30E-01 6.60E-01 
TKN4 Ssc.23153.1.S1_at 9.20E-01 2.90E-01 8.00E-01 4.30E-01 2.70E-01 1.30E-01 5.10E-01 
TKNK Ssc.19565.1.S1_at 8.00E-01 5.40E-01 8.10E-01 4.80E-01 2.50E-01 1.50E-01 2.50E-02 
  Ssc.19565.2.A1_at 1.90E-01 3.00E-01 7.00E-01 8.00E-01 3.30E-01 3.30E-01 1.40E-02 
UTS2 Ssc.437.1.S1_a_at 4.70E-01 4.40E-01 8.90E-01 4.00E-01 1.20E-01 8.90E-02 5.50E-01 
VEGFC Ssc.12790.1.A1_at 1.50E-09 5.30E-01 5.50E-02 3.80E-01 1.50E-01 1.50E-01 4.40E-01 
VEGFD Ssc.29289.1.A1_at 3.70E-01 3.90E-01 3.00E-01 7.80E-01 4.60E-01 5.90E-01 7.80E-02 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   6.60E-01 5.00E-01 6.20E-02 9.10E-02 9.90E-03 6.50E-01 2.50E-01 
PCSK2 Ssc.109.1.S1_at 4.20E-01 3.60E-01 4.60E-01 6.30E-01 5.10E-01 1.00E-01 5.70E-01 
PCSK7 Ssc.5628.1.S1_at 1.00E-02 6.90E-01 1.30E-01 9.90E-01 5.30E-01 2.00E-01 1.10E-01 
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Supplementary Table S2. (cont.) 
Total P-
value in 
Column 
<0.005  8 0 2 2 0 3 4 
Totals by 
Group      12  7 
 
Symbol Affy Probe ID 
Experiments 
Muscle 
GSE18653 GSE19275 GSE8974 GSE14643 GSE15211 GSE21096 GSE16348-D 
ADM5 Ssc.26627.1.A1_at 8.10E-01 1.70E-02 1.20E-01 9.80E-01 1.30E-01 1.10E-01 2.50E-01 
ADML Ssc.314.1.S1_at 6.60E-01 2.90E-02 6.30E-04 2.80E-01 7.50E-01 2.20E-01 3.30E-01 
ANF Ssc.16245.1.S1_at 4.60E-01 2.50E-01 9.80E-01 1.20E-01 3.50E-01 2.30E-04 5.20E-02 
ANFB Ssc.629.1.S1_at 6.10E-01 8.20E-02 2.40E-02 1.20E-01 3.80E-01 1.10E-03 9.60E-02 
ANFC Ssc.23867.1.A1_at 1.40E-01 2.40E-02 9.70E-01 9.40E-01 1.20E-01 1.00E-02 7.30E-01 
AUGN Ssc.22487.1.S1_at 6.00E-01 8.80E-01 3.90E-01 6.90E-01 2.90E-01 1.70E-04 7.20E-01 
CART Ssc.15900.1.S1_at 6.50E-01 4.60E-01 6.00E-01 4.30E-01 2.10E-02 1.00E-02 7.60E-02 
CCKN Ssc.717.1.S1_at 1.40E-01 2.80E-02 9.40E-01 5.80E-01 3.80E-01 2.10E-04 5.90E-02 
CMGA Ssc.4653.1.S1_at 1.00E+00 9.80E-02 4.30E-01 8.30E-01 8.40E-01 9.80E-02 1.00E-01 
COLI Ssc.14556.1.S1_at 1.10E-01 3.40E-01 8.20E-01 4.90E-01 1.60E-01 5.70E-02 1.00E-01 
CRSP1 Ssc.3741.1.S1_at 7.90E-01 1.60E-01 2.60E-01 7.80E-01 2.80E-01 2.10E-02 4.50E-01 
CRSP2 Ssc.18558.1.S1_at 1.60E-01 1.80E-02 7.00E-02 6.00E-01 4.80E-02 2.10E-02 7.80E-02 
CRSP3 Ssc.17879.1.S1_at 8.10E-02 6.00E-02 4.80E-01 8.20E-01 1.60E-01 5.30E-02 6.50E-02 
EDN1 Ssc.9364.1.S1_at 9.90E-01 1.00E-02 3.40E-01 4.30E-01 2.10E-01 3.20E-01 1.00E-01 
GALA Ssc.713.1.S1_at 1.00E-01 3.90E-02 9.40E-01 5.10E-01 2.70E-01 3.00E-02 1.10E-01 
GALP Ssc.4875.1.S1_at 1.90E-01 8.30E-04 5.50E-01 6.10E-01 4.90E-01 7.20E-03 3.80E-01 
GAST Ssc.644.1.S1_at 9.70E-01 3.70E-01 4.80E-01 9.00E-01 1.10E-01 6.80E-02 1.50E-01 
GHRL Ssc.440.1.S1_at 7.50E-01 1.30E-02 7.40E-01 4.90E-01 1.40E-01 3.40E-02 1.60E-01 
GLUC Ssc.17225.1.S1_at 7.90E-02 4.70E-01 7.50E-01 2.90E-01 3.50E-01 7.50E-03 1.20E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID Muscle 
GSE18653 GSE19275 GSE8974 GSE14643 GSE15211 GSE21096 GSE16348-D 
GON1 Ssc.16310.1.S1_at 3.20E-01 2.00E-02 8.30E-01 3.30E-01 3.10E-02 4.10E-02 5.80E-02 
HEPC Ssc.376.1.S1_at 3.70E-01 2.90E-02 9.30E-01 2.10E-01 2.70E-01 3.10E-02 1.30E-01 
IAPP Ssc.8324.1.A1_at 1.20E-01 5.10E-02 7.70E-01 2.00E-01 8.00E-01 5.20E-02 5.80E-02 
IGF1 
Ssc.16231.1.S1_a_
at 3.00E-01 5.30E-01 1.30E-01 5.70E-01 9.30E-01 2.20E-02 5.20E-02 
 
Ssc.16231.2.A1_a_
at 4.80E-01 1.70E-01 6.20E-01 2.30E-01 1.40E-01 6.00E-02 3.10E-01 
 
Ssc.16231.3.S1_a_
at 6.00E-01 7.10E-01 8.00E-02 1.00E+00 9.10E-01 2.10E-02 3.20E-01 
IGF2 Ssc.9365.1.S1_at 4.10E-01 3.50E-01 6.60E-01 3.90E-01 3.10E-01 1.80E-02 2.70E-01 
 Ssc.9365.2.S1_a_at 5.10E-01 6.20E-02 1.10E-01 7.50E-01 6.30E-01 7.90E-02 4.20E-01 
 Ssc.9365.3.S1_a_at 7.30E-01 1.00E-01 9.50E-01 7.50E-01 3.60E-01 4.30E-02 1.60E-01 
 Ssc.9365.3.S1_x_at 5.60E-01 1.50E-01 2.00E-01 5.30E-01 4.10E-01 3.50E-02 2.50E-01 
 Ssc.9365.4.S1_a_at 5.70E-01 2.60E-02 8.50E-01 1.80E-01 9.90E-02 4.10E-02 2.60E-01 
 Ssc.9365.5.A1_at 4.10E-01 6.80E-02 8.90E-01 9.70E-01 1.60E-01 7.90E-02 2.50E-01 
 Ssc.9365.5.S1_at 5.70E-01 2.60E-01 4.10E-01 4.30E-01 1.20E-01 2.80E-02 3.10E-01 
 Ssc.9365.5.S1_a_at 3.80E-01 1.90E-01 8.40E-01 6.40E-01 7.30E-01 1.10E-01 3.80E-01 
 Ssc.9365.6.A1_a_at 2.60E-01 7.30E-01 7.60E-01 7.60E-01 7.00E-01 9.10E-02 3.40E-01 
 
Ssc.9365.6.A1_x_a
t 2.60E-01 3.60E-01 7.30E-01 9.40E-01 5.30E-01 5.00E-03 1.70E-02 
 Ssc.9365.6.S1_x_at 3.30E-01 3.40E-01 7.30E-01 3.20E-01 2.40E-01 8.50E-03 1.10E-01 
 
Ssc.9365.7.A1_x_a
t 4.50E-01 4.60E-01 8.70E-01 9.40E-01 8.10E-02 1.20E-01 3.30E-02 
INS Ssc.583.1.S1_at 3.80E-01 2.70E-02 8.60E-01 4.10E-01 1.00E+00 1.20E-02 1.00E-02 
INSL3 Ssc.11990.1.S1_at 1.60E-01 2.60E-01 9.20E-01 3.50E-01 2.60E-01 7.90E-02 4.00E-01 
MCH Ssc.3287.1.S1_at 9.80E-01 1.80E-02 2.30E-01 8.80E-01 3.60E-01 7.80E-02 7.00E-02 
MOTI Ssc.714.1.S1_at 2.40E-01 1.00E-02 9.70E-01 2.70E-01 3.40E-01 3.80E-02 9.70E-02 
NEU1 Ssc.15668.1.A1_at 1.20E-01 1.30E-02 7.40E-01 3.70E-01 5.10E-02 6.70E-03 4.80E-02 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID Muscle 
GSE18653 GSE19275 GSE8974 GSE14643 GSE15211 GSE21096 GSE16348-D 
NEU2 Ssc.4210.1.S1_at 8.00E-02 3.50E-02 7.80E-01 4.60E-01 7.10E-02 2.90E-03 1.40E-02 
NMB Ssc.2083.1.A1_at 5.40E-01 2.10E-02 2.60E-01 6.20E-01 6.90E-02 4.40E-02 7.10E-02 
NMU Ssc.12508.1.A1_at 1.20E-01 1.30E-02 7.80E-01 2.00E-01 7.80E-01 5.00E-02 6.40E-02 
NPW Ssc.15796.1.S1_at 1.10E-01 2.20E-01 7.30E-01 8.50E-01 1.50E-01 3.90E-02 2.70E-01 
NPY Ssc.15981.1.A1_at 1.80E-01 1.90E-01 4.50E-01 5.80E-01 3.80E-01 3.00E-03 1.30E-01 
 Ssc.15981.1.S1_at 3.40E-01 2.90E-02 5.70E-01 4.40E-01 5.50E-01 3.40E-02 9.50E-02 
OREX Ssc.15983.1.S1_at 6.50E-01 1.70E-01 7.40E-01 2.80E-01 1.10E-01 9.90E-01 9.40E-02 
PACA Ssc.27598.1.S1_at 2.80E-01 2.30E-02 8.10E-01 2.00E-01 2.60E-01 2.30E-01 5.60E-01 
PAHO Ssc.456.1.S1_at 2.70E-01 3.10E-02 8.70E-01 3.10E-01 2.00E-01 3.20E-02 9.30E-02 
PCSK1 Ssc.17429.1.S1_at 3.50E-01 9.30E-01 5.10E-02 1.80E-01 9.30E-02 9.40E-02 1.30E-01 
PDGFA Ssc.6173.3.S1_a_at 1.90E-01 7.70E-01 2.90E-01 2.60E-01 9.10E-01 1.40E-01 2.70E-02 
PDYN Ssc.121.1.S1_at 1.60E-01 4.60E-02 1.90E-01 2.50E-01 8.00E-01 2.50E-01 3.10E-02 
PENK Ssc.11281.1.A1_at 4.30E-02 3.50E-01 5.60E-01 2.70E-01 7.40E-01 6.20E-02 9.40E-01 
  Ssc.11281.2.S1_at 3.90E-01 8.60E-01 9.40E-01 3.90E-01 1.00E-01 1.90E-01 1.10E-01 
PNOC Ssc.15910.1.A1_at 6.30E-01 1.20E-01 8.70E-01 7.70E-01 9.70E-01 1.90E-01 3.50E-01 
  Ssc.15910.1.S1_at 4.10E-01 2.10E-02 9.90E-01 3.60E-01 5.40E-01 1.80E-01 1.90E-01 
PTHR Ssc.9991.1.S1_at 3.80E-02 1.80E-01 2.10E-01 3.80E-01 1.90E-01 3.20E-01 4.80E-01 
PTHY Ssc.668.1.S1_at 2.20E-01 7.90E-03 7.80E-01 6.10E-01 5.90E-01 2.50E-02 4.90E-02 
REL1 Ssc.162.1.S1_at 4.70E-01 9.70E-03 9.50E-01 2.70E-01 4.90E-01 1.00E-01 1.40E-01 
SCG1 Ssc.15718.1.A1_at 2.10E-01 3.90E-01 2.80E-01 3.10E-01 3.70E-01 2.40E-02 9.50E-02 
SCG2 Ssc.13645.1.A1_at 1.50E-01 3.50E-01 2.40E-01 2.70E-01 3.90E-01 8.00E-03 1.60E-01 
SCG3 Ssc.6770.1.A1_at 1.70E-01 1.00E-01 8.80E-01 2.90E-01 4.50E-01 6.20E-03 1.10E-01 
SECR Ssc.710.1.S1_at 4.70E-01 3.70E-01 2.60E-01 6.40E-01 1.70E-01 4.20E-02 8.00E-01 
SMS Ssc.19520.1.A1_at 4.70E-01 8.80E-01 2.50E-02 2.10E-01 3.30E-01 4.90E-02 2.80E-03 
TKN1 Ssc.18075.1.A1_at 2.90E-01 6.30E-03 9.00E-01 1.60E-01 6.60E-01 7.20E-02 2.70E-02 
  Ssc.18075.2.S1_at 2.30E-01 9.10E-03 6.90E-01 5.50E-01 1.00E-01 2.50E-02 4.40E-02 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID Muscle 
GSE18653 GSE19275 GSE8974 GSE14643 GSE15211 GSE21096 GSE16348-D 
TKN4 Ssc.23153.1.S1_at 3.60E-01 4.80E-02 4.40E-01 9.40E-01 5.50E-01 5.70E-01 1.00E-01 
TKNK Ssc.19565.1.S1_at 1.60E-01 1.20E-02 7.50E-01 5.50E-01 2.10E-01 1.40E-02 9.70E-02 
  Ssc.19565.2.A1_at 8.20E-01 3.50E-01 8.10E-01 2.30E-01 2.30E-01 4.50E-02 6.00E-02 
UTS2 Ssc.437.1.S1_a_at 3.00E-01 1.10E-02 8.60E-01 3.60E-01 3.70E-01 3.50E-02 5.60E-02 
VEGFC Ssc.12790.1.A1_at 8.90E-01 1.90E-01 1.20E-01 9.50E-01 7.40E-03 4.30E-06 6.10E-02 
VEGFD Ssc.29289.1.A1_at 5.60E-01 5.30E-02 4.40E-01 4.60E-01 4.20E-01 2.90E-02 1.80E-01 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   1.50E-01 1.30E-02 8.50E-01 2.20E-01 2.80E-01 7.90E-02 3.40E-02 
PCSK2 Ssc.109.1.S1_at 2.10E-01 1.40E-01 8.40E-01 1.90E-01 2.90E-01 1.30E-02 8.80E-02 
PCSK7 Ssc.5628.1.S1_at 1.60E-01 1.30E-01 1.90E-01 2.40E-01 1.00E-01 2.40E-02 3.30E-01 
Total P-
value in 
Column 
<0.005  0 1 1 0 0 7 1 
Totals by 
Group        10 
 
  Experiments 
Symbol Affy Probe ID 
Fat 
GSE17309 GSE14373 GSE14739-B GSE9333 
GSE18359-
A 
GSE18359-
L 
GSE13528-
F 
GSE13528
-L 
ADM5 Ssc.26627.1.A1_at 4.60E-01 9.90E-01 7.00E-02 4.80E-01 4.00E-01 3.10E-01 2.00E-01 3.30E-01 
ADML Ssc.314.1.S1_at 6.00E-01 3.40E-01 7.60E-01 8.60E-01 2.00E-01 3.40E-01 1.60E-01 2.60E-01 
ANF Ssc.16245.1.S1_at 6.30E-01 6.20E-01 1.50E-01 7.10E-01 2.20E-01 6.60E-01 4.20E-01 4.50E-01 
ANFB Ssc.629.1.S1_at 3.10E-01 3.60E-01 2.30E-01 1.80E-01 3.60E-01 9.40E-01 6.40E-01 9.20E-01 
ANFC Ssc.23867.1.A1_at 5.90E-01 5.80E-01 7.70E-01 3.70E-01 6.50E-01 8.80E-01 8.20E-02 9.70E-01 
AUGN Ssc.22487.1.S1_at 6.40E-01 3.80E-01 3.40E-01 9.10E-01 5.20E-01 1.20E-01 2.70E-04 3.60E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Fat 
GSE17309 GSE14373 GSE14739-B GSE9333 
GSE18359-
A 
GSE18359-
L 
GSE13528-
F 
GSE13528
-L 
CART Ssc.15900.1.S1_at 4.60E-01 9.40E-01 1.60E-01 7.90E-01 7.60E-01 7.40E-01 1.70E-01 5.00E-01 
CCKN Ssc.717.1.S1_at 5.20E-01 2.50E-01 8.20E-01 3.90E-01 5.30E-01 6.90E-01 1.80E-01 1.20E-02 
CMGA Ssc.4653.1.S1_at 7.20E-01 7.40E-01 3.30E-01 3.30E-01 4.30E-01 7.80E-01 1.20E-03 3.30E-01 
COLI Ssc.14556.1.S1_at 6.20E-01 9.50E-02 8.70E-01 3.60E-01 4.00E-01 5.70E-01 4.00E-01 9.20E-01 
CRSP1 Ssc.3741.1.S1_at 4.40E-01 1.10E-01 1.70E-01 4.40E-01 6.10E-01 5.50E-01 6.00E-01 3.30E-01 
CRSP2 Ssc.18558.1.S1_at 6.00E-01 6.10E-01 2.00E-01 8.00E-01 6.30E-01 9.90E-01 3.10E-01 9.10E-01 
CRSP3 Ssc.17879.1.S1_at 3.80E-01 9.00E-01 5.00E-02 5.10E-01 9.20E-01 9.90E-01 5.00E-01 8.60E-01 
EDN1 Ssc.9364.1.S1_at 5.80E-01 9.60E-01 9.90E-01 7.90E-01 6.80E-01 3.40E-01 3.70E-03 2.90E-01 
GALA Ssc.713.1.S1_at 5.60E-01 6.70E-01 2.30E-01 7.60E-01 7.40E-01 9.80E-01 7.80E-01 9.50E-01 
GALP Ssc.4875.1.S1_at 3.30E-01 7.20E-01 9.00E-02 6.10E-01 4.30E-01 6.60E-01 8.40E-01 7.90E-01 
GAST Ssc.644.1.S1_at 7.40E-01 7.30E-01 6.60E-01 1.60E-01 5.10E-01 8.50E-01 2.30E-01 3.60E-01 
GHRL Ssc.440.1.S1_at 8.20E-01 5.30E-01 5.40E-01 6.20E-01 9.30E-01 9.90E-01 3.30E-01 3.20E-01 
GLUC Ssc.17225.1.S1_at 4.10E-01 4.60E-01 3.10E-01 4.90E-01 6.20E-01 8.60E-01 4.10E-01 9.10E-01 
GON1 Ssc.16310.1.S1_at 6.00E-01 5.20E-01 1.30E-01 5.70E-01 9.70E-01 9.10E-01 5.70E-01 5.20E-01 
HEPC Ssc.376.1.S1_at 1.50E-01 7.80E-01 8.30E-02 1.00E+00 4.50E-01 8.90E-02 3.30E-01 3.30E-01 
IAPP Ssc.8324.1.A1_at 6.10E-01 6.80E-01 1.00E-01 5.30E-01 9.10E-01 9.10E-01 5.10E-01 7.60E-01 
IGF1 
Ssc.16231.1.S1_a
_at 7.40E-02 5.30E-01 4.40E-01 6.50E-01 5.60E-03 7.10E-03 6.10E-03 2.70E-01 
  
Ssc.16231.2.A1_a
_at 6.70E-01 9.10E-01 3.80E-01 9.70E-01 5.10E-01 8.30E-01 2.10E-01 9.80E-01 
  
Ssc.16231.3.S1_a
_at 1.50E-01 7.50E-01 2.80E-01 4.90E-01 3.50E-02 7.50E-02 1.30E-02 2.90E-01 
IGF2 Ssc.9365.1.S1_at 5.20E-01 8.20E-01 6.50E-01 7.80E-01 5.40E-01 7.80E-01 2.90E-01 8.70E-01 
 
Ssc.9365.2.S1_a_
at 2.70E-01 1.80E-02 4.20E-03 6.20E-01 8.40E-01 8.40E-01 3.40E-02 1.80E-02 
 
Ssc.9365.3.S1_a_
at 5.80E-01 5.00E-03 8.20E-02 5.90E-01 6.40E-01 9.00E-01 1.10E-01 3.80E-02 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Fat 
GSE17309 GSE14373 GSE14739-B GSE9333 
GSE18359-
A 
GSE18359-
L 
GSE13528-
F 
GSE13528
-L 
 
Ssc.9365.3.S1_x_
at 4.90E-01 9.30E-03 2.40E-02 5.70E-01 7.50E-01 7.80E-01 3.10E-02 2.60E-02 
 
Ssc.9365.4.S1_a_
at 2.20E-01 8.90E-01 3.30E-01 7.30E-01 8.30E-01 9.10E-01 4.00E-01 2.30E-01 
 Ssc.9365.5.A1_at 9.10E-01 9.70E-01 5.10E-02 4.70E-01 5.70E-01 8.10E-01 2.90E-01 9.40E-01 
 Ssc.9365.5.S1_at 4.30E-01 3.40E-01 2.30E-01 4.50E-01 8.40E-01 6.20E-01 5.40E-01 5.30E-01 
 Ssc.9365.5.S1_a_
at 4.40E-01 3.70E-03 1.20E-01 6.50E-01 6.10E-01 9.30E-01 6.40E-02 3.70E-02 
 Ssc.9365.6.A1_a_
at 9.10E-01 9.20E-01 8.10E-01 6.00E-01 9.80E-01 7.60E-01 2.60E-01 9.30E-01 
 Ssc.9365.6.A1_x_
at 4.40E-01 4.60E-01 3.30E-01 2.80E-01 7.20E-01 9.90E-01 4.90E-01 6.80E-01 
 Ssc.9365.6.S1_x_
at 3.70E-01 2.00E-02 9.70E-02 9.20E-01 5.20E-01 7.80E-01 5.30E-02 5.30E-02 
  
Ssc.9365.7.A1_x_
at 9.80E-01 9.30E-01 3.80E-01 4.90E-01 8.20E-01 8.40E-01 5.00E-01 9.90E-01 
INS Ssc.583.1.S1_at 8.80E-01 6.30E-01 3.30E-02 9.10E-01 5.10E-01 9.80E-01 2.40E-01 7.60E-01 
INSL3 Ssc.11990.1.S1_at 7.50E-01 5.90E-01 8.00E-01 9.10E-01 5.30E-01 7.10E-01 6.80E-01 7.40E-01 
MCH Ssc.3287.1.S1_at 4.90E-01 7.50E-01 1.10E-01 9.60E-01 8.10E-01 9.60E-01 4.70E-01 7.50E-01 
MOTI Ssc.714.1.S1_at 4.80E-01 9.90E-01 5.60E-01 4.10E-01 6.40E-02 5.40E-01 2.30E-01 3.90E-01 
NEU1 Ssc.15668.1.A1_at 9.10E-01 5.50E-01 8.50E-02 4.60E-01 6.80E-01 9.60E-01 3.10E-01 7.60E-01 
NEU2 Ssc.4210.1.S1_at 7.30E-01 9.10E-01 1.50E-01 7.70E-01 3.20E-01 6.40E-01 4.60E-01 5.50E-01 
NMB Ssc.2083.1.A1_at 4.70E-01 1.90E-01 1.20E-01 3.00E-01 1.80E-01 9.50E-01 6.50E-02 9.00E-01 
NMU Ssc.12508.1.A1_at 8.40E-01 4.80E-01 7.20E-01 9.60E-01 5.80E-01 9.90E-01 7.60E-01 7.70E-01 
NPW Ssc.15796.1.S1_at 8.40E-01 9.80E-01 6.70E-01 8.00E-01 6.80E-01 9.00E-01 2.80E-01 5.20E-01 
NPY Ssc.15981.1.A1_at 6.30E-01 7.70E-01 2.30E-02 7.00E-01 5.00E-01 9.60E-01 2.10E-01 9.00E-01 
  Ssc.15981.1.S1_at 5.00E-01 5.80E-01 8.40E-02 8.80E-01 7.30E-01 9.50E-01 5.10E-01 6.60E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Fat 
GSE17309 GSE14373 GSE14739-B GSE9333 
GSE18359-
A 
GSE18359-
L 
GSE13528-
F 
GSE13528
-L 
OREX Ssc.15983.1.S1_at 8.30E-01 6.90E-01 2.00E-02 6.50E-01 4.10E-01 1.90E-01 2.70E-01 8.00E-01 
PACA Ssc.27598.1.S1_at 6.00E-01 8.00E-01 5.60E-03 7.10E-01 4.00E-01 1.80E-01 4.40E-01 4.20E-01 
PAHO Ssc.456.1.S1_at 4.90E-01 8.40E-01 1.60E-01 6.20E-01 8.60E-01 9.60E-01 4.50E-01 6.00E-01 
PCSK1 Ssc.17429.1.S1_at 4.60E-01 6.70E-01 6.20E-01 9.90E-01 7.50E-01 9.40E-01 2.50E-01 1.40E-01 
PDGFA Ssc.6173.3.S1_a_at 1.10E-01 3.50E-01 6.10E-02 4.30E-01 4.50E-01 2.40E-01 1.00E+00 4.40E-01 
PDYN Ssc.121.1.S1_at 5.00E-01 9.90E-01 5.10E-02 7.40E-01 4.60E-01 9.90E-01 6.20E-01 7.40E-01 
PENK Ssc.11281.1.A1_at 5.60E-01 7.20E-01 6.90E-01 5.80E-01 7.60E-01 1.00E+00 5.80E-05 9.00E-01 
  Ssc.11281.2.S1_at 6.10E-01 5.20E-01 4.50E-01 4.90E-01 3.60E-01 9.40E-01 6.40E-02 9.70E-01 
PNOC Ssc.15910.1.A1_at 4.40E-01 1.80E-01 4.90E-01 4.90E-01 4.10E-01 2.10E-01 9.90E-02 2.40E-01 
  Ssc.15910.1.S1_at 6.20E-01 7.40E-01 1.70E-01 5.70E-01 6.30E-01 8.60E-01 1.30E-01 7.80E-01 
PTHR Ssc.9991.1.S1_at 9.90E-01 6.30E-01 4.50E-01 8.70E-01 4.30E-01 9.80E-01 3.20E-01 7.80E-01 
PTHY Ssc.668.1.S1_at 6.20E-01 8.80E-01 1.20E-01 9.00E-01 7.60E-01 1.00E+00 5.90E-01 9.00E-01 
REL1 Ssc.162.1.S1_at 6.20E-01 6.10E-02 3.20E-02 5.10E-01 4.90E-01 1.00E+00 9.30E-01 1.00E+00 
SCG1 Ssc.15718.1.A1_at 7.10E-01 8.70E-01 6.90E-01 7.40E-01 3.80E-01 9.90E-01 4.90E-01 9.90E-01 
SCG2 Ssc.13645.1.A1_at 3.60E-03 8.40E-01 6.20E-01 8.40E-01 9.10E-01 9.50E-01 6.00E-01 8.30E-01 
SCG3 Ssc.6770.1.A1_at 6.40E-01 3.50E-01 4.50E-01 2.90E-01 5.70E-01 9.70E-01 6.20E-01 6.20E-01 
SECR Ssc.710.1.S1_at 6.70E-01 2.10E-02 2.80E-01 5.30E-01 2.10E-01 3.90E-02 4.30E-01 6.40E-02 
SMS Ssc.19520.1.A1_at 9.80E-01 1.70E-01 1.00E-01 7.60E-01 7.80E-01 9.80E-01 5.50E-01 4.40E-01 
TKN1 Ssc.18075.1.A1_at 7.50E-01 6.50E-01 7.70E-01 6.00E-01 5.40E-02 9.30E-01 5.20E-01 8.20E-01 
  Ssc.18075.2.S1_at 6.40E-01 9.20E-01 2.20E-01 7.90E-01 7.50E-01 9.70E-01 1.20E-01 9.40E-01 
TKN4 Ssc.23153.1.S1_at 9.40E-01 7.60E-01 5.00E-01 6.10E-01 9.00E-01 8.80E-01 4.10E-01 1.90E-01 
TKNK Ssc.19565.1.S1_at 5.50E-01 6.30E-01 4.20E-01 7.30E-01 5.20E-01 9.90E-01 6.60E-01 9.70E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Fat 
GSE17309 GSE14373 GSE14739-B GSE9333 
GSE18359-
A 
GSE18359-
L 
GSE13528-
F 
GSE13528
-L 
  Ssc.19565.2.A1_at 6.30E-01 1.00E+00 6.30E-01 5.30E-01 2.30E-01 8.30E-01 3.10E-01 3.30E-01 
UTS2 Ssc.437.1.S1_a_at 8.20E-01 9.10E-01 4.60E-02 4.60E-01 8.70E-01 9.40E-01 8.30E-01 9.40E-01 
VEGFC Ssc.12790.1.A1_at 6.70E-01 4.40E-01 5.70E-01 8.20E-01 6.20E-03 1.50E-01 5.30E-02 3.80E-01 
VEGFD Ssc.29289.1.A1_at 6.10E-01 8.70E-01 6.50E-01 7.00E-01 1.10E-02 5.70E-01 2.10E-01 4.40E-01 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   3.10E-01 7.80E-01 4.70E-01 2.80E-01 4.10E-01 1.00E+00 1.20E-01 8.40E-01 
PCSK2 Ssc.109.1.S1_at 3.10E-01 6.50E-01 2.50E-01 6.30E-01 4.30E-01 3.30E-01 5.10E-01 8.40E-01 
PCSK7 Ssc.5628.1.S1_at 4.30E-01 1.00E-01 5.90E-01 4.90E-01 9.20E-01 4.40E-01 5.70E-01 5.40E-01 
Total P-
value in 
Column 
<0.005  1 1 1 0 0 0 4 0 
Totals by 
Group         7 
 
  Experiments 
Symbol Affy Probe ID 
Gut 
GSE13457 GSE15256 
ADM5 Ssc.26627.1.A1_at 3.90E-01 4.90E-02 
ADML Ssc.314.1.S1_at 3.00E-01 4.40E-04 
ANF Ssc.16245.1.S1_at 7.80E-02 5.50E-01 
ANFB Ssc.629.1.S1_at 6.00E-01 5.50E-01 
ANFC Ssc.23867.1.A1_at 5.90E-01 1.20E-01 
AUGN Ssc.22487.1.S1_at 7.90E-01 3.40E-01 
CART Ssc.15900.1.S1_at 5.90E-01 2.60E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Gut 
GSE13457 GSE15256 
CCKN Ssc.717.1.S1_at 2.30E-01 1.10E-01 
CMGA Ssc.4653.1.S1_at 9.80E-01 7.60E-04 
COLI Ssc.14556.1.S1_at 1.00E-01 2.00E-01 
CRSP1 Ssc.3741.1.S1_at 6.80E-01 4.40E-01 
CRSP2 Ssc.18558.1.S1_at 3.30E-02 7.10E-01 
CRSP3 Ssc.17879.1.S1_at 1.80E-01 4.50E-01 
EDN1 Ssc.9364.1.S1_at 2.80E-01 2.40E-01 
GALA Ssc.713.1.S1_at 5.70E-01 9.40E-04 
GALP Ssc.4875.1.S1_at 1.70E-01 1.50E-01 
GAST Ssc.644.1.S1_at 5.30E-01 6.80E-01 
GHRL Ssc.440.1.S1_at 3.30E-01 4.70E-02 
GLUC Ssc.17225.1.S1_at 2.80E-01 3.50E-03 
GON1 Ssc.16310.1.S1_at 1.20E-01 4.00E-01 
HEPC Ssc.376.1.S1_at 3.40E-01 2.90E-01 
IAPP Ssc.8324.1.A1_at 6.60E-01 2.20E-01 
IGF1 Ssc.16231.1.S1_a_at 4.30E-01 3.50E-01 
  Ssc.16231.2.A1_a_at 5.80E-01 7.00E-01 
  Ssc.16231.3.S1_a_at 1.10E-01 6.30E-02 
IGF2 Ssc.9365.1.S1_at 9.00E-01 1.70E-01 
  Ssc.9365.2.S1_a_at 1.80E-01 2.50E-02 
  Ssc.9365.3.S1_a_at 4.80E-01 2.80E-02 
  Ssc.9365.3.S1_x_at 4.70E-02 6.50E-03 
  Ssc.9365.4.S1_a_at 8.70E-02 5.00E-01 
  Ssc.9365.5.A1_at 4.70E-02 4.40E-01 
  Ssc.9365.5.S1_at 8.60E-02 3.60E-01 
  Ssc.9365.5.S1_a_at 9.50E-02 2.00E-02 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Gut 
GSE13457 GSE15256 
  Ssc.9365.6.A1_a_at 5.50E-02 7.10E-01 
  Ssc.9365.6.A1_x_at 5.40E-01 2.80E-01 
  Ssc.9365.6.S1_x_at 1.40E-01 5.30E-03 
  Ssc.9365.7.A1_x_at 9.20E-02 1.90E-01 
INS Ssc.583.1.S1_at 3.80E-02 1.00E-01 
INSL3 Ssc.11990.1.S1_at 8.10E-02 7.20E-01 
MCH Ssc.3287.1.S1_at 6.10E-01 2.00E-01 
MOTI Ssc.714.1.S1_at 6.60E-01 5.20E-01 
NEU1 Ssc.15668.1.A1_at 4.30E-02 2.40E-01 
NEU2 Ssc.4210.1.S1_at 4.20E-02 7.20E-01 
NMB Ssc.2083.1.A1_at 1.20E-01 3.30E-01 
NMU Ssc.12508.1.A1_at 7.40E-01 8.70E-01 
NPW Ssc.15796.1.S1_at 5.60E-02 4.40E-01 
NPY Ssc.15981.1.A1_at 6.20E-02 3.00E-01 
  Ssc.15981.1.S1_at 7.20E-02 2.20E-01 
OREX Ssc.15983.1.S1_at 5.70E-01 3.60E-01 
PACA Ssc.27598.1.S1_at 9.30E-02 1.00E-01 
PAHO Ssc.456.1.S1_at 1.70E-01 3.70E-01 
PCSK1 Ssc.17429.1.S1_at 8.10E-01 1.10E-02 
PDGFA Ssc.6173.3.S1_a_at 6.90E-01 7.80E-07 
PDYN Ssc.121.1.S1_at 3.40E-01 1.40E-01 
PENK Ssc.11281.1.A1_at 2.80E-01 1.80E-08 
  Ssc.11281.2.S1_at 3.40E-02 3.00E-01 
PNOC Ssc.15910.1.A1_at 9.00E-01 5.00E-01 
  Ssc.15910.1.S1_at 8.30E-01 1.60E-01 
PTHR Ssc.9991.1.S1_at 3.60E-01 1.60E-01 
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Supplementary Table S2. (cont.) 
Symbol Affy Probe ID 
Gut 
GSE13457 GSE15256 
PTHY Ssc.668.1.S1_at 9.40E-01 1.90E-01 
REL1 Ssc.162.1.S1_at 2.00E-01 8.50E-01 
SCG1 Ssc.15718.1.A1_at 9.00E-01 4.60E-09 
SCG2 Ssc.13645.1.A1_at 7.90E-01 6.60E-06 
SCG3 Ssc.6770.1.A1_at 4.10E-01 1.20E-01 
SECR Ssc.710.1.S1_at 4.80E-01 1.20E-01 
SMS Ssc.19520.1.A1_at 7.30E-01 2.90E-01 
TKN1 Ssc.18075.1.A1_at 5.40E-01 5.20E-01 
  Ssc.18075.2.S1_at 5.20E-02 5.10E-01 
TKN4 Ssc.23153.1.S1_at 7.70E-01 7.00E-02 
TKNK Ssc.19565.1.S1_at 8.70E-01 6.20E-01 
  Ssc.19565.2.A1_at 6.80E-01 1.80E-01 
UTS2 Ssc.437.1.S1_a_at 1.40E-01 4.60E-01 
VEGFC Ssc.12790.1.A1_at 5.10E-01 3.70E-03 
VEGFD Ssc.29289.1.A1_at 6.40E-02 6.70E-01 
Prohormone Convertase 
PCSK1 Ssc.141.1.S1_at   3.40E-01 6.50E-07 
PCSK2 Ssc.109.1.S1_at 7.40E-01 5.40E-01 
PCSK7 Ssc.5628.1.S1_at 8.40E-01 1.20E-03 
Total P-value in Column <0.005  0 11 
Totals by Group   11 
Total for all Groups 116   
1Experiment Class 
2Experiment Identification 
 
